
<html lang="en"     class="pb-page"  data-request-id="71aa75d1-0629-4ccb-ab0f-2a9e43da5b5e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b01514"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads" /></meta><meta name="dc.Creator" content="Ye  Ding" /></meta><meta name="dc.Creator" content="Dengfeng  Li" /></meta><meta name="dc.Creator" content="Chunyong  Ding" /></meta><meta name="dc.Creator" content="Pingyuan  Wang" /></meta><meta name="dc.Creator" content="Zhiqing  Liu" /></meta><meta name="dc.Creator" content="Eric A.  Wold" /></meta><meta name="dc.Creator" content="Na  Ye" /></meta><meta name="dc.Creator" content="Haiying  Chen" /></meta><meta name="dc.Creator" content="Mark A.  White" /></meta><meta name="dc.Creator" content="Qiang  Shen" /></meta><meta name="dc.Creator" content="Jia  Zhou" /></meta><meta name="dc.Description" content="Covalent drug discovery has undergone a resurgence in recent years due to comprehensive optimization of the structure–activity relationship (SAR) and the structure–reactivity relationship (SRR) for..." /></meta><meta name="Description" content="Covalent drug discovery has undergone a resurgence in recent years due to comprehensive optimization of the structure–activity relationship (SAR) and the structure–reactivity relationship (SRR) for..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 12, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01514" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01514" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01514" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01514" /></link>
        
    
    

<title>Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01514" /></meta><meta property="og:title" content="Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0014.jpeg" /></meta><meta property="og:description" content="Covalent drug discovery has undergone a resurgence in recent years due to comprehensive optimization of the structure–activity relationship (SAR) and the structure–reactivity relationship (SRR) for covalent drug candidates. The natural product oridonin maintains an impressive pharmacological profile through its covalent enone warhead on the D-ring and has attracted substantial SAR studies to characterize its potential in the development of new molecular entities for the treatment of various human cancers and inflammation. Herein, for the first time, we report the excessive reactivity of this covalent warhead and mediation of the covalent binding capability through a Rh2(esp)2-catalyzed mild and concise regio- and stereospecific aziridination approach. Importantly, aziridonin 44 (YD0514), with a more-druglike irreversible covalent warhead, has been identified to significantly induce apoptosis and inhibit colony formation against triple-negative breast cancer with enhanced antitumor effects in vitro and in vivo while displaying lower toxicity to normal human mammary epithelial cells in comparison to oridonin." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01514"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01514">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01514&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01514&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01514&amp;href=/doi/10.1021/acs.jmedchem.7b01514" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2737-2752</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01312" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01570" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ye Ding</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ye Ding</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ye++Ding">Ye Ding</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dengfeng Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dengfeng Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States</div><div class="loa-info-affiliations-info">Department of Thyroid and Breast, Division of General Surgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dengfeng++Li">Dengfeng Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chunyong Ding</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunyong Ding</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunyong++Ding">Chunyong Ding</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pingyuan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pingyuan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pingyuan++Wang">Pingyuan Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiqing Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiqing Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqing++Liu">Zhiqing Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric A. Wold</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric A. Wold</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric+A.++Wold">Eric A. Wold</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6434-7562" title="Orcid link">http://orcid.org/0000-0001-6434-7562</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Na Ye</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Na Ye</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Na++Ye">Na Ye</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haiying Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haiying Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haiying++Chen">Haiying Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark A. White</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark A. White</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++White">Mark A. White</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiang Shen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiang Shen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Q.S. e-mail: <a href="/cdn-cgi/l/email-protection#0475776c616a446960656a606176776b6a2a6b7663"><span class="__cf_email__" data-cfemail="0273716a676c426f66636c666770716d6c2c6d7065">[email protected]</span></a>; phone: (713) 834-6357; fax: (713) 834-6350.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiang++Shen">Qiang Shen</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jia Zhou</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><span class="conrtib-corresp"><strong>*</strong>J.Z. e-mail: <a href="/cdn-cgi/l/email-protection#81ebe8fbe9eef4c1f4f5ece3afe4e5f4"><span class="__cf_email__" data-cfemail="a5cfccdfcdcad0e5d0d1c8c78bc0c1d0">[email protected]</span></a>; phone: (409) 772-9748; fax: (409) 772-9818.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Zhou">Jia Zhou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01514&amp;href=/doi/10.1021%2Facs.jmedchem.7b01514" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2737–2752</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 October 2017</li><li><span class="item_label"><b>Published</b> online</span>12 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01514" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01514</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2737%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYe%2BDing%252C%2BDengfeng%2BLi%252C%2BChunyong%2BDing%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D7%26contentID%3Dacs.jmedchem.7b01514%26title%3DRegio-%2Band%2BStereospecific%2BSynthesis%2Bof%2BOridonin%2BD-Ring%2BAziridinated%2BAnalogues%2Bfor%2Bthe%2BTreatment%2Bof%2BTriple-Negative%2BBreast%2BCancer%2Bvia%2BMediated%2BIrreversible%2BCovalent%2BWarheads%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2752%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01514"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1953</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01514" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ye&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Dengfeng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Chunyong&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Pingyuan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhiqing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;A. Wold&quot;},{&quot;first_name&quot;:&quot;Na&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Haiying&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. White&quot;},{&quot;first_name&quot;:&quot;Qiang&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Zhou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2737-2752&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01514&quot;},&quot;abstract&quot;:&quot;Covalent drug discovery has undergone a resurgence in recent years due to comprehensive optimization of the structure–activity relationship (SAR) and the structure–reactivity relationship (SRR) for covalent drug candidates. The natural product oridonin maintains an impressive pharmacological profile through its covalent enone warhead on the D-ring and has attracted substantial SAR studies to characterize its potential in the development of new molecular entities for the treatment of various human cancers and inflammation. Herein, for the first time, we report the excessive reactivity of this covalent warhead and mediation of the covalent binding capability through a Rh2(esp)2-catalyzed mild and concise regio- and stereospecific aziridination approach. Importantly, aziridonin 44 (YD0514), with a more-druglike irreversible covalent warhead, has been identified to significantly induce apoptosis and inhibit colony formation against triple-negative breast cancer with enhanced antitumor effects in vitro and in vivo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01514&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01514" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01514&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01514" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01514&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01514" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01514&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01514&amp;href=/doi/10.1021/acs.jmedchem.7b01514" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01514" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01514" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01514%26sid%3Dliteratum%253Aachs%26pmid%3D29528645%26genre%3Darticle%26aulast%3DDing%26date%3D2018%26atitle%3DRegio-%2Band%2BStereospecific%2BSynthesis%2Bof%2BOridonin%2BD-Ring%2BAziridinated%2BAnalogues%2Bfor%2Bthe%2BTreatment%2Bof%2BTriple-Negative%2BBreast%2BCancer%2Bvia%2BMediated%2BIrreversible%2BCovalent%2BWarheads%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D7%26spage%3D2737%26epage%3D2752%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292193" title="Aziridines">Aziridines</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291452" title="Reactivity">Reactivity</a>,</li><li><a href="/action/doSearch?ConceptID=291258" title="Enones">Enones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/jmcmar.2018.61.issue-7/20180412/jmcmar.2018.61.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Covalent drug discovery has undergone a resurgence in recent years due to comprehensive optimization of the structure–activity relationship (SAR) and the structure–reactivity relationship (SRR) for covalent drug candidates. The natural product oridonin maintains an impressive pharmacological profile through its covalent enone warhead on the D-ring and has attracted substantial SAR studies to characterize its potential in the development of new molecular entities for the treatment of various human cancers and inflammation. Herein, for the first time, we report the excessive reactivity of this covalent warhead and mediation of the covalent binding capability through a Rh<sub>2</sub>(esp)<sub>2</sub>-catalyzed mild and concise regio- and stereospecific aziridination approach. Importantly, aziridonin <b>44</b> (YD0514), with a more-druglike irreversible covalent warhead, has been identified to significantly induce apoptosis and inhibit colony formation against triple-negative breast cancer with enhanced antitumor effects in vitro and in vivo while displaying lower toxicity to normal human mammary epithelial cells in comparison to oridonin.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Covalent drugs can possess exceptionally high potency, ligand efficiency, and long-lasting effects given that they directly react with targets to form covalent bonds and thereby generate corresponding bioactivities. Throughout the history of modern medicine, covalent drugs have been profoundly successful therapies for a wide array of human diseases. For example, from 1982–2009, 39 covalent drugs had been approved by the FDA, with the majority having been approved before the year 2000.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, due to potential toxicities and safety risks, electrophiles have been considered undruglike and were virtually nonexistent in modern target-specific drug discovery and development for many years.</div><div class="NLM_p">Recently, the notion of exploring new generations of covalent drugs has resurged with the advent of targeted covalent inhibitors, promising a positive benefit-to-risk ratio.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> The electrophilic Michael acceptor enamides and ynamides (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <b>1</b>–<b>5</b>) are frequently utilized as covalent warheads in the design of novel synthetic kinase inhibitors to enhance the biological efficacy, extend the duration of action, and overcome drug resistance.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8">(4−8)</a> The successful comeback of covalent drugs is partially ascribed to the optimal mix of structure–activity relationship (SAR) of entire molecules and structure–reactivity relationship (SRR) of attached electrophiles, aiming to acquire the most-suitable candidates.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> An additional support for covalent drug discovery is the broadly applied, simple, and efficient methodology for determining the SRR by the assessment of the reaction rate between covalent warheads and a biologically relevant substrate glutathione (GSH) in vitro.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9−13)</a> An optimal balance of warhead reactivity is necessary because the excess reactivity of covalent warheads may hinder the overall selectivity and safety of drugs, while reduced reactivity may lead to failed covalent binding to the target protein to produce the corresponding effect.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Representative molecules bearing covalent warheads enamide and ynamide (highlighted in red). (B) Representative molecules with covalent warheads epoxide and aziridine (highlighted in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the above-mentioned covalent synthetic drugs, covalent natural products from aspirin found in 1899 to the sesquiterpenoid artemisinin have revolutionized medicine and have been an invaluable inspiration for the development of various therapeutic agents.<a onclick="showRef(event, 'ref1 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref1 ref14 ref15">(1,14,15)</a> In the kingdom of covalent natural products and derivatives, the enone, ethylene oxide, and aziridine groups are three representative classes of warheads (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <b>6</b>–<b>12</b>), all of which can react with nucleophilic groups of target proteins, such as the thiol of cysteine residues, and share a similar reaction mechanism to form covalent bonds.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a></div><div class="NLM_p">Besides these examples depicted in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, another covalent natural product, the kaurane-type diterpenoid oridonin (<b>13</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), has attracted increased attention in recent years due to its high natural abundance, historic application in traditional herbal medicine (available over the counter as “Donglingcao Pian”), and impressive anti-inflammation and anticancer pharmacological activities.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Thus, oridonin as a single drug ingredient is currently undergoing a clinical observational study in China (ChiCTR-OOB-16007883; <a href="http://www.chictr.org.cn/enIndex.aspx" class="extLink">http://www.chictr.org.cn/enIndex.aspx</a>). Over the past decade, several independent research groups, including our team, have utilized oridonin as a chemical lead for the design and synthesis of novel oridonin derivatives, with these studies resulting in pivotal SAR information.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Briefly, modifications on the A-ring, the C-14 position (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 1, highlighted in blue), appear to be tolerable for improving the biological efficacy and druglike profiles of oridonin. The enone system in D-ring (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 1, highlighted in red), as a classical covalent warhead, was identified to be a requisite Michael acceptor for biological activities,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and removal of this enone system generally resulted in a dramatic loss of activity.<a onclick="showRef(event, 'ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref23">(21,23)</a> Importantly, among the bioactive oridonin derivatives depicted in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <b>14</b> was advanced into a phase-I human clinical trial for the treatment of leukemia in 2015 (CTR20150246; <a href="http://www.chinadrugtrials.org.cn" class="extLink">www.chinadrugtrials.org.cn</a>), while all of the others in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> are currently in preclinical development.<a onclick="showRef(event, 'ref24 ref26 ref27 ref28 ref30 ref32 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref24 ref26 ref27 ref28 ref30 ref32 ref34 ref35">()</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of the Preclinical and Clinical Development of Oridonin-like Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0011.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p last">Inspired by recent advances of both synthetic and natural product covalent drugs, our approach reported here was guided by the idea that the exploring the SRR information on the covalent enone warhead in the D-ring is additionally beneficial to the further optimization for the biological activities, safety, and other druglike properties of oridonin. To our knowledge, this is the first attempt to measure the reactivity of the electrophile enone in D-ring with GSH. Based on our SRR, favorable and druglike covalent groups have been designed and incorporated to replace the overly reactive enone in the D-ring through a mild and concise homogeneous Rh<sub>2</sub>(esp)<sub>2</sub>-catalyzed direct aziridination in a regio- and stereospecific manner. As a continuation of our previous effort in the identification of novel oridonin analogues with the bioactive functionalities diversely installed in the A-ring, herein, we describe the discovery of a new analog (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11′<i>S</i>,11a′<i>S</i>)-1-acryloyl-7′,11′-dihydroxy-5′,5′,8′,8′-tetramethyldecahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6<i>a</i>,11<i>a</i>](epoxymethano)[3,3<i>a</i><sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxin]-14′-one (aziridonin <b>44</b>, YD0514) with a more-druglike irreversible covalent warhead capable of significantly inducing apoptosis and inhibiting colony formation against triple-negative breast cancer with comparable enhanced antitumor effects in vitro and in vivo while displaying lower toxicity to normal human mammary epithelial cells in comparison to oridonin.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Activity and Reactivity of the Covalent Enone Warhead in the D-Ring</h3><div class="NLM_p">GSH is viewed as a major reducing small molecule participating in cellular redox reactions with reactive oxygen and nitrogen species (ROS/RNS) and maintaining intracellular redox balance. Accumulating evidence indicates that treatment with oridonin could decrease the intracellular GSH concentration, resulting in the increase of ROS and ROS-induced apoptosis in cancer cell lines.<a onclick="showRef(event, 'ref25 ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref25 ref36 ref37 ref38 ref39">(25,36−39)</a> The enone fragment in the D-ring of oridonin has been identified as a classical covalent warhead Michael acceptor, which reacts with various thiol groups and residues of small molecules (e.g., GSH) and target proteins (e.g., thioredoxin reductase) to afford irreversible inhibition.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A similar mechanism was revealed in the studies of oridonin-like kaurane diterpenoids.<a onclick="showRef(event, 'ref22 ref40'); return false;" href="javascript:void(0);" class="ref ref22 ref40">(22,40)</a> Interestingly, the reduction of this enone by Pd/C-catalyzed hydrogenation significantly decreases antiproliferation effects.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Thus, the efficacy of oridonin is believed to largely depend on this D-ring enone pharmacophore by Michael addition with GSH and other protein targets.</div><div class="NLM_p">Given that systematic studies on the reactivities of various covalent groups with GSH and the corresponding SRR are useful for the development of novel covalent kinase inhibitors, we utilized nuclear magnetic resonance (NMR) spectroscopy to determine the experimental GSH reaction rates of oridonin and its C-14 position derivatives <b>14</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and <b>20</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The oridonin-like substrates were incubated at 37 °C with 1.5–2 equiv of GSH in 0.5 mL of DMSO-<i>d</i><sup>6</sup> and 0.05 mL of sodium phosphate deuterium oxide buffer (pH 7.4). The samples were measured by <sup>1</sup>H NMR spectrum at time points of 1st, 5th, and 10th min, respectively, for quantitatively describing the reactivities of the enones presented in these substrates with GSH. The reaction half-life (<i>t</i><sub>1/2</sub>) of oridonin with GSH was found to be markedly less than 1 min (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The resultant product was further validated with high-resolution mass spectrometry (HRMS), indicating that the transformation of oridonin to its adduct <b>19</b> was complete (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Figure S1</a>). Additionally, the alanine ester at the C-14 position (<b>14</b>) may enhance the enone’s reactivity (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Figure S2</a>). Introducing a sterically hindered acetonide group at the nearby C-7/C-14 positions (<b>20</b>) slightly weakens the reactivity of the enone; however, the <i>t</i><sub>1/2</sub> of the drug substrate is still less than 1 min (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Figure S3</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reactivity of oridonin with GSH determined by <sup>1</sup>H NMR analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Previous studies on the development of covalent inhibitors for epidermal growth factor receptor (EGFR) suggest that the suitable reactivity window of a covalent drug, in terms of <i>t</i><sub>1/2</sub>, is from 25 to 400 min.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The half-life of the covalent drug dimethyl fumarate (Tecfidera), an antimultiple sclerosis (MS) blockbuster approved by the FDA in 2013, was identified to be approximately 50–60 min with 2 equiv of GSH at pH 7.4.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> Additionally, the binding of the natural covalent drug bardoxolone methyl (<b>6</b>) with GSH was confirmed to be mild and reversible.<a onclick="showRef(event, 'ref16 ref42 ref44'); return false;" href="javascript:void(0);" class="ref ref16 ref42 ref44">(16,42,44)</a> In comparison to the reactivity window of these reference compounds, oridonin displays a notably short half-life to form adducts and possesses highly irreversible binding with GSH, thereby leading to potential off-target effects and safety concerns for preclinical and clinical development. In particular, we found that the efficacious dose of oridonin-like compounds was between 5 and 15 mg/kg (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) in vivo, while the median lethal dose (LD<sub>50</sub>) of oridonin was 37.5 mg/kg.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> A prodrug strategy, as utilized in human phase-I clinical trial candidate <b>14,</b> could decrease the toxicity of oridonin and remedy the safety concerns.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, for continued development and safety we believe structural optimization of the enone remains imperative. From a chemistry standpoint, excessive reactivity, to a large degree, is ascribed to the exocyclic double bond of enone in a densely functionalized chemical microenvironment near the D-ring. Hence, we envisioned that the replacement of the enone with a more-druglike covalent warhead could maintain the original anticancer efficacy while decreasing the covalent binding reactivity to a suitable half-life value. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, epoxide and aziridine groups are two feasible covalent warheads for the replacement of the enone. Furthermore, aziridines are milder than epoxides in chemical reactions and have better aqueous solubility. Inspired by the approved, aziridinated drug <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), the aziridine group was selected as a mild covalent warhead for our investigation on oridonin derivatives.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry for Aziridinated Oridonin Analogues</h3><div class="NLM_p">Aziridines, the smallest nitrogenous heterocycles, are important synthetic target structures and building blocks.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> Although several methodologies are available for the synthesis of aziridines from olefins, the development of an efficient and stereospecific aziridination with conjugated olefins remains a challenge.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Additionally, the oridonin skeleton is not stable for a relatively long time (hours) in strong acidic or basic media,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and therefore, our ideal aziridination should be performed in a mild and near-neutral condition. Recently, Jat et al. published a moderate and scalable aziridination of olefins, utilizing <i>O</i>-(2,4-dinitrophenyl)hydroxylamine (DPH) as the aminating agent and Du Bois’s catalyst Rh(esp)<sub>2</sub> at room temperature.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> However, the practical application of their new methodology was not extended to the aziridination of enone substrates. However, some researchers report that the aziridination of enones could be promoted by specific organic amine catalysts under basic conditions.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51−53)</a></div><div class="NLM_p">Given the chemical sensitivity of oridonin to strong acidic or basic conditions, our investigation began by subjecting mixtures of the representative oridonin-like substrates (<b>15</b> and <b>21</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) and DPH in the presence of 5% mol equivalent of various homogeneous rhodium catalysts at room temperature, referring to the method reported by Jat et al. The direct aziridination of <b>15</b> failed to proceed in our initial screening of rhodium catalysts. However, the transformation of its C-7 and C-14 acetonide–protected substrate <b>21</b> to the corresponding aziridine <b>22</b> as a sole regio-specific product could be efficiently promoted by Rh<sub>2</sub>(esp)<sub>2</sub> or Rh<sub>2</sub>(OAc)<sub>4</sub> under mild conditions (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entries 1–5). The equivalent amount of DPH was optimized from 2.2 to 1.5 for improving efficiency of the aminating agent and eliminating the serious dyeing effect (dark yellow) of DPH, further leading to a more scalable purification in a best yield of 66% (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entries 6–7). The structure of <b>22</b>, obtained under the reaction condition illustrated in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> (entry 7), was unambiguously determined by X-ray crystallographic analysis (CCDC no 1050339; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Table S3</a>), indicating that the carbon atom of <b>21</b> at the C-16 position was stereospecifically converted to the <i>R</i> stereo configuration. Interestingly, the olefin at the C1–C2 position of <b>21</b> or <b>22</b> could not be further aziridinated to compound <b>23</b>, even utilizing more aminating agent, higher temperature, or extended time (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entries 8–10). This selectivity of our aziridination may be owing to the steric hindrance of the oridonin skeleton, consequently inactivating the olefin at the A-ring. Hereafter, the deprotection of C1–C14 dihydroxyl of <b>22</b> with 5% HCl aqueous solution afforded compound <b>24</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Exploration and Optimization of Oridonin-Based Aziridination<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0012.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entries</th><th class="colsep0 rowsep0" align="center" char=".">DPH amount (equiv)</th><th class="colsep0 rowsep0" align="center">catalyst<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">temp/time</th><th class="colsep0 rowsep0" align="center">recovery of <b>21</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">yield of products<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">Rh<sub>2</sub>(esp)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">rt./12 h</td><td class="colsep0 rowsep0" align="left">trace</td><td class="colsep0 rowsep0" align="char" char=".">22 (69%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">Rh<sub>2</sub>(OAc)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">rt./12 h</td><td class="colsep0 rowsep0" align="left">trace</td><td class="colsep0 rowsep0" align="char" char=".">22 (58%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">Rh<sub>2</sub>(TPA)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">rt./12 h</td><td class="colsep0 rowsep0" align="left">>80%</td><td class="colsep0 rowsep0" align="char" char=".">22 (trace)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">Rh<sub>2</sub>(<i>R</i>-DOSP)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">rt./12 h</td><td class="colsep0 rowsep0" align="left">>80%</td><td class="colsep0 rowsep0" align="char" char=".">22 (NA)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">Rh<sub>2</sub>(<i>S</i>-DOSP)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">rt./12 h</td><td class="colsep0 rowsep0" align="left">>80%</td><td class="colsep0 rowsep0" align="char" char=".">22 (NA)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">Rh<sub>2</sub>(esp)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">rt./12 h</td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="char" char=".">22 (54%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="left">Rh<sub>2</sub>(esp)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">rt./12 h</td><td class="colsep0 rowsep0" align="left">5%</td><td class="colsep0 rowsep0" align="char" char=".">22 (66%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">8</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">4.4</td><td class="colsep0 rowsep0" rowspan="2" align="left">Rh<sub>2</sub>(esp)<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="left">rt./24 h</td><td class="colsep0 rowsep0" rowspan="2" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">22 (71%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">23 (NA)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">9</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">4.4</td><td class="colsep0 rowsep0" rowspan="2" align="left">Rh<sub>2</sub>(esp)<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="left">50 °C/24 h</td><td class="colsep0 rowsep0" rowspan="2" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">22 (66%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">23 (NA)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">10</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">4.4</td><td class="colsep0 rowsep0" rowspan="2" align="left">Rh<sub>2</sub>(esp)<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="left">reflux/48 h</td><td class="colsep0 rowsep0" rowspan="2" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">22 (56%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">23 (NA)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">All reaction conditions in this table were performed, utilizing <b>21</b> as the substrate.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The equivalent of catalyst is 5%.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">The data were based on isolated yields.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">NA: not available.</p></div></div></div><div class="NLM_p">To further explore the practicality and scope of this aziridination reaction, several diverse and bioactive oridonin derivatives, identified from our previous efforts (e.g., <b>16</b>, <b>20</b>, <b>26</b>, and <b>28</b>), were selected as representative substrates and successfully converted to the corresponding oridonin-like aziridines (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entries 1–4). However, the thiazole analogue <b>31</b> failed to be transformed, likely due to the catalyst poisoning by sulfur in the thiazole moiety. Interestingly, the small regular cyclic or exocyclic enones (e.g., <b>32</b> and <b>33</b>) also failed in the examination of the aziridination reaction (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entries 6–7).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Practical Extension of Rh-Catalyzed Aziridination</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0013.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The data were based on isolated yields.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">NR: no reaction.</p></div></div><div></div></div><div class="NLM_p">In the structural analysis of the reactive fragment (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, substructure of <b>21</b>) and the similar inactive substrate (<b>33</b>), we turned our attention to the possible critical role of the neighboring substituted oxygen (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, red) in the Rh<sub>2</sub>(esp)<sub>2</sub>-catalyzed regio- and stereospecific aziridination. The catalyst Rh<sub>2</sub>(esp)<sub>2</sub>, with large steric hindrance (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), captures “:NH” from DPH to afford triplet-spin-state nitrene intermediate <b>34</b>.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> We assumed that the electron density of <b>33</b>’s olefin is decreased by the α-site ketone, thereby inducing chemical inactivation, while the intermediate <b>34</b> charges the corresponding olefin (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). The neighboring substituted oxygen donates electron density to the olefin, leading to the reactivation of the olefin for aziridination. Meanwhile, this oxygen group anchors the “:NH” group of nitrene <b>34</b> at one side of the olefin via an intermolecular hydrogen bond, consequently leading to the regio- and stereospecific aziridination. Otherwise, the regio- and stereospecific properties of the aziridination may be alternatively ascribed to the interactions between the unique steric microenvironment of oridonin’s D-ring and nitrene intermediate <b>34</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plausible reaction mechanism for Rh<sub>2</sub>(esp)<sub>2</sub> catalyzed regio- and stereospecific aziridination of oridonin-like substrates. (A) Analysis of the reactive substructure and substrate participating in the aziridination. (B) The structures of Rh<sub>2</sub>(esp)<sub>2</sub>. (C, D) The comparison of two different substrates (C) <b>33</b> vs (D) <b>21</b>, assisted by the neighboring oxygen group participation in the Rh<sub>2</sub>(esp)<sub>2</sub>-promoted regio- and stereospecific aziridination.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To pursue diverse aziridine derivatives and highlight the application potential of our chemistry, the follow-up synthesis commenced with the preparation of oridonin aziridinated analogs with selected substrates, as mentioned above. The deprotection of C1–C14 dihydroxyl of <b>25</b>, <b>27</b>, <b>29</b>, or <b>30</b> with 5% HCl aqueous solution achieved the desired compounds <b>35</b>–<b>38</b>, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A). According to the previously established SAR, the fused thiazole moieties on A-ring could significantly enhance anticancer activities of oridonin (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 6). With the aim of further improving the anticancer profiles of oridonin aziridines, the representative target compound <b>43</b> was designed with an additional <i>N</i>-allyl substituted thiazole at the A-ring and synthesized from an aziridinated substrate <b>27</b> prior to the thiazole ring formation due to the aforementioned reason for aziridination failure of <b>31</b> directly (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 5). As depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B, protection of the secondary amine of aziridine <b>27</b> with Fmoc chloride in the presence of Na<sub>2</sub>CO<sub>3</sub> provided <b>39</b> in 34% yield. Treatment of <b>39</b> with 5% aqueous HCl readily resulted in the deprotected derivative <b>40</b> in 75% yield. Subsequently, compound <b>40</b> was brominated by PyHBr<sub>3</sub> in THF, followed by the Hantzsch reaction of <b>41</b>, with <i>N</i>-allylthiourea yielding the thiazole <b>42</b>. Finally, removal of the acetonide protection group with piperidine in DMF afforded the desired compound <b>43</b>. Moreover, the secondary amine of aziridine provides an additional site for further structural modifications or the formation of salts to improve the bioactivities and druglike properties such as aqueous solubility. As presented in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C, we could attach various functional fragments such as an additional enone to the aziridine ring leading to compound <b>44</b>, and a noncovalent propionyl moiety leading to <b>45</b> for comparison through different conventional mild reactions. Such mediated covalent warheads at the secondary amine may directly exert bioactivities independent of the aziridine ring and, alternatively, regulate the covalent bond formation reactivities of the aziridine ring indirectly.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Aziridinated Oridonin Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5% HCl (aq), MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 15 min, 28∼62%; (b) Fmoc chloride, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 0 °C → rt, 12 h, 34%; (c) 5% HCl (aq), MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 15 min, 75%; (d) PyHBr<sub>3</sub>, THF, 0 °C, 2 h, 82%; (e) <i>N</i>-allylthiourea, EtOH, reflux, 5 h, 44%; (f) piperidine, DMF, rt, 1 h, 82%; (g) acrylic acid, HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 12 h, 33%; (h) propionic acid, HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 12 h, 74%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Covalent Bond Formation Reactivity of the New Warheads</h3><div class="NLM_p">From our initial investigation of reactions between aziridines and thiol groups from the SciFinder database, we found that the representative compound 2-aziridinecarboxylic acid, which is similar to the reactive fragments of our aziridinated oridonin analogs, could react with the thiol of cysteine in buffer at room temperature for 20 h in high yield (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Figure S4</a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a>To determine the experimental GSH reaction rates of aziridinated oridonin analogs, compound <b>25</b> was incubated at 37 °C with 1.5–2 equiv of GSH in 0.5 mL of <i>d</i><sup>6</sup>-DMSO and 0.05 mL of sodium phosphate deuterium oxide buffer (pH 7.4). The sample was analyzed by <sup>1</sup>H NMR at 11 time points (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) and indicated that the reactivity of the covalent warhead aziridine in the D-ring is much more moderate than the enone at the same position. Based on the integrated area of <sup>1</sup>H NMR peak d generated from the reaction, <i>t</i><sub>1/2</sub> was identified as approximately 4–6 h. Additionally, the adduct product was also validated by HRMS analysis of the reaction at 5 h, indicating the dominant component of the sample as the adduct <b>46</b>. Meanwhile, the signals of starting materials GSH and aziridine <b>25</b> were obviously observed in such analysis, suggesting that aziridinated oridonin analogs are much more stable compared to oridonin with exposure to GSH (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Figure S5</a>). Moreover, compound <b>25</b> with the aziridination of the D-ring enone has higher microsomal and plasma stability compared to oridonin in vitro (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Table S2 and Figure S9</a>), indicating that the D-ring aziridine is a druglike pharmacophore as well as an available site of modification for improving pharmacokinetics profiles.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reactivity of aziridinated oridonin analogue <b>25</b> with GSH determined by <sup>1</sup>H NMR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Under the same conditions, the acrylamide analogue <b>44</b> possesses a more reactive warhead in comparison to the aziridinated oridonin <b>25</b>. Based on the integrated area of a <sup>1</sup>H NMR peak disappearing during the reaction, the half-life is identified from 30 to 60 min (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Similarly, the adduct product <b>47</b> was validated by HRMS analysis after the reaction at 1 h (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Figure S7</a>). In conclusion, the aziridine or acrylamide aziridine attached to the D-ring of oridonin are milder covalent warheads with suitable reactivity in terms of the half-life values, which are in line with the reactivity window (25∼400 min)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> suggested for covalent drugs.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Reactivity of aziridinated oridonin analogue <b>44</b> with GSH determined by <sup>1</sup>H NMR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Biological Activities against Breast Cancer Cell Lines</h3><div class="NLM_p">The growth inhibitory effects of these newly synthesized oridonin aziridinated derivatives were initially evaluated in two breast cancer cell lines, MCF-7 (ER-positive) and MDA-MB-231 (ER-negative and triple-negative) using MTT assays as described in the in vitro screening protocol (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental section">Experimental section</a>). The ability of these new analogs to inhibit the growth of cancer cells was summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">Table S1</a> and compared to oridonin. Given that the original enone warhead in the D-ring is a critical pharmacophore, it is not surprising that the overall antiproliferative effects of these aziridinated oridonin molecules are overall lower than those lead compounds we previously reported.<a onclick="showRef(event, 'ref31 ref33 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref31 ref33 ref55 ref56">(31,33,55,56)</a> However, several aziridinated oridonin derivatives such as <b>42</b> and <b>43</b> displayed moderate activities. Compound <b>44</b> exhibited significantly improved antiproliferative effects against highly invasive triple-negative breast cancer MDA-MB-231 cells and MCF-7 cells with IC<sub>50</sub> values of 8.32 and 9.39 μM, respectively, in comparison with oridonin (IC<sub>50</sub> values of 29.4 μM and 6.72 μM against corresponding cell lines). Interestingly, replacement of the covalent warhead enamide of <b>44</b> with a noncovalent propionyl moiety (compound <b>45</b>) resulted in a complete loss of activity, indicating the important presence of the covalent warhead for biological activity. Next, aziridinated oridonin analogue <b>44</b> was selected for the colony formation assay and was found to significantly inhibit the colony formation of highly invasive triple-negative breast cancer cells MDA-MB-231, SK-BR3, and MDA-MB-468 and also the ER-positive breast cancer cells MCF-7 at low micromolar concentrations of the compound (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, <b>44</b> also suppressed the proliferation of MDA-MB-231, SK-BR3, MDA-MB-468, and MCF-7 breast cancer cells in a dose-dependent manner.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Growth inhibitory effects of <b>44</b> against MDA-MB-231, SK-BR3, MDA-MB-468, and MCF-7 breast cancer cells. (A) <b>44</b> significantly inhibits colony formation of MDA-MB-231, SK-BR3, MDA-MB-468, and MCF-7 cells. (B) <b>44</b> suppresses the proliferation of MDA-MB-231, SK-BR3, MDA-MB-468, and MCF-7 cells. Data are presented as the mean ± SD of at least three independent experiments. Significance between different groups was determined by using one-way ANOVA; <i>p</i> = 0.0003 (MDA-MB-231), <i>p</i> = 0.0002 (MDA-MB-468), <i>p</i> < 0.0001 (SK-BR3), and <i>p</i> = 0.0012 (MCF-7).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on its antiproliferative effects shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, further preliminary mechanistic studies of <b>44</b> were explored to determine whether <b>44</b> can induce apoptosis of breast cancer cells. MDA-MB-231 cells were treated with <b>44</b> at varying concentrations (1, 5, 10, 15, or 20 μM) for 48 h and stained with FITC-Annexin V and propidium iodide (PI). The percentages of apoptotic MDA-MB-231 cells were determined by flow cytometry. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B, <b>44</b> can induce apoptosis in breast cancer cells at 10 μM (18.2%), 15 μM (26.8%), and 20 μM (47.6%) concentrations at 48 h (early and late apoptosis together) dose-dependently compared to vehicle control. Apparently, <b>44</b> induces apoptosis of MDA-MB-231 cells, which at least in part contributes to its antiproliferative effects. Previous studies have demonstrated that oridonin induces apoptosis of cancer cells by regulating a series of transcription factors and protein kinases as well as pro- and anti-apoptotic proteins such as NF-κB<a onclick="showRef(event, 'ref37 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref37 ref57 ref58">(37,57,58)</a> and Bcl-2.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> To elucidate the potential mechanisms contributing to apoptosis induction by <b>44</b>, expression levels of several proteins related to apoptosis were determined by Western blotting. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C, treatment of MDA-MB-231 cells with <b>44</b> dose-dependently led to the down-regulation of NF-κB (p65) protein and up-regulation of cleaved PARP, with the latter as an apoptosis marker. In addition, <b>44</b> also reduced the ratio of Bcl-2 to Bax, which are important apoptotic marker proteins. These results suggest that <b>44</b> is capable of inducing apoptosis to decrease cellular proliferation. The parental chemotype, oridonin, has been reported to inhibit tumor cell proliferation and induce cancer cell death through cell cycle arrest,<a onclick="showRef(event, 'ref58 ref59 ref61'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref61">(58,59,61)</a> autophagy,<a onclick="showRef(event, 'ref37 ref57 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref37 ref57 ref62 ref63">(37,57,62,63)</a> and necrosis.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Therefore, more-extensive mechanistic studies in terms of major drug targets and signaling pathways associated with <b>44</b> are under investigation, and the results will be reported in due course.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Induction of apoptosis in MDA-MB-231 breast cancer cells by <b>44</b>. (A) Flow-cytometry analysis of apoptotic MDA-MB-231 breast cancer cells induced by <b>44</b> at different concentrations. (B) Apoptotic ratio of different concentrations of <b>44</b> in MDA-MB-231 breast cancer cells. The values are means ± SD of at least three independent experiments. A single asterisk represents <i>p</i> < 0.05, two asterisks represent <i>p</i> < 0.01, and three asterisks represent <i>p</i> < 0.001 to 0 μM group (DMSO, vehicle control). (C) Western-blot analysis of biomarkers for apoptosis induced by <b>44</b> in MDA-MB-231 breast cancer cells at different concentrations (48 h).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Growth Inhibition on Normal Mammary Epithelial Cells</h3><div class="NLM_p">Selective toxicity for cancer, but not normal cells, is essential in the development of targeted cancer experimental therapeutics. To investigate whether the improved antiproliferative effects of <b>44</b> against breast cancer cells were attributed to undesired cell toxicities, we further examined its inhibitory effects on the growth of normal mammary epithelial cells MCF-10A. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <b>44</b> exhibited comparable (0–10 μM) or significantly lower (15∼100 μM) growth-inhibitory activity against MCF-10A cells at all tested concentrations while displaying significantly enhanced anticancer activities against triple-negative MDA-MB-231 cancer cells in comparison to oridonin. These results provide a proof of concept that designing novel covalent warheads in the D-ring of oridonin could be beneficial in lead optimization for improved biological activities, safety, and other druglike properties.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>44</b> and oridonin on normal mammary epithelial cells (MCF-10A) proliferation. MCF-10A cells were treated with varying concentrations of <b>44</b> and oridonin for 48 h. Values are mean ± SD of three independent experiments. Statistical significance was determined using a Student <i>t</i>-test, in comparison to the corresponding value of oridonin treatment at the same concentration. ns indicates not significant, a single asterisk indicates <i>p</i> < 0.05, triple asterisks indicate <i>p</i> < 0.001, and quadruple asterisks indicate <i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Growth Suppression of <b>44</b> on Triple-Negative Breast Cancer Xenografts in Mice</h3><div class="NLM_p">Compound <b>44</b> was further evaluated for its suppression of tumor growth in the triple-negative breast cancer MDA-MB-231 xenograft model. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, mice treated with 10 and 15 mg/kg of <b>44</b> (intraperitoneal) showed a significant inhibitory effect on tumor growth compared to the mice treated with vehicle. The dose of 15 mg/kg group with the treatment of <b>44</b> showed a better inhibitory effect than the oridonin group (one-way ANOVA, <i>p</i> = 0.0023), while both <b>44</b> and oridonin displayed a comparable efficacy at 10 mg/kg. These findings suggest that <b>44</b> is a potential anticancer drug candidate with effective antitumor activity and better druglike properties for further preclinical development.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In vivo efficacy of <b>44</b> in suppressing the xenograft tumor growth of triple-negative breast cancer. The breast cancer cell line MDA-MB-231 was used to generate xenograft tumors in nude mice for 10 and 15 mg/kg doses via intraperitoneal injection, respectively. Data are presented as the mean ± SEM of tumor volume at each time point. Significance between different groups was determined by using one-way ANOVA; <i>p</i> = 0.0023.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">From incidental discovery to rational design, the SRR of warheads has been recognized as a critical index in the development of covalent drugs. For the first time, SRR studies on the natural product oridonin have been implemented by <sup>1</sup>H NMR and HRMS analyses monitoring its reaction with GSH and determining its D-ring electrophile enone reactivity. To explore more-druglike oridonin derivatives with optimized covalent warheads, we utilized a mild and efficient Rh<sub>2</sub>(esp)<sub>2</sub>-catalyzed reaction to regio- and stereospecifically construct new aziridinated oridonin analogues, replacing the overly reactive enone at the same site on D-ring. For the synthetic chemistry approach, this Rh<sub>2</sub>(esp)<sub>2</sub> promoted reaction may undergo the neighboring oxygen group participation. Moreover, the reaction methodology was demonstrated to be feasible for the aziridination of various oridonin-like substrates. Furthermore, the reactivities of the representative aziridinated oridonin derivatives <b>25</b> and <b>44</b> have been successfully mediated to be much milder than oridonin. The initial GSH <i>t</i><sub>1/2</sub> values of oridonin, <b>25</b> and <b>44</b> are classified to be <1 min (excessively active), 240–360 min (relatively inactive) and 30–60 min (druglike), respectively, indicating that new aziridinated analogues have more-suitable druglike properties, in line with the referenced reactivity window of covalent drugs. Accordingly, aziridonin <b>44</b> has demonstrated significantly enhanced apoptosis induction and colony formation inhibition against triple-negative breast cancer in vitro and in vivo with lower toxicity to normal human mammary epithelial cells in comparison to oridonin. Taken together, our findings support that optimization of diverse bioactive functionalities at the A-ring, while moderation of the covalent warhead reactivities at the D-ring may be a viable approach to the discovery and development of effective and druglike oridonin derivatives in the future.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General</h3><div class="NLM_p">All commercially available starting materials and solvents were reagent grade and used without further purification. Reactions were performed under a nitrogen atmosphere in dry glassware with magnetic stirring. Preparative column chromatography was performed using silica gel 60 and a particle size of 0.063–0.200 mm (70–230 mesh, flash). Analytical TLC was carried out employing silica gel 60 F254 plates (Merck, Darmstadt, Germany). Visualization of the developed chromatograms was performed with detection by UV (254 nm). NMR spectra were recorded on a Bruker-600 (<sup>1</sup>H, 300 MHz; <sup>13</sup>C, 75 MHz) spectrometer. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with TMS as an internal reference. Chemical shifts down-field from TMS were expressed in parts per million, and <i>J</i> values were given in hertz. High-resolution mass spectra (HRMS) were obtained from Thermo Fisher LTQ Orbitrap Elite mass spectrometer. Parameters include the following: nano ESI spray voltage was 1.8 kV, capillary temperature was 275 °C, and the resolution was 60 000; ionization was achieved by positive mode. Melting points were measured on a Thermo Scientific Electrothermal digital melting point apparatus and uncorrected. Purity of final compounds was determined by analytical HPLC, which was carried out on a Shimadzu HPLC system (model: CBM-20A LC-20AD SPD-20A UV–vis). HPLC analysis conditions: Waters μBondapak C18 (300 mm × 3.9 mm), flow rate 0.5 mL/min, and UV detection at 270 and 254 nm, linear gradient from 10% acetonitrile in water (0.1% TFA) to 100% acetonitrile (0.1% TFA) in 20 min, followed by 30 min of the last-named solvent. All biologically evaluated compounds are >95% pure.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11a′<i>R</i>)-7′-Hydroxy-5′,5′,8′,8′-tetramethyl-1′,3′,3a′,7′,7a′,8′,9′,11b′-octahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6a,11a](epoxymethano)[3,3a1]ethanophenanthro[1,10-<i>de</i>][1,3]dioxin]-14′-one (<b>22</b>)</h4><div class="NLM_p last">To a suspension of <b>21</b><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> (28.2 mg, 0.07 mmol) in CF<sub>3</sub>CH<sub>2</sub>OH (0.7 mL) was added Rh<sub>2</sub>(esp)<sub>2</sub> (1.1 mg) and DPH (17.5 mg, 0.09 mmol) at room temperature. The resulting mixture was stirred at room temperature for 24 h. Next, the solvent was removed under reduced pressure, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The organic layer was washed with water (20 mL) and saturated brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give an oily residue. The residue was purified using silica gel column; elution with 50% EtOAc in hexanes afforded the desired product <b>22</b> (21.6 mg, 74%) as a yellowish amorphous solid; [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −72.4 (<i>c</i> 0.20, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 5.81 (m, 1H), 5.24 (m, 1H), 5.11 (d, <i>J</i> = 11.7 Hz, 1H), 4.97 (d, <i>J</i> = 1.8 Hz, 1H), 4.07–3.79 (m, 3H), 2.47–2.34 (m, 1H), 2.24 (d, <i>J</i> = 9.2 Hz, 2H), 2.04–1.72 (m, 6H), 1.69 (s, 3H), 1.64 (d, <i>J</i> = 6.2 Hz, 3H), 1.41 (s, 3H), 1.18 (s, 3H), 1.07 (s, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 216.8, 130.4, 124.1, 101.4, 95.2, 72.0, 70.9, 65.0, 58.1, 56.6, 48.9, 48.7, 41.1, 38.5, 38.0, 32.3, 31.9, 31.1, 30.3, 26.5, 25.4, 22.1, 17.2; HRMS (ESI): [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>32</sub>NO<sub>5</sub>, 402.2280; found, 402.2268. The stereochemistry of <b>22</b> was secured by X-ray crystallographic analysis. The data have been assigned at the Cambridge Crystallographic Data Centre to the deposition number CCDC 1050339.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (2<i>R</i>,5′<i>S</i>,6′<i>S</i>,6a′<i>R</i>,9′<i>S</i>,11b′<i>R</i>,14′<i>R</i>)-5′,6′,14′-Trihydroxy-4′,4′-dimethyl-4′,4a′,5′,6′,9′,10′,11′,11a′-octahydro-3′<i>H</i>,7′<i>H</i>-spiro[aziridine-2,8′-[6,11b](epoxymethano)[6a,9]methanocyclohepta[<i>a</i>]naphthalen]-7′-one (<b>24</b>)</h4><div class="NLM_p last">To a solution of <b>22</b> (101.0 mg, 0.24 mmol) in MeOH (2 mL) and CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was added hydrochloric acid aqueous solution (1 N, 0.5 mL) at room temperature. The resulting mixture was stirred at room temperature for 15 min. The solvent was removed under reduced pressure and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and saturated NaHCO<sub>3</sub> aqueous solution (10 mL). The organic layer was washed with water (20 mL) and saturated brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give an oily residue. The residue was purified using silica gel column; elution with 2.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> afforded the desired product <b>24</b> (71.0 mg, 78%) as a white amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −102.5 (<i>c</i> 0.11, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 5.91–5.77 (m, 1H), 5.25–5.14 (m, 1H), 4.95 (s, 1H), 4.78 (d, <i>J</i> = 11.3 Hz, 1H), 4.06–3.66 (m, 6H), 2.54–2.22 (m, 2H), 2.02–1.46 (m, 6H), 1.41 (m, 1H), 1.32–1.23 (m, 1H), 1.18 (s, 3H), 1.06 (s, 3H), 0.99–0.80 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 216.0, 130.9, 124.1, 97.2, 74.6, 72.8, 65.2, 63.7, 58.4, 52.3, 49.7, 43.7, 41.1, 38.4, 32.4, 30.9, 22.2, 22.1, 21.8, 16.2. HRMS [M + H]<sup>+</sup>: calcd for C<sub>20</sub>H<sub>28</sub>NO<sub>5</sub>, 362.1967; found, 362.1958.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11′<i>S</i>,11a′<i>S</i>)-7′,11′-Dihydroxy-5′,5′,8′,8′-tetramethyldecahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6a,11a](epoxymethano)[3,3a<sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxin]-14′-one (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> (211.6 mg) was prepared from <b>20</b><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> in 76% yield by a procedure similar to that used to prepare compound <b>22</b>. The title compound <b>25</b> was obtained as a yellowish amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −102.8 (<i>c</i> 0.13, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 5.46 (d, <i>J</i> = 11.6 Hz, 1H), 4.94 (d, <i>J</i> = 1.7 Hz, 1H), 4.28 (dd, <i>J</i> = 9.9, 1.5 Hz, 1H), 4.06 (dd, <i>J</i> = 9.9, 1.2 Hz, 1H), 3.90 (dd, <i>J</i> = 11.6, 7.6 Hz, 1H), 3.50 (m, 1H), 2.39 (m, 1H), 2.23 (m, 2H), 1.92 (m, 3H), 1.82–1.21 (m, 15H), 1.20–1.11 (m, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 217.9, 101.1, 94.7, 74.5, 73.0, 70.9, 62.8, 59.0, 56.6, 50.5, 49.3, 40.7, 39.0, 38.2, 33.7, 33.3, 31.9, 30.4, 29.8, 26.8, 25.4, 22.6, 19.9. HRMS [M + H]<sup>+</sup>: calcd for C<sub>23</sub>H<sub>34</sub>NO<sub>6</sub>, 420.2386; found, 420.2371.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11a′<i>S</i>)-7′-Hydroxy-5′,5′,8′,8′-tetramethyloctahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6a,11a](epoxymethano)[3,3a<sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxine]-11′,14′(7′<i>H</i>)-dione (<b>27</b>)</h4><div class="NLM_p last">Compound <b>27</b> (20.1 mg) was prepared from <b>26</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> in 82% yield by a procedure similar to that used to prepare compound <b>22</b>. The title compound <b>27</b> was obtained as obtained as a yellowish amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −59.6 (<i>c</i> 0.18, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 4.97 (dd, <i>J</i> = 6.7, 5.0 Hz, 2H), 4.25 (dd, <i>J</i> = 10.2, 1.5 Hz, 1H), 4.06 (dd, <i>J</i> = 10.1, 1.6 Hz, 1H), 3.94 (dd, <i>J</i> = 11.7, 8.7 Hz, 1H), 2.43 (m, 3H), 2.25 (m 2H), 2.11 (m, 1H), 2.02–1.62 (m, 10H), 1.54 (m, 1H), 1.40 (s, 3H), 1.22 (s, 3H), 1.07 (s, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 217.1, 211.5, 101.5, 95.6, 71.8, 70.8, 64.7, 59.9, 56.0, 48.9, 48.1, 46.5, 38.4, 38.3, 35.8, 33.0, 32.1, 31.0, 30.2, 26.4, 25.3, 23.1, 18.6; HRMS [M + H]<sup>+</sup>: calcd for C<sub>23</sub>H<sub>32</sub>NO<sub>6</sub>, 418.2230; found, 418.2215.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11a′<i>R</i>)-7′-Hydroxy-5′,5′,8′,8′-tetramethyl-1′,3′,3a′,7a′,8′,11b′-hexahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6a,11a](epoxymethano)[3,3a<sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxine]-9′,14′(7′<i>H</i>)-dione (<b>29</b>)</h4><div class="NLM_p last">Compound <b>29</b> (29.1 mg) was prepared from <b>28</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> in 61% yield by a procedure similar to that used to prepare compound <b>22</b>. The title compound <b>29</b> was obtained as obtained as a yellowish amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −95.4 (<i>c</i> 0.29, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 6.33 (d, <i>J</i> = 10.2 Hz, 1H), 6.04 (d, <i>J</i> = 10.3 Hz, 1H), 5.23 (d, <i>J</i> = 11.8 Hz, 1H), 5.00 (d, <i>J</i> = 1.6 Hz, 1H), 4.11 (m, 3H), 2.44 (m, 1H), 2.27 (m, 2H), 2.06 (s, 1H), 2.02–1.53 (m, 8H), 1.50–1.07 (m, 10H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 216.6, 203.2, 142.4, 129.9, 101.7, 95.2, 70.8, 70.7, 64.3, 56.2, 56.1, 48.8, 48.0, 44.6, 38.7, 32.1, 30.2, 26.3, 25.4, 23.9, 22.5, 17.1, 14.2; HRMS [M + H]<sup>+</sup>: calcd for C<sub>23</sub>H<sub>30</sub>NO<sub>6</sub>, 416.2073; found, 416.2058.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a1′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11a′<i>S</i>)-7′-Hydroxy-5′,5′,8′,8′-tetramethyl-1′,3′,3a′,7a′,8′,11b′-hexahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6a,11a](epoxymethano)[3,3a<sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxine]-11′,14′(7′<i>H</i>)-dione (<b>30</b>)</h4><div class="NLM_p last">Compound <b>30</b> (11.0 mg) was prepared from <b>16</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> in 71% yield by a procedure similar to that used to prepare compound <b>22</b>. The title compound <b>30</b> was obtained as obtained as a yellowish amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −111.6 (<i>c</i> 0.10, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 6.81 (d, <i>J</i> = 10.1 Hz, 1H), 5.87 (d, <i>J</i> = 10.1 Hz, 1H), 5.17–4.96 (m, 2H), 4.27 (dd, <i>J</i> = 9.9, 1.6 Hz, 1H), 4.16–4.03 (m, 2H), 2.45–2.32 (m, 1H), 2.29–2.18 (m, 2H), 2.04 (d, <i>J</i> = 7.3 Hz, 2H), 1.97–1.85 (m, 2H), 1.77–1.65 (m, 6H), 1.41 (d, <i>J</i> = 2.2 Hz, 6H), 1.27 (d, <i>J</i> = 2.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 217.3, 196.3, 162.1, 126.7, 101.5, 95.5, 71.6, 70.8, 65.2, 56.6, 56.2, 49.0, 47.1, 45.7, 38.2, 35.9, 32.1, 30.4, 30.2, 26.5, 25.3, 25.0, 19.1; HRMS [M + H]<sup>+</sup>: calcd for C<sub>23</sub>H<sub>30</sub>NO<sub>6</sub>, 416.2073; found, 416.2063.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (6<i>S</i>,6a<i>R</i>,6a<sup>1</sup><i>R</i>,9a<i>R</i>,10<i>S</i>,12b<i>R</i>)-2-(Cyclohexylamino)-6-hydroxy-5,5,8,8-tetramethyl-15-methylene-4,5,5a,6,9a,10,12,12a-octahydro-11<i>H</i>-6a,12b-(epoxymethano)-6a<sup>1</sup>,10-ethano[1,3]dioxino[4′,5′,6′:8,9]phenanthro[4,3-<i>d</i>]thiazol-16-one (<b>31</b>)</h4><div class="NLM_p last">To a solution of <b>18a</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (190.8 mg, 0.38 mmol) in acetone (10 mL) was added 2,2-dimethoxypropane (1.5 mL) and <i>p</i>-TsOH (10 mg) at room temperature. The resulting mixture was refluxed for 8 h. The solvent was removed under reduced pressure, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and saturated NaHCO<sub>3</sub> aqueous solution (10 mL). The organic layer was washed with water (20 mL) and saturated brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give an oily residue. The residue was purified using silica gel column; elution with 25% EtOAc in hexane afforded the desired product <b>31</b> (168.1 mg, 82%) as a white amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −68.0 (<i>c</i> 0.10, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 6.13 (d, <i>J</i> = 1.3 Hz, 1H), 5.54–5.47 (m, 2H), 4.92 (d, <i>J</i> = 1.7 Hz, 1H), 4.81 (d, <i>J</i> = 7.8 Hz, 1H), 4.33 (dd, <i>J</i> = 9.8, 1.5 Hz, 1H), 4.04–3.86 (m, 2H), 3.25–3.10 (m, 1H), 3.05 (dd, <i>J</i> = 8.9, 1.6 Hz, 1H), 2.57–2.44 (m, 2H), 2.29 (m, 1H), 2.10–1.94 (m, 4H), 1.92–1.83 (m, 1H), 1.78–1.69 (m, 3H), 1.64–1.55 (m, 2H), 1.36 (s, 4H), 1.27 (m, 6H), 1.19 (m, 3H), 1.01 (s, 3H), 0.88 (s, 1H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 204.8, 165.1, 150.9, 142.9, 120.0, 118.5, 101.0, 95.4, 72.0, 70.2, 65.0, 58.5, 56.6, 54.7, 49.9, 40.4, 40.2, 39.0, 34.9, 33.2, 33.1, 30.9, 30.7, 30.2, 25.5, 25.4, 24.7, 24.7, 21.4, 20.1. HRMS [M + H]<sup>+</sup>: calcd for C<sub>30</sub>H<sub>41</sub>N<sub>2</sub>O<sub>5</sub>S, 541.2736; found, 541.2734.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (1′<i>S</i>,2<i>R</i>,5′<i>S</i>,6′<i>S</i>,6a′<i>R</i>,9′<i>S</i>,11b′<i>S</i>,14′<i>R</i>)-1′,5′,6′,14′-Tetrahydroxy-4′,4′-dimethyldecahydro-1′<i>H</i>,7′<i>H</i>-spiro[aziridine-2,8′-[6,11<i>b</i>](epoxymethano)[6<i>a</i>,9]methanocyclohepta[<i>a</i>]naphthalen]-7′-one (<b>35</b>)</h4><div class="NLM_p last">Compound <b>35</b> (30.1 mg) was prepared from <b>25</b> in 62% yield by a procedure similar to that used to prepare compound <b>24</b>. The title compound <b>35</b> was obtained as a white amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −110.9 (<i>c</i> 0.11, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 5.18 (<i>d</i>, <i>J</i> = 11.1 Hz, 1H), 4.93 (<i>d</i>, <i>J</i> = 1.3 Hz, 1H), 4.27–4.09 (m, 2H), 3.89–3.76 (m, 2H), 3.68 (d, <i>J</i> = 12.1 Hz, 1H), 3.46 (dd, J = 11.0, 5.9 Hz, 1H), 2.49–2.26 (m, 2H), 2.22–1.98 (m, 1H), 1.80–1.38 (m, 7H), 1.37–1.20 (m, 2H), 1.14 (m, 8H), 0.95–0.80 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 217.9, 96.6, 75.0, 73.7, 73.6, 67.0, 63.9, 62.9, 59.8, 54.4, 49.7, 43.2, 41.3, 38.7, 33.8, 32.8, 30.0, 22.3, 21.9, 18.4. HRMS [M + H]<sup>+</sup>: calcd for C<sub>20</sub>H<sub>30</sub>NO<sub>6</sub>, 380.2073; found, 380.2063.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (2<i>R</i>,5′<i>S</i>,6′<i>S</i>,6a′<i>R</i>,9′<i>S</i>,11b′<i>S</i>,14′<i>R</i>)-5′,6′,14′-Trihydroxy-4′,4′-dimethyldecahydro-1′<i>H</i>,7′<i>H</i>-spiro[aziridine-2,8′-[6,11<i>b</i>](epoxymethano)[6<i>a</i>,9]methanocyclohepta[<i>a</i>]naphthalene]-1″,7′-dione (<b>36</b>)</h4><div class="NLM_p last">Compound <b>36</b> (79.1 mg) was prepared from <b>27</b> in 28% yield by a procedure similar to that used to prepare compound <b>24</b>. The title compound <b>36</b> was obtained as a white amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −100.0 (<i>c</i> 0.14, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 5.37 (d, <i>J</i> = 11.1 Hz, 1H), 5.04 (s, 1H), 4.27 (dd, <i>J</i> = 10.4, 1.4 Hz, 1H), 4.03 (dd, <i>J</i> = 10.4, 1.4 Hz, 1H), 3.90–3.74 (m, 1H), 2.54–2.24 (m, 5H), 2.11 (m, 1H), 2.00–1.53 (m, 7H), 1.39–1.21 (m, 2H), 1.16 (s, 3H), 1.01 (s, 3H), 0.96–0.63 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 217.9, 211.7, 97.9, 73.2, 72.8, 64.9, 61.5, 60.1, 49.1, 49.1, 48.4, 40.5, 38.4, 35.7, 32.9, 31.5, 30.5, 26.0, 23.3, 18.6. HRMS [M + H]<sup>+</sup>: calcd for C<sub>20</sub>H<sub>28</sub>NO<sub>6</sub>, 378.1917; found, 378.1907.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (2<i>R</i>,5′<i>S</i>,6′<i>S</i>,6a′<i>R</i>,9′<i>S</i>,11b′<i>R</i>,14′<i>R</i>)-5′,6′,14′-Trihydroxy-4′,4′-dimethyl-4′,4a′,5′,6′,9′,10′,11′,11a′-octahydro-3′<i>H</i>,7′<i>H</i>-spiro[aziridine-2,8′-[6,11<i>b</i>](epoxymethano)[6<i>a</i>,9]methanocyclohepta[<i>a</i>]naphthalene]-3′,7′-dione (<b>37</b>)</h4><div class="NLM_p last">Compound <b>37</b> (16.6 mg) was prepared from <b>29</b> in 35% yield by a procedure similar to that used to prepare compound <b>24</b>. The title compound <b>37</b> was obtained as a white amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −55.0 (<i>c</i> 0.12, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 6.35 (d, <i>J</i> = 10.4 Hz, 1H), 6.05 (d, <i>J</i> = 10.4 Hz, 1H), 5.51 (s, 1H), 5.14 (s, 1H), 4.29–3.83 (m, 3H), 2.57–2.21 (m, 3H), 1.93 (m, 4H), 1.72 (m, 3H), 1.30 (m, 7H), 0.89 (m, 1H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 217.7, 202.8, 142.6, 130.2, 97.5, 73.4, 72.0, 64.7, 61.8, 56.1, 50.7, 44.5, 40.5, 39.0, 31.6, 29.7, 26.0, 23.6, 22.1, 17.3; HRMS [M + H]<sup>+</sup>: calcd for C<sub>20</sub>H<sub>26</sub>NO<sub>6</sub>, 376.1760; found, 376.1750.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2<i>R</i>,5′<i>S</i>,6′<i>S</i>,6a′<i>R</i>,9′<i>S</i>,11b′<i>S</i>,14′<i>R</i>)-5′,6′,14′-Trihydroxy-4′,4′-dimethyl-4′,4a′,5′,6′,9′,10′,11′,11a′-octahydro-1′<i>H</i>,7′<i>H</i>-spiro[aziridine-2,8′-[6,11<i>b</i>](epoxymethano)[6<i>a</i>,9]methanocyclohepta[<i>a</i>]naphthalene]-1′,7′-dione (<b>38</b>)</h4><div class="NLM_p last">Compound <b>38</b> (11.0 mg) was prepared from <b>30</b> in 61% yield by a procedure similar to that used to prepare compound <b>24</b>. The title compound <b>38</b> was obtained as a white amorphous solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −206.9 (<i>c</i> 0.19, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 6.80 (d, <i>J</i> = 10.1 Hz, 1H), 5.89 (d, <i>J</i> = 10.1 Hz, 1H), 5.51 (d, <i>J</i> = 11.5 Hz, 1H), 5.10 (d, <i>J</i> = 23.9 Hz, 2H), 4.31 (d, <i>J</i> = 10.2 Hz, 1H), 4.05 (dd, <i>J</i> = 19.5, 10.0 Hz, 2H), 3.51 (s, 1H), 2.28 (d, <i>J</i> = 11.7 Hz, 3H), 2.07 (d, <i>J</i> = 4.1 Hz, 2H), 1.90 (d, <i>J</i> = 9.0 Hz, 2H), 1.62 (d, <i>J</i> = 8.8 Hz, 3H), 1.37 (s, 2H), 1.27 (d, <i>J</i> = 5.5 Hz, 4H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 218.3, 196.2, 161.3, 127.1, 97.8, 73.4, 72.6, 65.6, 62.0, 56.5, 49.8, 49.2, 46.2, 40.5, 35.8, 30.0, 29.7, 26.2, 24.7, 19.0; HRMS [M + H]<sup>+</sup>: calcd for C<sub>20</sub>H<sub>26</sub>NO<sub>6</sub>, 376.1760; found, 376.1750.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (9<i>H</i>-Fluoren-9-yl)methyl (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11a′<i>S</i>)-7′-hydroxy-5′,5′,8′,8′-tetramethyl-11′,14′-dioxodecahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6<i>a</i>,11<i>a</i>](epoxymethano)[3,3<i>a</i><sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxine]-1-carboxylate (<b>39</b>)</h4><div class="NLM_p last">To a solution of <b>27</b> (203.1 mg, 0.49 mmol) and Na<sub>2</sub>CO<sub>3</sub> (154.7 mg, 1.46 mmol) in dioxane (20 mL) was added Fmoc chloride (151.0 mg, 0.58 mmol) at 0 °C. The resulting mixture was stirred at room temperature for 12 h. Next, the solution was removed, and the residue was dissolved with CH<sub>2</sub>Cl<sub>2</sub> (50 mL). The organic layer was washed with saturated NaHCO<sub>3</sub> solution (50 mL) and brine (50 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give an oily residue. The residue was purified using silica gel column; elution with 33% EtOAc in hexane afforded the desired product <b>39</b> as a white solid (106.1 mg, 34%). [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −45.9 (<i>c</i> 0.19, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 7.83–7.73 (m, 2H), 7.65 (dd, <i>J</i> = 10.5, 7.4 Hz, 2H), 7.37 (dtt, <i>J</i> = 26.4, 7.6, 1.4 Hz, 4H), 4.99 (d, <i>J</i> = 1.5 Hz, 1H), 4.65 (d, <i>J</i> = 11.9 Hz, 1H), 4.61–4.49 (m, 1H), 4.36–4.19 (m, 3H), 4.08 (dd, <i>J</i> = 10.1, 1.5 Hz, 1H), 3.96 (dd, <i>J</i> = 11.9, 8.8 Hz, 1H), 2.75 (d, <i>J</i> = 1.1 Hz, 1H), 2.56–2.32 (m, 5H), 2.15–2.07 (m, 1H), 1.99–1.54 (m, 9H), 1.44 (s, 3H), 1.22 (s, 3H), 1.08 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 211.9, 211.2, 159.4, 143.6, 143.6, 141.2, 141.2, 127.7, 127.7, 127.1, 127.1, 125.4, 125.4, 119.9, 119.9, 101.9, 95.5, 71.8, 70.4, 68.7, 64.7, 59.6, 56.2, 54.5, 48.2, 46.9, 46.8, 38.5, 38.2, 35.8, 35.4, 33.0, 31.0, 29.8, 26.5, 25.4, 23.0, 18.5. HRMS [M + H]<sup>+</sup>: calcd for C<sub>38</sub>H<sub>42</sub>NO<sub>8</sub>, 640.2943; found, 640.2897.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (9<i>H</i>-Fluoren-9-yl)methyl (2<i>R</i>,5′<i>S</i>,6′<i>S</i>,6a′<i>R</i>,9′<i>S</i>,11b′<i>S</i>,14′<i>R</i>)-5′,6′,14′-trihydroxy-4′,4′-dimethyl-1′,7′-dioxodecahydro-1′<i>H</i>,7′<i>H</i>-spiro[aziridine-2,8′-[6,11<i>b</i>](epoxymethano)[6<i>a</i>,9]methanocyclohepta[a]naphthalene]-1-carboxylate (<b>40</b>)</h4><div class="NLM_p last">Compound <b>40</b> (106.1 mg) was prepared in 75% yield by a procedure similar to that used to prepare compound <b>24</b>. The title compound <b>40</b> was obtained as a white solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −110.2 (<i>c</i> 0.13, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub> and CD<sub>3</sub>OD, δ): 7.72 (d, <i>J</i> = 7.4 Hz, 2H), 7.54 (dd, <i>J</i> = 7.1, 2.3 Hz, 2H), 7.44–7.20 (m, 4H), 5.98 (d, <i>J</i> = 125.4 Hz, 1H), 5.05 (d, <i>J</i> = 11.6 Hz, 1H), 4.85 (s, 1H), 4.45–4.14 (m, 4H), 4.04–3.92 (m, 1H), 3.85–3.53 (m, 2H), 2.60–2.39 (m, 2H), 2.30 (ddt, <i>J</i> = 15.3, 11.5, 5.8 Hz, 2H), 2.12–1.98 (m, 2H), 1.97–1.53 (m, 5H), 1.24 (dt, <i>J</i> = 10.7, 5.4 Hz, 2H), 1.13 (s, 3H), 0.97 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub> and CD<sub>3</sub>OD, δ): 214.2, 211.6, 154.8, 143.8, 143.7, 141.2, 141.2, 127.6, 127.6, 127.1, 127.1, 125.1, 125.1, 119.9, 119.9, 97.8, 73.3, 72.7, 67.2, 66.8, 64.7, 62.7, 59.8, 49.1, 48.2, 47.0, 44.5, 44.0, 38.2, 35.7, 32.8, 30.4, 23.1, 21.1, 17.1. HRMS [M + H]<sup>+</sup>: calcd for C<sub>35</sub>H<sub>38</sub>NO<sub>8</sub>, 600.2597; found, 600.2587.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (9<i>H</i>-Fluoren-9-yl)methyl (2<i>R</i>,6′<i>S</i>,7′<i>S</i>,7a′<i>R</i>,10′<i>S</i>,12b′<i>R</i>,15′<i>R</i>)-2′-(allylamino)-6′,7′,15′-trihydroxy-5′,5′-dimethyl-8′-oxo-5′,5a′,6′,7′,10′,11′,12′,12a′-octahydro-4′<i>H</i>,8′<i>H</i>-spiro[aziridine-2,9′-[7,12<i>b</i>](epoxymethano)[7<i>a</i>,10]methanocyclohepta[7,8]naphtho[1,2-<i>d</i>]thiazole]-1-carboxylate (<b>42</b>)</h4><div class="NLM_p last">To a solution of <b>40</b> (70.0 mg, 0.12 mmol) in THF (4 mL) was added PyHBr<sub>3</sub> (41.6 mg, 0.13 mmol) at room temperature. The reaction mixture was stirred at room temperature for 4 h and then poured into water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL × 3). The combined organic layer was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give a crude oily product <b>41</b> (65.2 mg, 82%), which was directly used in the next reaction. To a solution of <b>41</b> (65.2 mg, 0.10 mmol) in ethanol (4 mL) was added <i>N</i>-allylthiourea (13.4 mg, 0.12 mmol) at room temperature. The reaction mixture was heated under reflux for 6 h. After cooling and basifying with saturated NaHCO<sub>3</sub> aqueous solution, the mixture was concentrated in vacuo to give an oily residue. The residue was purified by silica gel column; elution with 33% EtOAc in hexane afforded the desired product <b>42</b> (29.4 mg, 44%) as an amorphous gel. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −102.5 (<i>c</i> 0.08, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 7.76 (d, <i>J</i> = 7.5 Hz, 2H), 7.59 (d, <i>J</i> = 7.4 Hz, 2H), 7.40 (t, <i>J</i> = 7.4 Hz, 2H), 7.33 (d, <i>J</i> = 7.4 Hz, 2H), 6.13 (s, 1H), 5.90 (ddt, <i>J</i> = 16.2, 10.7, 5.6 Hz, 1H), 5.49 (s, 1H), 5.34–5.12 (m, 4H), 5.07 (s, 1H), 4.53 (d, <i>J</i> = 10.2 Hz, 1H), 4.32 (ddd, <i>J</i> = 31.8, 13.6, 7.6 Hz, 3H), 3.96 (d, <i>J</i> = 10.2 Hz, 1H), 3.88–3.78 (m, 2H), 3.65 (d, <i>J</i> = 12.1 Hz, 1H), 2.63–2.46 (m, 2H), 2.45–2.28 (m, 2H), 2.05–1.88 (m, 2H), 1.84–1.74 (m, 1H), 1.61 (d, <i>J</i> = 9.4 Hz, 1H), 1.26 (d, <i>J</i> = 8.3 Hz, 6H), 0.98 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 214.6, 166.6, 154.7, 144.0, 143.9, 142.1, 141.3, 141.3, 133.6, 133.6, 127.6, 127.6, 127.1, 127.1, 125.2, 125.2, 119.9, 119.7, 117.3, 97.6, 73.5, 73.4, 67.7, 66.7, 65.3, 64.0, 57.7, 52.8, 48.3, 47.1, 44.7, 41.0, 38.8, 35.0, 30.4, 29.7, 21.7, 20.9, 18.6. HRMS [M + H]<sup>+</sup>: calcd for C<sub>39</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>S, 696.2743; found, 696.2698.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (2<i>R</i>,6′<i>S</i>,7′<i>S</i>,7a′<i>R</i>,10′<i>S</i>,12b′<i>R</i>,15′<i>R</i>)-2′-(Allylamino)-6′,7′,15′-trihydroxy-5′,5′-dimethyl-5′,5a′,6′,7′,10′,11′,12′,12a′-octahydro-4′<i>H</i>,8′<i>H</i>-spiro[aziridine-2,9′-[7,12b](epoxymethano)[7a,10]methanocyclohepta[7,8]naphtho[1,2-<i>d</i>]thiazol]-8′-one (<b>43</b>)</h4><div class="NLM_p last">To a solution of <b>42</b> (28.0 mg, 0.04 mmol) in DMF (0.8 mL) was added piperidine (0.2 mL) at room temperature. The reaction mixture was stirred at room temperature for 1 h and then poured into water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (10 mL × 3). The combined organic layer was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give a crude oily residue. The residue was purified by silica gel column; elution with 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> afforded the desired product <b>43</b> (15.6 mg, 82%) as an amorphous gel. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −30.8 (<i>c</i> 0.13, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 5.90 (ddt, <i>J</i> = 17.2, 10.2, 5.6 Hz, 1H), 5.38–5.11 (m, 3H), 5.07 (d, <i>J</i> = 1.3 Hz, 1H), 4.86 (d, <i>J</i> = 11.6 Hz, 1H), 4.39 (dd, <i>J</i> = 10.1, 1.4 Hz, 1H), 4.00 (dd, <i>J</i> = 10.1, 1.4 Hz, 1H), 3.91 (dd, <i>J</i> = 11.3, 8.8 Hz, 1H), 3.82 (d, <i>J</i> = 3.9 Hz, 2H), 3.73 (d, <i>J</i> = 25.0 Hz, 2H), 3.50 (s, 1H), 2.94 (d, <i>J</i> = 22.3 Hz, 2H), 2.58–2.25 (m, 4H), 2.23–1.97 (m, 2H), 1.97–1.62 (m, 3H), 1.62–1.54 (m, 1H), 1.27 (d, <i>J</i> = 2.4 Hz, 5H), 1.00 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 218.5, 165.7, 142.8, 133.8, 119.7, 117.2, 97.5, 73.3, 73.2, 65.6, 62.7, 58.2, 52.7, 49.2, 48.2, 40.8, 38.9, 35.0, 31.8, 30.5, 29.7, 26.5, 21.0, 19.9. HRMS [M + H]<sup>+</sup>: calcd for C<sub>24</sub>H<sub>32</sub>N<sub>3</sub>O<sub>5</sub>S, 474.2063; found, 474.2053.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11′<i>S</i>,11a′<i>S</i>)-1-Acryloyl-7′,11′-dihydroxy-5′,5′,8′,8′-tetramethyldecahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6<i>a</i>,11<i>a</i>](epoxymethano)[3,3<i>a</i><sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxin]-14′-one (<b>44</b>)</h4><div class="NLM_p last">To a solution of <b>25</b> (66.0 mg, 0.16 mmol), acrylic acid (12.5 mg, 0.17 mmol), and DIPEA (60.9 mg, 0.47 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added HBTU (89.5 mg, 0.24 mmol) at 0 °C. The resulting mixture was stirred at room temperature for 12 h. Next, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL). The organic layer was washed with saturated NaHCO<sub>3</sub> solution (50 mL) and brine (50 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give an oily residue. The residue was purified using silica gel column; elution with 33% EtOAc in hexane afforded the desired product <b>44</b> as a white solid (48.1 mg, 65%). [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −25.4 (<i>c</i> 0.13, MeOH); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 6.71–5.96 (m, 2H), 5.89–5.52 (m, 1H), 4.97 (m, 2H), 4.56–3.98 (m, 2H), 3.88 (m, 1H), 3.47 (m, 1H), 2.77 (m, 4H), 2.43 (m, 3H), 1.95 (m, 3H), 1.72 (m, 4H), 1.43 (m, 4H), 1.24 (m, 2H), 1.12 (m, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 212.1, 175.0, 131.0, 129.0, 101.6, 94.7, 74.5, 72.9, 70.7, 62.7, 58.2, 56.8, 55.1, 51.2, 41.0, 39.0, 38.1, 34.5, 33.6, 33.4, 29.9, 29.8, 27.5, 25.5, 22.7, 19.8. HRMS [M + H]<sup>+</sup>: calcd for C<sub>26</sub>H<sub>36</sub>NO<sub>7</sub>, 474.2492; found, 474.2478; [M + Na]<sup>+</sup>: calcd for C<sub>26</sub>H<sub>35</sub>NNaO<sub>7</sub>, 496.2311; found, 496.2303.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (2<i>R</i>,3′<i>S</i>,3a′<i>R</i>,3a<sup>1</sup>′<i>R</i>,6a′<i>R</i>,7′<i>S</i>,11′<i>S</i>,11a′<i>S</i>)-7′,11′-Dihydroxy-5′,5′,8′,8′-tetramethyl-1-propionyldecahydro-2′<i>H</i>-spiro[aziridine-2,15′-[6<i>a</i>,11<i>a</i>](epoxymethano)[3,3<i>a</i><sup>1</sup>]ethanophenanthro[1,10-<i>de</i>][1,3]dioxin]-14′-one (<b>45</b>)</h4><div class="NLM_p last">Compound <b>45</b> (35.0 mg) was prepared in 74% yield by a procedure similar to that used to prepare compound <b>44</b>. The title compound <b>45</b> was obtained as a white solid. [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −36.0 (<i>c</i> 0.10, CHCl<sub>3</sub>); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 5.03 (d, <i>J</i> = 12.0 Hz, 1H), 4.99–4.92 (m, 1H), 4.28 (d, <i>J</i> = 9.9 Hz, 1H), 4.05 (d, <i>J</i> = 9.9 Hz, 1H), 3.91 (dd, <i>J</i> = 12.0, 8.1 Hz, 1H), 3.48 (dd, <i>J</i> = 11.4, 5.5 Hz, 1H), 2.69 (d, <i>J</i> = 1.0 Hz, 1H), 2.55–2.28 (m, 5H), 2.03–1.88 (m, 2H), 1.79 (m, 1H), 1.73 (s, 3H), 1.71–1.57 (m, 2H), 1.57–1.45 (m, 2H), 1.43 (s, 3H), 1.35–1.22 (m, 3H), 1.15 (s, 3H), 1.13 (s, 3H),1.08 (m, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, δ): 213.5, 184.8, 101.6, 94.7, 74.4, 73.0, 70.8, 62.8, 58.3, 56.9, 54.9, 51.2, 40.9, 39.0, 38.2, 34.7, 33.6, 33.4, 30.3, 29.9, 29.7, 27.4, 25.5, 22.7, 19.8, 8.6. HRMS [M + H]<sup>+</sup>: calcd for C<sub>26</sub>H<sub>38</sub>NO<sub>7</sub>, 476.2648; found, 476.2632.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Measuring Compound Reactivity with GSH</h3><div class="NLM_p last">The oridonin or its derivatives (10.0 mg) were incubated with an excess of GSH (15–20 mg) in deuterated phosphate buffer at pH 7.4 (0.05 mL) and <i>d</i><sup>6</sup>-DMSO (0.50 mL) at 37 °C. The reaction was monitored by the change of representative hydrogen signals with <sup>1</sup>H NMR analysis, and the adduct products were confirmed with the HRMS. The reactivities of the covalent warheads could be initially classified based on the integration change of the representative proton NMR.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> In Vitro Determination of Newly Synthesized Compounds against Cancer Cell Proliferation</h3><div class="NLM_p last">Breast cancer cells (MDA-MB-231, MDA-MB-468, SK-BR3, and MCF-7 lines) were seeded in 96-well plates at a density of 1 × 10<sup>4</sup> cells per well and treated with DMSO or testing compounds at 0.1, 0.33, 1.0, 3.3, and 10 μM concentrations for 72 h. Proliferation was measured by treating cells with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) in a CellTiter 96t aqueous non-radioactive cell proliferation assay kit (Promega, Madison, WI). Absorbance of all wells was determined by measuring OD at 560 nm after 1 h incubation at 37 °C on a 96-well iMark microplate absorbance reader (BioRad, Hercules, CA). Each individual compound was tested in quadruplicate wells for each concentration.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Colony-Formation Assay</h3><div class="NLM_p last">Breast cancer MDA-MB-231 cells were seeded in 6-well tissue culture plates with a density of 600 cells per well and maintained in regular culture media. Similarly, breast cancer MDA-MB-468, SK-BR3, or MCF-7 cells were seeded with a density of 800 cells per well. After 24 h, the cells were treated with <b>44</b> at different concentrations (1, 5, 10, 15, and 20 μM) or DMSO as the vehicle. The culture media with the compounds were changed every 72 h. At the end of 2 weeks, the wells were washed twice with PBS buffer, and 2 mL of 0.01% crystal violet staining buffer was added to each well and incubated for 10 min. The wells were then washed with PBS for 5 min three times and allowed to dry. Photographs were then taken.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Cellular-Apoptosis Assay</h3><div class="NLM_p last">Breast cancer MDA-MB-231 cells were incubated in 6-well plates (2.5 × 10<sup>5</sup> cells per well). Cells were then treated with DMSO, oridonin, or testing compounds at different concentrations for 48 h, and then both adherent and floating cells were collected and washed once with PBS. Resuspended cells were incubated with 100 μL of PBS containing 1% BSA and 100 μL of Annexin V and dead-cell detection reagent at room temperature for 20 min. Apoptosis was measured immediately using the Muse Cell Analyzer with the Muse Apoptosis Kit (catalog no. MCH100105).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Western-Blot Analysis</h3><div class="NLM_p last">Breast cancer MDA-MB-231 cells were treated with DMSO or <b>44</b> at different concentrations. After 48 h of treatment, cells were harvested and lysed. Protein concentrations were quantified by the method of Bradford with bovine serum albumin as the standard. Equal amounts of total cellular protein extract (40 μg) was separated by electrophoresis on sodium dodecyl sulfate–polyacrylamide gels and transferred to NC membranes. After blocking with 5% nonfat milk, the membrane was incubated with the desired primary antibody overnight at the following dilution: anti-Bcl-2 (1:200), anticleaved-PARP (1:500), anti-NF-κB (1:1000), and β-actin (1:2000), and anti-Bax (1:1000). Subsequently, the membrane was incubated with appropriate secondary antibody. The immunoreactive bands were visualized by enhanced chemiluminescence, as recommended by the manufacturer.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> In Vivo Antitumor Activity Determination</h3><div class="NLM_p last">All procedures including mice and in vivo experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of UT M. D. Anderson Cancer Center (MDACC). A total of 31 female nude mice were obtained from MDACC and were used for orthotopic tumor studies at 6 to 8 weeks of age. The mice were maintained in a barrier unit with 12 h of light–dark switching. Freshly harvested MDA-MB-231 cells (1.0 × 10<sup>6</sup> cells per mouse, resuspended in 100 μL of PBS) were injected into the no. 3 mammary fat pad of each mice and then randomly assigned into 4 groups. The mice were treated daily with 10 or 15 mg/kg of <b>44</b>, oridonin or vehicle through intraperitoneal injection when the tumor volume reached 80–100 mm<sup>3</sup> in volume. All agents were dissolved in DMSO for in vivo administration. Body weights and tumors volume were measured daily, and tumor volume was calculated according to the formula <i>V</i> = 0.5 × <i>L</i> × W<sup>2</sup>, where <i>L</i> = length (mm) and <i>W</i> = width (mm).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Statistical Analysis</h3><div class="NLM_p last">Statistical significance was determined using a Student <i>t</i> test or one-way ANOVA in vivo experiments. A single asterisk represents a <i>p</i> value of less than 0.05, double asterisks represent a <i>p</i> value of less than 0.01, and triple asterisks represent a <i>p</i> value of less than 0.001.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01514" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01514" class="ext-link">10.1021/acs.jmedchem.7b01514</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures showing the reactivity of oridonin and its derivatives with GSH determined by the <sup>1</sup>H NMR and HRMS, the reaction of representative aziridine compound and oridonin analogue, growth-inhibitory effects of the oridonin derivatives on MCF-7 and MDA-MB-231 cell lines, cell viability, microsomal and plasma stability, cell density, and <sup>1</sup>H and <sup>13</sup>C NMR spectra for the new compounds described in this paper. A table showing X-ray CIF file for compound <b>22</b>. Molecular formula strings. (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Crystallographic data for a selection of experimental compounds. (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf">jm7b01514_si_001.pdf (10.52 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_002.csv">jm7b01514_si_002.csv (1.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01514" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiang Shen</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Cancer Prevention, Division of Cancer Prevention and Population
Sciences, The University of Texas MD Anderson
Cancer Center, Houston, Texas 77030, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ed9c9e858883ad80898c8389889f9e8283c3829f8a"><span class="__cf_email__" data-cfemail="4637352e2328062b22272822233435292868293421">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Zhou</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4e24273426213b0e3b3a232c602b2a3b"><span class="__cf_email__" data-cfemail="b9d3d0c3d1d6ccf9cccdd4db97dcddcc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ye Ding</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dengfeng Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Cancer Prevention, Division of Cancer Prevention and Population
Sciences, The University of Texas MD Anderson
Cancer Center, Houston, Texas 77030, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Thyroid and Breast, Division of General Surgery, Shanghai Tenth
People’s Hospital, Tongji University
School of Medicine, Shanghai 200072, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunyong Ding</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pingyuan Wang</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqing Liu</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric A. Wold</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6434-7562" title="Orcid link">http://orcid.org/0000-0001-6434-7562</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Na Ye</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiying Chen</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. White</span> - <span class="hlFld-Affiliation affiliation">Sealy Center
for Structural Biology and Molecular Biophysics and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.D. and D.L. contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d97e3989-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Breast Cancer Research Program (BCRP) Breakthrough Award (grant nos. BC160038 and BC160038P1) from the Department of Defense (DoD) (to J.Z. and Q.S.), grant nos. P30 DA028821 and R01 DA038446 from the National Institutes of Health (to J.Z.), Sanofi Innovation Awards (iAward) Program (to J.Z.), the Cancer Prevention Research Institute of Texas (CPRIT) award (to J.Z.), Cancer Center Support grant no. P30 CA016672 from the United States National Institutes of Health (to The University of Texas MD Anderson Cancer Center), startup funds from MD Anderson Cancer Center (to Q.S.), and the Duncan Family Institute Seed Funding Research Program (to Q.S). We thank Dr. Lawrence C. Sowers at the Department of Pharmacology as well as Dr. Tianzhi Wang at the NMR core facility of UTMB for the NMR spectroscopy assistance and Dr. Xuemei Luo at UTMB mass spectrometry core with funding support from the UT system proteomics network for the HRMS analysis.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATION USED</td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SRR</td><td class="NLM_def"><p class="first last">structure–reactivity relationship</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">NRF2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid-derived 2-like 2</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">p53</td><td class="NLM_def"><p class="first last">tumor protein p53</p></td></tr><tr><td class="NLM_term">p21</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase inhibitor 1</p></td></tr><tr><td class="NLM_term">OTC</td><td class="NLM_def"><p class="first last">over-the-counter</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">Bcl-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2</p></td></tr><tr><td class="NLM_term">Bax</td><td class="NLM_def"><p class="first last">Bcl-2-associated X protein</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">DR5</td><td class="NLM_def"><p class="first last">death receptor 5</p></td></tr><tr><td class="NLM_term">XBP1</td><td class="NLM_def"><p class="first last">X-box binding protein 1</p></td></tr><tr><td class="NLM_term">Rh<sub>2</sub>(esp)<sub>2</sub></td><td class="NLM_def"><p class="first last">bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)]</p></td></tr><tr><td class="NLM_term">RNS</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">LD<sub>50</sub></td><td class="NLM_def"><p class="first last">median lethal dose</p></td></tr><tr><td class="NLM_term">DPH</td><td class="NLM_def"><p class="first last"><i>O</i>-(2,4-dinitrophenyl)hydroxylamine</p></td></tr><tr><td class="NLM_term">Rh<sub>2</sub>(OAc)<sub>4</sub></td><td class="NLM_def"><p class="first last">rhodium(II) acetate dimer</p></td></tr><tr><td class="NLM_term">Rh<sub>2</sub>(TPA)<sub>4</sub></td><td class="NLM_def"><p class="first last">rhodium(II) triphenylacetate dimer</p></td></tr><tr><td class="NLM_term">Rh<sub>2</sub>(<i>R</i>-DOSP)<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrakis[1-[[4-alkyl(C<sub>11</sub>–C<sub>13</sub>)phenyl]sulfonyl]-(2<i>R</i>)-pyrrolidinecarboxylate]dirhodium(II)</p></td></tr><tr><td class="NLM_term">Rh<sub>2</sub>(<i>S</i>-DOSP)<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrakis[1-[[4-alkyl(C<sub>11</sub>–C<sub>13</sub>)phenyl]sulfonyl]-(2<i>S</i>)-pyrrolidinecarboxylate]dirhodium(II)</p></td></tr><tr><td class="NLM_term">PyHBr<sub>3</sub></td><td class="NLM_def"><p class="first last">pyridinium tribromide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">Tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">BCA</td><td class="NLM_def"><p class="first last">bicinchoninic acid</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">SDS</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate</p></td></tr><tr><td class="NLM_term">NC</td><td class="NLM_def"><p class="first last">nitrocellulose</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span> <span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0li7TBxE7whanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaptein, A.</span></span> <span> </span><span class="NLM_article-title">Irreversible protein kinase inhibitors: balancing the benefits and risks</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6243</span>– <span class="NLM_lpage">6262</span>, <span class="refDoi"> DOI: 10.1021/jm3003203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6243-6262&author=T.+Barfauthor=A.+Kaptein&title=Irreversible+protein+kinase+inhibitors%3A+balancing+the+benefits+and+risks&doi=10.1021%2Fjm3003203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks</span></div><div class="casAuthors">Barf, Tjeerd; Kaptein, Allard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6243-6262</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Not applicable for a Perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4PLlisO0OVbVg90H21EOLACvtfcHk0li7TBxE7whanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVerur8%253D&md5=5d87850857d37faab02e6037ef8140a4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm3003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003203%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DKaptein%26aufirst%3DA.%26atitle%3DIrreversible%2520protein%2520kinase%2520inhibitors%253A%2520balancing%2520the%2520benefits%2520and%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6243%26epage%3D6262%26doi%3D10.1021%2Fjm3003203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Developing irreversible inhibitors of the protein kinase cysteinome</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.chembiol.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=23438744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=146-159&author=Q.+Liuauthor=Y.+Sabnisauthor=Z.+Zhaoauthor=T.+Zhangauthor=S.+J.+Buhrlageauthor=L.+H.+Jonesauthor=N.+S.+Gray&title=Developing+irreversible+inhibitors+of+the+protein+kinase+cysteinome&doi=10.1016%2Fj.chembiol.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome</span></div><div class="casAuthors">Liu, Qingsong; Sabnis, Yogesh; Zhao, Zheng; Zhang, Tinghu; Buhrlage, Sara J.; Jones, Lyn H.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-159</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a large family of approx. 530 highly conserved enzymes that transfer a γ-phosphate group from ATP to a variety of amino acid residues, such as tyrosine, serine, and threonine, that serves as a ubiquitous mechanism for cellular signal transduction.  The clin. success of a no. of kinase-directed drugs and the frequent observation of disease causing mutations in protein kinases suggest that a large no. of kinases may represent therapeutically relevant targets.  To date, the majority of clin. and preclin. kinase inhibitors are ATP competitive, noncovalent inhibitors that achieve selectivity through recognition of unique features of particular protein kinases.  Recently, there has been renewed interest in the development of irreversible inhibitors that form covalent bonds with cysteine or other nucleophilic residues in the ATP-binding pocket.  Irreversible kinase inhibitors have a no. of potential advantages including prolonged pharmacodynamics, suitability for rational design, high potency, and ability to validate pharmacol. specificity through mutation of the reactive cysteine residue.  Here, we review recent efforts to develop cysteine-targeted irreversible protein kinase inhibitors and discuss their modes of recognizing the ATP-binding pocket and their biol. activity profiles.  In addn., we provided an informatics assessment of the potential "kinase cysteinome" and discuss strategies for the efficient development of new covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGD7TX3oIeLVg90H21EOLACvtfcHk0lgDeeRLJfQHfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D&md5=cef80823123bae88362e816a0a638133</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSabnis%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDeveloping%2520irreversible%2520inhibitors%2520of%2520the%2520protein%2520kinase%2520cysteinome%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D146%26epage%3D159%26doi%3D10.1016%2Fj.chembiol.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8249</span>– <span class="NLM_lpage">8267</span>, <span class="refDoi"> DOI: 10.1021/jm500973a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500973a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8249-8267&author=M.+R.+Finlayauthor=M.+Andertonauthor=S.+Ashtonauthor=P.+Ballardauthor=P.+A.+Bethelauthor=M.+R.+Boxauthor=R.+H.+Bradburyauthor=S.+J.+Brownauthor=S.+Butterworthauthor=A.+Campbellauthor=C.+Chorleyauthor=N.+Colcloughauthor=D.+A.+Crossauthor=G.+S.+Currieauthor=M.+Gristauthor=L.+Hassallauthor=G.+B.+Hillauthor=D.+Jamesauthor=M.+Jamesauthor=P.+Kemmittauthor=T.+Klinowskaauthor=G.+Lamontauthor=S.+G.+Lamontauthor=N.+Martinauthor=H.+L.+McFarlandauthor=M.+J.+Mellorauthor=J.+P.+Ormeauthor=D.+Perkinsauthor=P.+Perkinsauthor=G.+Richmondauthor=P.+Smithauthor=R.+A.+Wardauthor=M.+J.+Waringauthor=D.+Whittakerauthor=S.+Wellsauthor=G.+L.+Wrigley&title=Discovery+of+a+potent+and+selective+EGFR+inhibitor+%28AZD9291%29+of+both+sensitizing+and+T790M+resistance+mutations+that+spares+the+wild+type+form+of+the+receptor&doi=10.1021%2Fjm500973a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor</span></div><div class="casAuthors">Finlay, M. Raymond V.; Anderton, Mark; Ashton, Susan; Ballard, Peter; Bethel, Paul A.; Box, Matthew R.; Bradbury, Robert H.; Brown, Simon J.; Butterworth, Sam; Campbell, Andrew; Chorley, Christopher; Colclough, Nicola; Cross, Darren A. E.; Currie, Gordon S.; Grist, Matthew; Hassall, Lorraine; Hill, George B.; James, Daniel; James, Michael; Kemmitt, Paul; Klinowska, Teresa; Lamont, Gillian; Lamont, Scott G.; Martin, Nathaniel; McFarland, Heather L.; Mellor, Martine J.; Orme, Jonathon P.; Perkins, David; Perkins, Paula; Richmond, Graham; Smith, Peter; Ward, Richard A.; Waring, Michael J.; Whittaker, David; Wells, Stuart; Wrigley, Gail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8249-8267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) inhibitors have been used clin. in the treatment of nonsmall-cell lung cancer (NSCLC) patients harboring sensitizing (or activating) mutations for a no. of years.  Despite encouraging clin. efficacy with these agents, in many patients resistance develops leading to disease progression.  In most cases, this resistance is in the form of the T790M mutation.  In addn., EGFR wild type receptor inhibition inherent with these agents can lead to dose limiting toxicities of rash and diarrhea.  The authors describe herein the evolution of an early, mutant selective lead to the clin. candidate AZD9291 I, an irreversible inhibitor of both EGFR sensitizing (EGFRm+) and T790M resistance mutations with selectivity over the wild type form of the receptor.  Following observations of significant tumor inhibition in preclin. models, the clin. candidate was administered clin. to patients with T790M pos. EGFR-TKI resistant NSCLC and early efficacy has been obsd., accompanied by an encouraging safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouPAWG9N0Ro7Vg90H21EOLACvtfcHk0lgDeeRLJfQHfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI&md5=db9db624bb4324c2e22b1ab12035263b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm500973a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500973a%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DAnderton%26aufirst%3DM.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%2BR.%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DChorley%26aufirst%3DC.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DKemmitt%26aufirst%3DP.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DG.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMcFarland%26aufirst%3DH.%2BL.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DRichmond%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DWrigley%26aufirst%3DG.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520EGFR%2520inhibitor%2520%2528AZD9291%2529%2520of%2520both%2520sensitizing%2520and%2520T790M%2520resistance%2520mutations%2520that%2520spares%2520the%2520wild%2520type%2520form%2520of%2520the%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8249%26epage%3D8267%26doi%3D10.1021%2Fjm500973a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getlik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Termathe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lategahn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer-Wrangowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grütter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlenbrock, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaumann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eppmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kibies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffgaard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menninger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Cuaran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuckmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinnefeld, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahedi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz-Fademrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kast, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span> <span> </span><span class="NLM_article-title">Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6844</span>– <span class="NLM_lpage">6863</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCjsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6844-6863&author=J.+Engelauthor=A.+Richtersauthor=M.+Getlikauthor=S.+Tomassiauthor=M.+Keulauthor=M.+Termatheauthor=J.+Lategahnauthor=C.+Beckerauthor=S.+Mayer-Wrangowskiauthor=C.+Gr%C3%BCtterauthor=N.+Uhlenbrockauthor=J.+Kr%C3%BCllauthor=N.+Schaumannauthor=S.+Eppmannauthor=P.+Kibiesauthor=F.+Hoffgaardauthor=J.+Heilauthor=S.+Menningerauthor=S.+Ortiz-Cuaranauthor=J.+M.+Heuckmannauthor=V.+Tinnefeldauthor=R.+P.+Zahediauthor=M.+L.+Sosauthor=C.+Schultz-Fademrechtauthor=R.+K.+Thomasauthor=S.+M.+Kastauthor=D.+Rauh&title=Targeting+drug+resistance+in+EGFR+with+covalent+inhibitors%3A+a+structure-based+design+approach&doi=10.1021%2Facs.jmedchem.5b01082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach</span></div><div class="casAuthors">Engel, Julian; Richters, Andre; Getlik, Matthaeus; Tomassi, Stefano; Keul, Marina; Termathe, Martin; Lategahn, Jonas; Becker, Christian; Mayer-Wrangowski, Svenja; Gruetter, Christian; Uhlenbrock, Niklas; Kruell, Jasmin; Schaumann, Niklas; Eppmann, Simone; Kibies, Patrick; Hoffgaard, Franziska; Heil, Jochen; Menninger, Sascha; Ortiz-Cuaran, Sandra; Heuckmann, Johannes M.; Tinnefeld, Verena; Zahedi, Rene P.; Sos, Martin L.; Schultz-Fademrecht, Carsten; Thomas, Roman K.; Kast, Stefan M.; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6844-6863</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Receptor tyrosine kinases represent one of the prime targets in cancer therapy, as the dysregulation of these elementary transducers of extracellular signals, like the epidermal growth factor receptor (EGFR), contributes to the onset of cancer, such as non-small cell lung cancer (NSCLC).  Strong efforts were directed to the development of irreversible inhibitors and led to compd. CO-1686, which takes advantage of increased residence time at EGFR by alkylating Cys797 and thereby preventing toxic effects.  Here, the authors present a structure-based approach, rationalized by subsequent computational anal. of conformational ligand ensembles in soln., to design novel and irreversible EGFR inhibitors based on a screening hit that was identified in a phenotype screen of 80 NSCLC cell lines against approx. 1500 compds.  Using protein x-ray crystallog., the authors deciphered the binding mode in engineered cSrc (T338M/S345C), a validated model system for EGFR-T790M, which constituted the basis for further rational design approaches.  Chem. synthesis led to further compd. collections that revealed increased biochem. potency and, in part, selectivity toward mutated (L858R and L858R/T790M) vs. nonmutated EGFR.  Further cell-based and kinetic studies were performed to substantiate the authors initial findings.  Utilizing proteolytic digestion and nano-LC-MS/MS anal., the authors confirmed the alkylation of Cys797.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGJPIuqoVObVg90H21EOLACvtfcHk0ljCgkeqvpZSVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCjsrvM&md5=d5264a2a99d7752af0e587f23aeb7723</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01082%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DRichters%26aufirst%3DA.%26aulast%3DGetlik%26aufirst%3DM.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DKeul%26aufirst%3DM.%26aulast%3DTermathe%26aufirst%3DM.%26aulast%3DLategahn%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DC.%26aulast%3DUhlenbrock%26aufirst%3DN.%26aulast%3DKr%25C3%25BCll%26aufirst%3DJ.%26aulast%3DSchaumann%26aufirst%3DN.%26aulast%3DEppmann%26aufirst%3DS.%26aulast%3DKibies%26aufirst%3DP.%26aulast%3DHoffgaard%26aufirst%3DF.%26aulast%3DHeil%26aufirst%3DJ.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DOrtiz-Cuaran%26aufirst%3DS.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DTinnefeld%26aufirst%3DV.%26aulast%3DZahedi%26aufirst%3DR.%2BP.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DKast%26aufirst%3DS.%2BM.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DTargeting%2520drug%2520resistance%2520in%2520EGFR%2520with%2520covalent%2520inhibitors%253A%2520a%2520structure-based%2520design%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6844%26epage%3D6863%26doi%3D10.1021%2Facs.jmedchem.5b01082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span> <span> </span><span class="NLM_article-title">Challenges and perspectives on the development of small-molecule EGFR inhibitors against T790M-mediated resistance in non-small-cell lung cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6580</span>– <span class="NLM_lpage">6594</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00840</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00840" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6580-6594&author=Z.+Songauthor=Y.+Geauthor=C.+Wangauthor=S.+Huangauthor=X.+Shuauthor=K.+Liuauthor=Y.+Zhouauthor=X.+Ma&title=Challenges+and+perspectives+on+the+development+of+small-molecule+EGFR+inhibitors+against+T790M-mediated+resistance+in+non-small-cell+lung+cancer&doi=10.1021%2Facs.jmedchem.5b00840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer</span></div><div class="casAuthors">Song, Zhendong; Ge, Yang; Wang, Changyuan; Huang, Shanshan; Shu, Xiaohong; Liu, Kexin; Zhou, Youwen; Ma, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6580-6594</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the development of drug-resistance mutations, particularly the "gatekeeper" threonine790-to-methionine790 (T790M) mutation in the ATP-binding pocket of the epidermal growth factor receptor (EGFR), the current generation of EGFR tyrosine kinase inhibitors lost their clin. efficacy.  Recently, a large no. of small-mol. inhibitors with striking inhibitory potency against EGFR mutants with the T790M change have been identified.  In particular, the inhibitors rociletinib and osimertinib, which can selectively target both sensitizing mutations and the T790M resistance while sparing the wild-type (WT) form of the receptor, have been designated as breakthrough therapies in the treatment of mutant non-small-cell lung cancer (NSCLC) by the U.S.  FDA in 2014.  We hope that this review on the small-mol. EGFR T790M inhibitors, along with their discovery strategies, will assist in the design of future T790M-contg. EGFR inhibitors with high levels of selectivity over WT EGFR, broad kinase selectivity, and desirable physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcAydAIVpNbVg90H21EOLACvtfcHk0ljCgkeqvpZSVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGntbo%253D&md5=2112d52e116494f61b1c8bd3f8f383d9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00840%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%26atitle%3DChallenges%2520and%2520perspectives%2520on%2520the%2520development%2520of%2520small-molecule%2520EGFR%2520inhibitors%2520against%2520T790M-mediated%2520resistance%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6580%26epage%3D6594%26doi%3D10.1021%2Facs.jmedchem.5b00840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzmic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolanos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1073/pnas.1313733111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1073%2Fpnas.1313733111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=24347635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=173-178&author=P.+A.+Schwartzauthor=P.+Kuzmicauthor=J.+Solowiejauthor=S.+Bergqvistauthor=B.+Bolanosauthor=C.+Almadenauthor=A.+Nagataauthor=K.+Ryanauthor=J.+Fengauthor=D.+Dalvieauthor=J.+C.+Kathauthor=M.+Xuauthor=R.+Waniauthor=B.+W.+Murray&title=Covalent+EGFR+inhibitor+analysis+reveals+importance+of+reversible+interactions+to+potency+and+mechanisms+of+drug+resistance&doi=10.1073%2Fpnas.1313733111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span></div><div class="casAuthors">Schwartz, Phillip A.; Kuzmic, Petr; Solowiej, James; Bergqvist, Simon; Bolanos, Ben; Almaden, Chau; Nagata, Asako; Ryan, Kevin; Feng, Junli; Dalvie, Deepak; Kath, John C.; Xu, Meirong; Wani, Revati; Murray, Brion William</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-178</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Covalent inhibition is a reemerging paradigm in kinase drug design, but the roles of inhibitor binding affinity and chem. reactivity in overall potency are not well-understood.  To characterize the underlying mol. processes at a microscopic level and det. the appropriate kinetic consts., specialized exptl. design and advanced numerical integration of differential equations are developed.  Previously uncharacterized investigational covalent drugs reported here are shown to be extremely effective epidermal growth factor receptor (EGFR) inhibitors (kinact/Ki in the range 105-107 M-1s-1), despite their low specific reactivity (kinact ≤ 2.1 × 10-3 s-1), which is compensated for by high binding affinities (Ki < 1 nM).  For inhibitors relying on reactivity to achieve potency, noncovalent enzyme-inhibitor complex partitioning between inhibitor dissocn. and bond formation is central.  Interestingly, reversible binding affinity of EGFR covalent inhibitors is highly correlated with antitumor cell potency.  Furthermore, cellular potency for a subset of covalent inhibitors can be accounted for solely through reversible interactions.  One reversible interaction is between EGFR-Cys797 nucleophile and the inhibitor's reactive group, which may also contribute to drug resistance.  Because covalent inhibitors target a cysteine residue, the effects of its oxidn. on enzyme catalysis and inhibitor pharmacol. are characterized.  Oxidn. of the EGFR cysteine nucleophile does not alter catalysis but has widely varied effects on inhibitor potency depending on the EGFR context (e.g., oncogenic mutations), type of oxidn. (sulfinylation or glutathiolation), and inhibitor architecture.  These methods, parameters, and insights provide a rational framework for assessing and designing effective covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTpPuRq8MwCLVg90H21EOLACvtfcHk0ljCgkeqvpZSVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D&md5=47197c5e7876a238eefb2e8e7de305ea</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1313733111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1313733111%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DKuzmic%26aufirst%3DP.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWani%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DCovalent%2520EGFR%2520inhibitor%2520analysis%2520reveals%2520importance%2520of%2520reversible%2520interactions%2520to%2520potency%2520and%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D173%26epage%3D178%26doi%3D10.1073%2Fpnas.1313733111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Páez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanning, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijaro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide covalent ligand discovery in native biological systems</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>534</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1038/nature18002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1038%2Fnature18002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27309814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2016&pages=570-574&author=K.+M.+Backusauthor=B.+E.+Correiaauthor=K.+M.+Lumauthor=S.+Forliauthor=B.+D.+Horningauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=S.+Chatterjeeauthor=B.+R.+Lanningauthor=J.+R.+Teijaroauthor=A.+J.+Olsonauthor=D.+W.+Wolanauthor=B.+F.+Cravatt&title=Proteome-wide+covalent+ligand+discovery+in+native+biological+systems&doi=10.1038%2Fnature18002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-wide covalent ligand discovery in native biological systems</span></div><div class="casAuthors">Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Forli, Stefano; Horning, Benjamin D.; Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Lanning, Bryan R.; Teijaro, John R.; Olson, Arthur J.; Wolan, Dennis W.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">7608</span>),
    <span class="NLM_cas:pages">570-574</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small mols. are powerful tools for investigating protein function and can serve as leads for new therapeutics.  Most human proteins, however, lack small-mol. ligands, and entire protein classes are considered 'undruggable'.  Fragment-based ligand discovery can identify small-mol. probes for proteins that have proven difficult to target using high-throughput screening of complex compd. libraries.  Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-mol. probes, including those that can access regions of proteins that are difficult to target through binding affinity alone.  Here we report a quant. anal. of cysteine-reactive small-mol. fragments screened against thousands of proteins in human proteomes and cells.  Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chem. probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins.  Among the atypical ligand-protein interactions discovered were compds. that react preferentially with pro- (inactive) caspases.  We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines vs. primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10.  Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compds. that can illuminate protein functions in native biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNJ88KALeSLVg90H21EOLACvtfcHk0ljpwYcLrtjwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN&md5=6fab087c042de735f8a5931e9f5b946c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature18002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18002%26sid%3Dliteratum%253Aachs%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHorning%26aufirst%3DB.%2BD.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DLanning%26aufirst%3DB.%2BR.%26aulast%3DTeijaro%26aufirst%3DJ.%2BR.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520covalent%2520ligand%2520discovery%2520in%2520native%2520biological%2520systems%26jtitle%3DNature%26date%3D2016%26volume%3D534%26spage%3D570%26epage%3D574%26doi%3D10.1038%2Fnature18002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppenheimer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span> <span> </span><span class="NLM_article-title">Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10072</span>– <span class="NLM_lpage">10079</span>, <span class="refDoi"> DOI: 10.1021/jm501412a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501412a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10072-10079&author=M.+E.+Flanaganauthor=J.+A.+Abramiteauthor=D.+P.+Andersonauthor=A.+Aulabaughauthor=U.+P.+Dahalauthor=A.+M.+Gilbertauthor=C.+Liauthor=J.+Montgomeryauthor=S.+R.+Oppenheimerauthor=T.+Ryderauthor=B.+P.+Schuffauthor=D.+P.+Uccelloauthor=G.+S.+Walkerauthor=Y.+Wuauthor=M.+F.+Brownauthor=J.+M.+Chenauthor=M.+M.+Haywardauthor=M.+C.+Noeauthor=R.+S.+Obachauthor=L.+Philippeauthor=V.+Shanmugasundaramauthor=M.+J.+Shapiroauthor=J.+Starrauthor=J.+Strohauthor=Y.+Che&title=Chemical+and+computational+methods+for+the+characterization+of+covalent+reactive+groups+for+the+prospective+design+of+irreversible+inhibitors&doi=10.1021%2Fjm501412a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors</span></div><div class="casAuthors">Flanagan, Mark E.; Abramite, Joseph A.; Anderson, Dennis P.; Aulabaugh, Ann; Dahal, Upendra P.; Gilbert, Adam M.; Li, Chao; Montgomery, Justin; Oppenheimer, Stacey R.; Ryder, Tim; Schuff, Brandon P.; Uccello, Daniel P.; Walker, Gregory S.; Wu, Yan; Brown, Matthew F.; Chen, Jinshan M.; Hayward, Matthew M.; Noe, Mark C.; Obach, R. Scott; Philippe, Laurence; Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Starr, Jeremy; Stroh, Justin; Che, Ye</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10072-10079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interest in drugs that covalently modify their target is driven by the desire for enhanced efficacy that can result from the silencing of enzymic activity until protein resynthesis can occur, along with the potential for increased selectivity by targeting uniquely positioned nucleophilic residues in the protein.  However, covalent approaches carry addnl. risk for toxicities or hypersensitivity reactions that can result from covalent modification of unintended targets.  Here we describe methods for measuring the reactivity of covalent reactive groups (CRGs) with a biol. relevant nucleophile, glutathione (GSH), along with kinetic data for a broad array of electrophiles.  We also describe a computational method for predicting electrophilic reactivity, which taken together can be applied to the prospective design of thiol-reactive covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzTSCv_Nj6bVg90H21EOLACvtfcHk0ljpwYcLrtjwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM&md5=3ccf59ab7a494655185e5eb5becf8c48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501412a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501412a%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DOppenheimer%26aufirst%3DS.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DSchuff%26aufirst%3DB.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DJ.%26aulast%3DChe%26aufirst%3DY.%26atitle%3DChemical%2520and%2520computational%2520methods%2520for%2520the%2520characterization%2520of%2520covalent%2520reactive%2520groups%2520for%2520the%2520prospective%2520design%2520of%2520irreversible%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10072%26epage%3D10079%26doi%3D10.1021%2Fjm501412a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Systematic study of the glutathione (GSH) reactivity of N-arylacrylamides: 1. effects of aryl substitution</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9171</span>– <span class="NLM_lpage">9178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9171-9178&author=V.+J.+Ceeauthor=L.+P.+Volakauthor=Y.+Chenauthor=M.+D.+Bartbergerauthor=C.+Tegleyauthor=T.+Arvedsonauthor=J.+McCarterauthor=A.+S.+Taskerauthor=C.+Fotsch&title=Systematic+study+of+the+glutathione+%28GSH%29+reactivity+of+N-arylacrylamides%3A+1.+effects+of+aryl+substitution&doi=10.1021%2Facs.jmedchem.5b01018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution</span></div><div class="casAuthors">Cee, Victor J.; Volak, Laurie P.; Chen, Yuping; Bartberger, Michael D.; Tegley, Chris; Arvedson, Tara; McCarter, John; Tasker, Andrew S.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9171-9178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Success in the design of targeted covalent inhibitors depends in part on a knowledge of the factors influencing electrophile reactivity.  In an effort to further develop an understanding of structure-reactivity relations among N-arylacrylamides, the authors detd. glutathione (GSH) reaction rates for a family of N-arylacrylamides independently substituted at ortho-, meta-, and para-positions with 11 different groups common to inhibitor design.  Substituent effects on reaction rates show a linear Hammett correlation for ortho-, meta-, and para-substitution.  The authors note a correlation between 1H and 13C NMR chem. shifts of the acrylamide with GSH reaction rates, suggesting that NMR chem. shifts may be a convenient surrogate measure of relative acrylamide reactivity.  D. functional theory calcns. reveal a correlation between computed activation parameters and exptl. detd. reaction rates, validating the use of such methodol. for the screening of synthetic candidates in a prospective fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAoYRfo0lRj7Vg90H21EOLACvtfcHk0ljpwYcLrtjwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN&md5=2f3a816446dd73d5be061ad8d2195e2d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01018%26sid%3Dliteratum%253Aachs%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DTegley%26aufirst%3DC.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DSystematic%2520study%2520of%2520the%2520glutathione%2520%2528GSH%2529%2520reactivity%2520of%2520N-arylacrylamides%253A%25201.%2520effects%2520of%2520aryl%2520substitution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9171%26epage%3D9178%26doi%3D10.1021%2Facs.jmedchem.5b01018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7025</span>– <span class="NLM_lpage">7048</span>, <span class="refDoi"> DOI: 10.1021/jm400822z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400822z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CltL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7025-7048&author=R.+A.+Wardauthor=M.+J.+Andertonauthor=S.+Ashtonauthor=P.+A.+Bethelauthor=M.+Boxauthor=S.+Butterworthauthor=N.+Colcloughauthor=C.+G.+Chorleyauthor=C.+Chuaquiauthor=D.+A.+Crossauthor=L.+A.+Dakinauthor=J.+%C3%89.+Debreczeniauthor=C.+Eberleinauthor=M.+R.+Finlayauthor=G.+B.+Hillauthor=M.+Gristauthor=T.+C.+Klinowskaauthor=C.+Laneauthor=S.+Martinauthor=J.+P.+Ormeauthor=P.+Smithauthor=F.+Wangauthor=M.+J.+Waring&title=Structure-+and+reactivity-based+development+of+covalent+inhibitors+of+the+activating+and+gatekeeper+mutant+forms+of+the+epidermal+growth+factor+receptor+%28EGFR%29&doi=10.1021%2Fjm400822z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)</span></div><div class="casAuthors">Ward, Richard A.; Anderton, Mark J.; Ashton, Susan; Bethel, Paul A.; Box, Matthew; Butterworth, Sam; Colclough, Nicola; Chorley, Christopher G.; Chuaqui, Claudio; Cross, Darren A. E.; Dakin, Les A.; Debreczeni, Judit E.; Eberlein, Cath; Finlay, M. Raymond V.; Hill, George B.; Grist, Matthew; Klinowska, Teresa C. M.; Lane, Clare; Martin, Scott; Orme, Jonathon P.; Smith, Peter; Wang, Fengjiang; Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7025-7048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of small-mol. inhibitors has been developed to target the double mutant form of the epidermal growth factor receptor (EGFR) tyrosine kinase, which is resistant to treatment with gefitinib and erlotinib.  Our reported compds. also show selectivity over wild-type EGFR.  Guided by mol. modeling, this series was evolved to target a cysteine residue in the ATP binding site via covalent bond formation and demonstrates high levels of activity in cellular models of the double mutant form of EGFR.  In addn., these compds. show significant activity against the activating mutations, which gefitinib and erlotinib target and inhibition of which gives rise to their obsd. clin. efficacy.  A glutathione (GSH)-based assay was used to measure thiol reactivity toward the electrophilic functionality of the inhibitor series, enabling both the identification of a suitable reactivity window for their potency and the development of a reactivity quant. structure-property relationship (QSPR) to support design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKi6oNvtQPEbVg90H21EOLACvtfcHk0ljYtwP-xnqY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CltL%252FN&md5=59c86415d71ac2abe5c6d4486e5d2517</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm400822z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400822z%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DChorley%26aufirst%3DC.%2BG.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDebreczeni%26aufirst%3DJ.%2B%25C3%2589.%26aulast%3DEberlein%26aufirst%3DC.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DKlinowska%26aufirst%3DT.%2BC.%26aulast%3DLane%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DStructure-%2520and%2520reactivity-based%2520development%2520of%2520covalent%2520inhibitors%2520of%2520the%2520activating%2520and%2520gatekeeper%2520mutant%2520forms%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7025%26epage%3D7048%26doi%3D10.1021%2Fjm400822z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palkowitz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of diverse N-acryloyl azetidines and evaluation of their enhanced thiol reactivities</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2270</span>– <span class="NLM_lpage">2273</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=2270-2273&author=M.+D.+Palkowitzauthor=B.+Tanauthor=H.+Huauthor=K.+Rothauthor=R.+A.+Bauer&title=Synthesis+of+diverse+N-acryloyl+azetidines+and+evaluation+of+their+enhanced+thiol+reactivities&doi=10.1021%2Facs.orglett.7b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span></div><div class="casAuthors">Palkowitz, Maximilian D.; Tan, Bo; Hu, Haitao; Roth, Kenneth; Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2270-2273</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl azetidines exhibit nonplanar hybridization, leading to lower amide-like character of the corresponding (O)C-N bonds.  This impacts N-acryloyl azetidines by producing enhanced electrophilicy at appended Michael acceptors.  Herein, reactivity data are reported in the presence of glutathione (GSH) in phosphate buffer (pH 7.4) at 37 °C.  Wide reactivity ranges are obsd. by varying substitution at the Michael acceptor or by modulating the electron-withdrawing character of substituents at the C3 position of the azetidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUFdHgOWgc7Vg90H21EOLACvtfcHk0ljYtwP-xnqY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D&md5=d65414bda2976c07bc76cd0df6d4a38d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPalkowitz%26aufirst%3DM.%2BD.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520of%2520diverse%2520N-acryloyl%2520azetidines%2520and%2520evaluation%2520of%2520their%2520enhanced%2520thiol%2520reactivities%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D2270%26epage%3D2273%26doi%3D10.1021%2Facs.orglett.7b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kathman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statsyuk, A. V.</span></span> <span> </span><span class="NLM_article-title">A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4969</span>– <span class="NLM_lpage">4974</span>, <span class="refDoi"> DOI: 10.1021/jm500345q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500345q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4969-4974&author=S.+G.+Kathmanauthor=Z.+Xuauthor=A.+V.+Statsyuk&title=A+fragment-based+method+to+discover+irreversible+covalent+inhibitors+of+cysteine+proteases&doi=10.1021%2Fjm500345q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases</span></div><div class="casAuthors">Kathman, Stefan G.; Xu, Ziyang; Statsyuk, Alexander V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4969-4974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel fragment-based drug discovery approach is reported which irreversibly tethers drug-like fragments to catalytic cysteines.  Acrylamides, acylaminoacrylates, vinylsulfonamides, and acylaminopropenyl sulfones were prepd. and the dependence of their rates of reaction with N-acetylcysteine Me ester on their structure was detd.; of the compds. tested, the rate of Michael addn. of N-acetylcysteine Me ester to acylaminoacrylates depended least on the acyl moiety.  A library of 100 fragment-substituted acylaminoacrylates was prepd.; addn. of subsets of the library to papain followed by mass spectrometric anal. identified three acylaminoacrylates which selectively reacted with the cysteine protease papain.  The kinetics of the inhibition of papain by the acylaminoacrylates, the effect of known inhibitors of papain on its inhibition by the acylaminoacrylates, and the lack of inhibition of other cysteine proteases (human rhinovirus 3C protease, the catalytic domain of the deubiquitinase USP08, and the E2 ubiquitin-conjugating enzyme UbcH7) by the acylaminoacrylates supported their identification as selective and irreversible papain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXt6xtGfQ_w7Vg90H21EOLACvtfcHk0ljYtwP-xnqY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWiur0%253D&md5=39dee964ac1ba26ed373eedbd86102ac</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm500345q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500345q%26sid%3Dliteratum%253Aachs%26aulast%3DKathman%26aufirst%3DS.%2BG.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DStatsyuk%26aufirst%3DA.%2BV.%26atitle%3DA%2520fragment-based%2520method%2520to%2520discover%2520irreversible%2520covalent%2520inhibitors%2520of%2520cysteine%2520proteases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4969%26epage%3D4974%26doi%3D10.1021%2Fjm500345q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q.</span></span> <span> </span><span class="NLM_article-title">Haem-activated promiscuous targeting of artemisinin in plasmodium falciparum</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10111</span>, <span class="refDoi"> DOI: 10.1038/ncomms10111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1038%2Fncomms10111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26694030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10111&author=J.+Wangauthor=C.+J.+Zhangauthor=W.+N.+Chiaauthor=C.+C.+Lohauthor=Z.+Liauthor=Y.+M.+Leeauthor=Y.+Heauthor=L.+X.+Yuanauthor=T.+K.+Limauthor=M.+Liuauthor=C.+X.+Liewauthor=Y.+Q.+Leeauthor=J.+Zhangauthor=N.+Luauthor=C.+T.+Limauthor=Z.+C.+Huaauthor=B.+Liuauthor=H.+M.+Shenauthor=K.+S.+Tanauthor=Q.+Lin&title=Haem-activated+promiscuous+targeting+of+artemisinin+in+plasmodium+falciparum&doi=10.1038%2Fncomms10111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Jigang; Zhang, Chong-Jing; Chia, Wan Ni; Loh, Cheryl C. Y.; Li, Zhengjun; Lee, Yew Mun; He, Yingke; Yuan, Li-Xia; Lim, Teck Kwang; Liu, Min; Liew, Chin Xia; Lee, Yan Quan; Zhang, Jianbin; Lu, Nianci; Lim, Chwee Teck; Hua, Zi-Chun; Liu, Bin; Shen, Han-Ming; Tan, Kevin S. W.; Lin, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10111</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of action of artemisinin and its derivs., the most potent of the anti-malarial drugs, is not completely understood.  Here we present an unbiased chem. proteomics anal. to directly explore this mechanism in Plasmodium falciparum.  We use an alkyne-tagged artemisinin analog coupled with biotin to identify 124 artemisinin covalent binding protein targets, many of which are involved in the essential biol. processes of the parasite.  Such a broad targeting spectrum disrupts the biochem. landscape of the parasite and causes its death.  Furthermore, using alkyne-tagged artemisinin coupled with a fluorescent dye to monitor protein binding, we show that haem, rather than free ferrous iron, is predominantly responsible for artemisinin activation.  The haem derives primarily from the parasite's haem biosynthesis pathway at the early ring stage and from Hb digestion at the latter stages.  Our results support a unifying model to explain the action and specificity of artemisinin in parasite killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsYEHWprDdeLVg90H21EOLACvtfcHk0lhcLJzgAg4Okg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO&md5=a532a76cdd2f33b0ca23e733e6247a0c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncomms10111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DChia%26aufirst%3DW.%2BN.%26aulast%3DLoh%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DL.%2BX.%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiew%26aufirst%3DC.%2BX.%26aulast%3DLee%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DC.%2BT.%26aulast%3DHua%26aufirst%3DZ.%2BC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DH.%2BM.%26aulast%3DTan%26aufirst%3DK.%2BS.%26aulast%3DLin%26aufirst%3DQ.%26atitle%3DHaem-activated%2520promiscuous%2520targeting%2520of%2520artemisinin%2520in%2520plasmodium%2520falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10111%26doi%3D10.1038%2Fncomms10111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Targeted covalent inhibitors for drug design</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1002/anie.201601091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.201601091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2-17&author=T.+A.+Baillie&title=Targeted+covalent+inhibitors+for+drug+design&doi=10.1002%2Fanie.201601091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601091%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DTargeted%2520covalent%2520inhibitors%2520for%2520drug%2520design%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2016%26volume%3D55%26spage%3D2%26epage%3D17%26doi%3D10.1002%2Fanie.201601091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copple, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of irreversible analogues of bardoxolone methyl for the identification of pharmacologically relevant targets and interaction sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2396</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2396-2409&author=M.+H.+Wongauthor=H.+K.+Bryanauthor=I.+M.+Coppleauthor=R.+E.+Jenkinsauthor=P.+H.+Chiuauthor=J.+Bibbyauthor=N.+G.+Berryauthor=N.+R.+Kitteringhamauthor=C.+E.+Goldringauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=Design+and+synthesis+of+irreversible+analogues+of+bardoxolone+methyl+for+the+identification+of+pharmacologically+relevant+targets+and+interaction+sites&doi=10.1021%2Facs.jmedchem.5b01292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites</span></div><div class="casAuthors">Wong, Michael H. L.; Bryan, Holly K.; Copple, Ian M.; Jenkins, Rosalind E.; Chiu, Pak Him; Bibby, Jaclyn; Berry, Neil G.; Kitteringham, Neil R.; Goldring, Christopher E.; O'Neill, Paul M.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2396-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Semisynthetic triterpenoids such as bardoxolone Me (methyl-2-cyano 3,12-dioxooleano-1,9-dien-28-oate; CDDO-Me) (I) are potent inducers of antioxidant and anti-inflammatory signaling pathways, including those regulated by the transcription factor Nrf2.  However, the reversible nature of the interaction between triterpenoids and thiols has hindered attempts to identify pharmacol. relevant targets and characterize the sites of interaction.  Here, we report a shortened synthesis and SAR profiling of I, enabling the design of analogs that react irreversibly with model thiols, as well as the model protein glutathione S-transferase P1, in vitro.  We show that one of these analogs, CDDO-epoxide (II), is comparable to I in terms of cytotoxicity and potency toward Nrf2 in rat hepatoma cells and stably modifies specific cysteine residues (namely, Cys-257, -273, -288, -434, -489, and -613) within Keap1, the major repressor of Nrf2, both in vitro and in living cells.  Supported by mol. modeling, these data demonstrate the value of II for identifying site(s) of interaction with pharmacol. relevant targets and informing the continuing development of triterpenoids as novel drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjC_Ca8KocPLVg90H21EOLACvtfcHk0lhcLJzgAg4Okg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D&md5=eb2c0d997a2b22ceb41b75c203bb27fc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01292%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DBryan%26aufirst%3DH.%2BK.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DChiu%26aufirst%3DP.%2BH.%26aulast%3DBibby%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520irreversible%2520analogues%2520of%2520bardoxolone%2520methyl%2520for%2520the%2520identification%2520of%2520pharmacologically%2520relevant%2520targets%2520and%2520interaction%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2396%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.5b01292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Federspiel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codreanu, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albertolle, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span> <span> </span><span class="NLM_article-title">Specificity of protein covalent modification by the electrophilic proteasome inhibitor carfilzomib in human cells</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3233</span>– <span class="NLM_lpage">3242</span>, <span class="refDoi"> DOI: 10.1074/mcp.M116.059709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1074%2Fmcp.M116.059709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27503896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=3233-3242&author=J.+D.+Federspielauthor=S.+G.+Codreanuauthor=S.+Goyalauthor=M.+E.+Albertolleauthor=E.+Loweauthor=J.+Teagueauthor=H.+L.+Wongauthor=F.+P.+Guengerichauthor=D.+C.+Liebler&title=Specificity+of+protein+covalent+modification+by+the+electrophilic+proteasome+inhibitor+carfilzomib+in+human+cells&doi=10.1074%2Fmcp.M116.059709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of protein covalent modification by the electrophilic proteasome inhibitor carfilzomib in human cells</span></div><div class="casAuthors">Federspiel, Joel D.; Codreanu, Simona G.; Goyal, Sandeep; Albertolle, Matthew E.; Lowe, Eric; Teague, Juli; Wong, Hansen; Guengerich, F. Peter; Liebler, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3233-3242</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Carfilzomib (CFZ) is a second-generation proteasome inhibitor that is Food and Drug Administration and European Commission approved for the treatment of relapsed or refractory multiple myeloma.  CFZ is an epoxomicin deriv. with an epoxyketone electrophilic warhead that irreversibly adducts the catalytic threonine residue of the β5 subunit of the proteasome.  Although CFZ produces a highly potent, sustained inactivation of the proteasome, the electrophilic nature of the drug could potentially produce off-target protein adduction.  To address this possibility, we synthesized an alkynyl analog of CFZ and investigated protein adduction by this analog in HepG2 cells.  Using click chem. coupled with streptavidin based IP and shotgun tandem mass spectrometry (MS/MS), we identified two off-target proteins, cytochrome P 450 27A1 (CYP27A1) and glutathione S-transferase omega 1 (GSTO1), as targets of the alkynyl CFZ probe.  We confirmed the adduction of CYP27A1 and GSTO1 by streptavidin capture and immunoblotting methodol. and then site-specifically mapped the adducts with targeted MS/MS methods.  Although CFZ adduction of CYP27A1 and GSTO1 in vitro decreased the activities of these enzymes, the small fraction of these proteins modified by CFZ in intact cells should limit the impact of these offtarget modifications.  The data support the high selectivity of CFZ for covalent modification of its therapeutic targets, despite the presence of a reactive electrophile.  The approach we describe offers a generalizable method to evaluate the safety profile of covalent protein-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1MWDdlf62B7Vg90H21EOLACvtfcHk0lgWEG0hvF7REQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCnsLs%253D&md5=ff2d31854362ad6b6c7f8ea2129acdc8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M116.059709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M116.059709%26sid%3Dliteratum%253Aachs%26aulast%3DFederspiel%26aufirst%3DJ.%2BD.%26aulast%3DCodreanu%26aufirst%3DS.%2BG.%26aulast%3DGoyal%26aufirst%3DS.%26aulast%3DAlbertolle%26aufirst%3DM.%2BE.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%2BL.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26atitle%3DSpecificity%2520of%2520protein%2520covalent%2520modification%2520by%2520the%2520electrophilic%2520proteasome%2520inhibitor%2520carfilzomib%2520in%2520human%2520cells%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2016%26volume%3D15%26spage%3D3233%26epage%3D3242%26doi%3D10.1074%2Fmcp.M116.059709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span> <span> </span><span class="NLM_article-title">Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1061</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.drudis.2015.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26002380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=1061-1073&author=R.+A.+Bauer&title=Covalent+inhibitors+in+drug+discovery%3A+from+accidental+discoveries+to+avoided+liabilities+and+designed+therapies&doi=10.1016%2Fj.drudis.2015.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies</span></div><div class="casAuthors">Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1061-1073</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Drugs that covalently bond to their biol. targets have a long history in drug discovery.  A look at drug approvals in recent years suggests that covalent drugs will continue to make impacts on human health for years to come.  Although fraught with concerns about toxicity, the high potencies and prolonged effects achievable with covalent drugs may result in less-frequent drug dosing and in wide therapeutic margins for patients.  Covalent inhibition can also dissoc. drug pharmacodynamics (PD) from pharmacokinetics (PK), which can result in desired drug efficacy for inhibitors that have short systemic exposure.  Evidence suggests that there is a reduced risk for the development of resistance against covalent drugs, which is a major challenge in areas such as oncol. and infectious disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkBDsUEu4arVg90H21EOLACvtfcHk0lgWEG0hvF7REQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOnu7s%253D&md5=6ba5b016d2804c7d56838a2724b9a0b9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DCovalent%2520inhibitors%2520in%2520drug%2520discovery%253A%2520from%2520accidental%2520discoveries%2520to%2520avoided%2520liabilities%2520and%2520designed%2520therapies%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D1061%26epage%3D1073%26doi%3D10.1016%2Fj.drudis.2015.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, J. K.</span></span> <span> </span><span class="NLM_article-title">Oridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">701</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2011.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.biocel.2011.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=21295154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=701-704&author=C.+Y.+Liauthor=E.+Q.+Wangauthor=Y.+Chengauthor=J.+K.+Bao&title=Oridonin%3A+an+active+diterpenoid+targeting+cell+cycle+arrest%2C+apoptotic+and+autophagic+pathways+for+cancer+therapeutics&doi=10.1016%2Fj.biocel.2011.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics</span></div><div class="casAuthors">Li, Chun-yang; Wang, En-qin; Cheng, Yan; Bao, Jin-ku</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">701-704</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is well-known that cell cycle arrest and/or death play a pivotal role in tumor progression, which has drawn a rising attention for cancer biologists due to their complex and intricate relationships.  In this review, we demonstrate the recent research on oridonin, an active diterpenoid with remarkable anti-proliferative activities, and then further explore its mol. mechanisms of cell cycle arrest, apoptosis, autophagy and their cross-talks in various cancer cells, which may provide a new perspective of oridonin as a candidate anti-neoplastic drug for future cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy8n0E52UccrVg90H21EOLACvtfcHk0lgWEG0hvF7REQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSmsL0%253D&md5=9e899aba27ef93235c383f30e2ddc436</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2011.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2011.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DJ.%2BK.%26atitle%3DOridonin%253A%2520an%2520active%2520diterpenoid%2520targeting%2520cell%2520cycle%2520arrest%252C%2520apoptotic%2520and%2520autophagic%2520pathways%2520for%2520cancer%2520therapeutics%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2011%26volume%3D43%26spage%3D701%26epage%3D704%26doi%3D10.1016%2Fj.biocel.2011.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">474</span>, <span class="refDoi"> DOI: 10.3390/molecules23020474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3390%2Fmolecules23020474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OhsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=474&author=J.+Xuauthor=E.+A.+Woldauthor=Y.+Dingauthor=Q.+Shenauthor=J.+Zhou&title=Therapeutic+potential+of+oridonin+and+its+analogs%3A+from+anticancer+and+antiinflammation+to+neuroprotection&doi=10.3390%2Fmolecules23020474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection</span></div><div class="casAuthors">Xu, Jimin; Wold, Eric A.; Ding, Ye; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">474/1-474/16</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Oridonin, a diterpenoid natural product commonly used in East Asian herbal medicine, is garnering increased attention in the biomedical community due to its extensive biol. activities that include antitumor, anti-inflammatory, antimicrobial, hepatic fibrosis prevention, and neurol. effects.  Over the past decade, significant progress has been made in structure activity relationship and mechanism of action studies of oridonin for the treatment of cancer and other diseases.  This review provides a brief summary on oridonin and its analogs in cancer drug discovery and antiinflammation and highlights its emerging therapeutic potential in neuroprotection applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgkNPnZO0SgrVg90H21EOLACvtfcHk0lgWEG0hvF7REQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OhsrvN&md5=022222bcdebc4dac9f398d7c0dea99ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020474%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DTherapeutic%2520potential%2520of%2520oridonin%2520and%2520its%2520analogs%253A%2520from%2520anticancer%2520and%2520antiinflammation%2520to%2520neuroprotection%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D474%26doi%3D10.3390%2Fmolecules23020474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of natural product oridonin-inspired anticancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.ejmech.2016.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27344488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=102-117&author=Y.+Dingauthor=C.+Dingauthor=N.+Yeauthor=Z.+Liuauthor=E.+A.+Woldauthor=H.+Chenauthor=C.+Wildauthor=Q.+Shenauthor=J.+Zhou&title=Discovery+and+development+of+natural+product+oridonin-inspired+anticancer+agents&doi=10.1016%2Fj.ejmech.2016.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of natural product oridonin-inspired anticancer agents</span></div><div class="casAuthors">Ding, Ye; Ding, Chunyong; Ye, Na; Liu, Zhiqing; Wold, Eric A.; Chen, Haiying; Wild, Christopher; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Natural products have historically been, and continue to be, an invaluable source for the discovery of various therapeutic agents.  Oridonin, a natural diterpenoid widely applied in traditional Chinese medicines, exhibits a broad range of biol. effects including anticancer and anti-inflammatory activities.  To further improve its potency, aq. soly. and bioavailability, the oridonin template serves as an exciting platform for drug discovery to yield better candidates with unique targets and enhanced drug properties.  A no. of oridonin derivs. (e.g. HAO472) have been designed and synthesized, and have contributed to substantial progress in the identification of new agents and relevant mol. mechanistic studies toward the treatment of human cancers and other diseases.  This review summarizes the recent advances in medicinal chem. on the explorations of novel oridonin analogs as potential anticancer therapeutics, and provides a detailed discussion of future directions for the development and progression of this class of mols. into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv6x0p1uhEt7Vg90H21EOLACvtfcHk0lhED91TqM-eyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsL3E&md5=0cce14ee999e3e59fe48cf6a1249d90b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520development%2520of%2520natural%2520product%2520oridonin-inspired%2520anticancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D122%26spage%3D102%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2016.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span> <span> </span><span class="NLM_article-title">ent-Kaurane diterpenoids from Chinese liverworts and their antitumor activities through Michael addition as detected in situ by a fluorescence probe</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3944</span>– <span class="NLM_lpage">3956</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3944-3956&author=Z.+Linauthor=Y.+Guoauthor=Y.+Gaoauthor=S.+Wangauthor=X.+Wangauthor=Z.+Xieauthor=H.+Niuauthor=W.+Changauthor=L.+Liuauthor=H.+Yuanauthor=H.+Lou&title=ent-Kaurane+diterpenoids+from+Chinese+liverworts+and+their+antitumor+activities+through+Michael+addition+as+detected+in+situ+by+a+fluorescence+probe&doi=10.1021%2Facs.jmedchem.5b00208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ent-Kaurane Diterpenoids from Chinese Liverworts and Their Antitumor Activities through Michael Addition As Detected in Situ by a Fluorescence Probe</span></div><div class="casAuthors">Lin, Zhaomin; Guo, Yanxia; Gao, Yanhui; Wang, Shuqi; Wang, Xiaoning; Xie, Zhiyu; Niu, Huanmin; Chang, Wenqiang; Liu, Lei; Yuan, Huiqing; Lou, Hongxiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3944-3956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is generally accepted that the origin of the cytotoxicity of ent-kaurane diterpenoids is due to the formation of reactive oxygen species (ROS) and that the α,β-unsatd. carbonyl is a pivotal moiety.  Herein we demonstrate the isolation of 32 new and 12 known ent-kaurane diterpenoids from two Chinese liverworts.  These compds. and three semisynthesized derivs. were screened against human cancer cell lines.  The results revealed that their anticancer activities are caused by ROS formation through Michael modification of the protein thiols and depletion of glutathione unselectively.  We also found that N-acetylcysteine reverses the cytotoxicity of these diterpenoids by forming Michael adducts, not through a well-recognized ROS scavenging pathway as previously reported.  In situ intracellular thiol detection helped us visualize the intracellular distribution of the diterpenoids and det. the potency of their cytotoxicity.  An alk. analog was found to be more selective because of the altered subcellular distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f8oGSL_Bz7Vg90H21EOLACvtfcHk0lhED91TqM-eyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2nsLo%253D&md5=18fd5c20f9f34fd87ef4c31058efe107</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00208%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLou%26aufirst%3DH.%26atitle%3Dent-Kaurane%2520diterpenoids%2520from%2520Chinese%2520liverworts%2520and%2520their%2520antitumor%2520activities%2520through%2520Michael%2520addition%2520as%2520detected%2520in%2520situ%2520by%2520a%2520fluorescence%2520probe%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3944%26epage%3D3956%26doi%3D10.1021%2Facs.jmedchem.5b00208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nan, F. J.</span>; <span class="NLM_string-name">Zhang, Y. M.</span>; <span class="NLM_string-name">Liu, H. N.</span>; <span class="NLM_string-name">Ding, J.</span>; <span class="NLM_string-name">Meng, L.
H.</span>; <span class="NLM_string-name">Xu, C. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Derivatization of an ent-Kaurane Diterpenoid</span>.  <i>Chinese Patent</i> <span class="NLM_patent">CN102584760A</span>, <span class="NLM_year">01/13/2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=01%2F13%2F2011&author=F.+J.+Nan&author=Y.+M.+Zhang&author=H.+N.+Liu&author=J.+Ding&author=L.%0AH.+Meng&author=C.+H.+Xu&title=Synthesis+and+Derivatization+of+an+ent-Kaurane+Diterpenoid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNan%26aufirst%3DF.%2BJ.%26atitle%3DSynthesis%2520and%2520Derivatization%2520of%2520an%2520ent-Kaurane%2520Diterpenoid%26jtitle%3DChinese%2520Patent%26date%3D01%252F13%252F2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response</span>. <i>Environ. Health Persp.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1289/ehp.11464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1289%2Fehp.11464" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2008&pages=1154-1161&author=Y.+Duauthor=N.+F.+Villeneuveauthor=X.+J.+Wangauthor=Z.+Sunauthor=W.+Chenauthor=J.+Liauthor=H.+Louauthor=P.+K.+Wongauthor=D.+D.+Zhang&title=Oridonin+confers+protection+against+arsenic-induced+toxicity+through+activation+of+the+Nrf2-mediated+defensive+response&doi=10.1289%2Fehp.11464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1289%2Fehp.11464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.11464%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DP.%2BK.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DOridonin%2520confers%2520protection%2520against%2520arsenic-induced%2520toxicity%2520through%2520activation%2520of%2520the%2520Nrf2-mediated%2520defensive%2520response%26jtitle%3DEnviron.%2520Health%2520Persp.%26date%3D2008%26volume%3D116%26spage%3D1154%26epage%3D1161%26doi%3D10.1289%2Fehp.11464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">127ra38</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1126%2Fscitranslmed.3003562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=22461642" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=127ra38&author=T.+Zhenauthor=C.+F.+Wuauthor=P.+Liuauthor=H.+Y.+Wuauthor=G.+B.+Zhouauthor=Y.+Luauthor=J.+X.+Liuauthor=Y.+Liangauthor=K.+K.+Liauthor=Y.+Y.+Wangauthor=Y.+Y.+Xieauthor=M.+M.+Heauthor=H.+M.+Caoauthor=W.+N.+Zhangauthor=L.+M.+Chenauthor=K.+Petrieauthor=S.+J.+Chenauthor=Z.+Chen&title=Targeting+of+AML1-ETO+in+t%288%3B21%29+leukemia+by+oridonin+generates+a+tumor+suppressor-like+protein&doi=10.1126%2Fscitranslmed.3003562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003562%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DC.%2BF.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DZhou%26aufirst%3DG.%2BB.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BY.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHe%26aufirst%3DM.%2BM.%26aulast%3DCao%26aufirst%3DH.%2BM.%26aulast%3DZhang%26aufirst%3DW.%2BN.%26aulast%3DChen%26aufirst%3DL.%2BM.%26aulast%3DPetrie%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DTargeting%2520of%2520AML1-ETO%2520in%2520t%25288%253B21%2529%2520leukemia%2520by%2520oridonin%2520generates%2520a%2520tumor%2520suppressor-like%2520protein%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D127ra38%26doi%3D10.1126%2Fscitranslmed.3003562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3441</span>– <span class="NLM_lpage">3450</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-06-032250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1182%2Fblood-2006-06-032250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=17197433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=3441-3450&author=G.+B.+Zhouauthor=H.+Kangauthor=L.+Wangauthor=L.+Gaoauthor=P.+Liuauthor=J.+Xieauthor=F.+X.+Zhangauthor=X.+Q.+Wengauthor=Z.+X.+Shenauthor=J.+Chenauthor=L.+J.+Guauthor=M.+Yanauthor=D.+E.+Zhangauthor=S.+J.+Chenauthor=Z.+Y.+Wangauthor=Z.+Chen&title=Oridonin%2C+a+diterpenoid+extracted+from+medicinal+herbs%2C+targets+AML1-ETO+fusion+protein+and+shows+potent+antitumor+activity+with+low+adverse+effects+on+t%288%3B21%29+leukemia+in+vitro+and+in+vivo&doi=10.1182%2Fblood-2006-06-032250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo</span></div><div class="casAuthors">Zhou, Guang-Biao; Kang, Hui; Wang, Lan; Gao, Li; Liu, Ping; Xie, Jun; Zhang, Feng-Xiang; Weng, Xiang-Qin; Shen, Zhi-Xiang; Chen, Jue; Gu, Long-Jun; Yan, Ming; Zhang, Dong-Er; Chen, Sai-Juan; Wang, Zhen-Yi; Chen, Zhu</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3441-3450</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Studies have documented the potential antitumor activities of oridonin, a compd. extd. from medicinal herbs.  However, whether oridonin can be used in the selected setting of hematol./oncol. remains obscure.  Here, we reported that oridonin induced apoptosis of t(8;21) acute myeloid leukemic (AML) cells.  Intriguingly, the t(8;21) product AML1-ETO (AE) fusion protein, which plays a crit. role in leukemogenesis, was degraded with generation of a catabolic fragment, while the expression pattern of AE target genes investigated could be reprogrammed.  The ectopic expression of AE enhanced the apoptotic effect of oridonin in U937 cells.  Preincubation with caspase inhibitors blocked oridonin-triggered cleavage of AE, while substitution of Ala for Asp at residues 188 in ETO moiety of the fusion abrogated AE degrdn.  Furthermore, oridonin prolonged lifespan of C57 mice bearing truncated AE-expressing leukemic cells without suppression of bone marrow or redn. of body wt. of animals, and exerted synergic effects while combined with cytosine arabinoside.  Oridonin also inhibited tumor growth in nude mice inoculated with t(8;21)-harboring Kasumi-1 cells.  These results suggest that oridonin may be a potential antileukemia agent that targets AE oncoprotein at residue D188 with low adverse effect, and may be helpful for the treatment of patients with t(8;21) AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_wey2HaXwrVg90H21EOLACvtfcHk0liMsXqjLs-SVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWhsrw%253D&md5=9cf2b38066ec9c39b8e6ac6280e35d3b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-06-032250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-06-032250%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%2BB.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%2BX.%26aulast%3DWeng%26aufirst%3DX.%2BQ.%26aulast%3DShen%26aufirst%3DZ.%2BX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DL.%2BJ.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DD.%2BE.%26aulast%3DChen%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DOridonin%252C%2520a%2520diterpenoid%2520extracted%2520from%2520medicinal%2520herbs%252C%2520targets%2520AML1-ETO%2520fusion%2520protein%2520and%2520shows%2520potent%2520antitumor%2520activity%2520with%2520low%2520adverse%2520effects%2520on%2520t%25288%253B21%2529%2520leukemia%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D3441%26epage%3D3450%26doi%3D10.1182%2Fblood-2006-06-032250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, K. M.</span></span> <span> </span><span class="NLM_article-title">Inflammatory aortitis controlled by the Chinese herbal remedy Donglingcao Pian</span>. <i>Rheumatology (Oxford, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1259</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/ken209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1093%2Frheumatology%2Fken209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=18577551" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1257-1259&author=C.+De%0ASilvaauthor=R.+Stevensauthor=K.+M.+Jordan&title=Inflammatory+aortitis+controlled+by+the+Chinese+herbal+remedy+Donglingcao+Pian&doi=10.1093%2Frheumatology%2Fken209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fken209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fken209%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSilva%26aufirst%3DC.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DK.%2BM.%26atitle%3DInflammatory%2520aortitis%2520controlled%2520by%2520the%2520Chinese%2520herbal%2520remedy%2520Donglingcao%2520Pian%26jtitle%3DRheumatology%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2008%26volume%3D47%26spage%3D1257%26epage%3D1259%26doi%3D10.1093%2Frheumatology%2Fken209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. W.</span></span> <span> </span><span class="NLM_article-title">Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B</span>. <i>J. Dig. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1111/1751-2980.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1111%2F1751-2980.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26718746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVCqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=104-112&author=Q.+Q.+Liuauthor=H.+L.+Wangauthor=K.+Chenauthor=S.+B.+Wangauthor=Y.+Xuauthor=Q.+Yeauthor=Y.+W.+Sun&title=Oridonin+derivative+ameliorates+experimental+colitis+by+inhibiting+activated+T-cells+and+translocation+of+nuclear+factor-kappa+B&doi=10.1111%2F1751-2980.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B</span></div><div class="casAuthors">Liu, Qian Qian; Wang, Hai Li; Chen, Ke; Wang, Shu Bei; Xu, Ying; Ye, Qiao; Sun, Yun Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Digestive Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">JDDOA9</span>;
        ISSN:<span class="NLM_cas:issn">1751-2972</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Objective : To confirm the potential therapeutic efficacy of HAO472 against inflammatory bowel disease (IBD), we investigated the modulatory functions of HAO472 in a mouse model of trinitrobenzene sulfonic acid (TNBS)-induced colitis.  Methods : Colitis was induced via an intrarectal injection of TNBS in mice.  HAO472 (5.0 mg/kg or 7.5 mg/kg) or 1 mg/kg dexamethasone (DX) was injected i.p. into the mice after the TNBS administration.  Behavioral and wt. changes, macroscopic and histol. assessments of colon, the expressions of tumor necrosis factor (TNF)-α, interferon (IFN)-γ and interleukin (IL)-17A, cyclooxygenase (COX)-2, inducible nitric oxide synthase (iNOS) and nuclear factor-kappa B (NF-κB) in the colonic tissues were evaluated.  The effect of HAO472 on NF-κB signaling pathway in lymphocytes was also investigated.  Results : HAO472 significantly ameliorated the clin. symptoms, reduced the severity of the inflammation and decreased mortality in the mouse model.  HAO472 also reduced TNF-α, IFN-γ, IL-17A, iNOS/COX-2 and lymphocyte proliferation.  These changes were assocd. with a significant decrease in NF-κB p65 expression and activity.  Conclusion : HAO472 has pos. effects on TNBS-induced colitis by modulating the subsets and functions of lymphocytes, suppressing inflammation and inhibiting the nuclear translocation of NF-κB p65 subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrPHOzXBkHmrVg90H21EOLACvtfcHk0liMsXqjLs-SVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVCqsrk%253D&md5=11a1af379ed95a81222dbb1e0e517211</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2F1751-2980.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1751-2980.12314%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%2BQ.%26aulast%3DWang%26aufirst%3DH.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%2BW.%26atitle%3DOridonin%2520derivative%2520ameliorates%2520experimental%2520colitis%2520by%2520inhibiting%2520activated%2520T-cells%2520and%2520translocation%2520of%2520nuclear%2520factor-kappa%2520B%26jtitle%3DJ.%2520Dig.%2520Dis.%26date%3D2016%26volume%3D17%26spage%3D104%26epage%3D112%26doi%3D10.1111%2F1751-2980.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P. Y.</span>; <span class="NLM_string-name">Wu, G.
L.</span>; <span class="NLM_string-name">Qiu, Z. J.</span>; <span class="NLM_string-name">Chen, Y. J.</span></span> <span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-alanine-(14-oridonin) Ester Trifluoroacetate as well as Preparation Method and Application</span>.  <i>Chinese Patent</i> <span class="NLM_patent">CN104017000A</span>, <span class="NLM_year">09/03/2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=09%2F03%2F2014&author=P.+Y.+Sun&author=G.%0AL.+Wu&author=Z.+J.+Qiu&author=Y.+J.+Chen&title=l-alanine-%2814-oridonin%29+Ester+Trifluoroacetate+as+well+as+Preparation+Method+and+Application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DP.%2BY.%26atitle%3Dl-alanine-%252814-oridonin%2529%2520Ester%2520Trifluoroacetate%2520as%2520well%2520as%2520Preparation%2520Method%2520and%2520Application%26jtitle%3DChinese%2520Patent%26date%3D09%252F03%252F2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohanon, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastellini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, R. S.</span></span> <span> </span><span class="NLM_article-title">Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis</span>. <i>J. Surg. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>199</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1016/j.jss.2015.07.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.jss.2015.07.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26409288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOmt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2015&pages=441-449&author=F.+J.+Bohanonauthor=X.+Wangauthor=B.+M.+Grahamauthor=C.+Dingauthor=Y.+Dingauthor=G.+L.+Radhakrishnanauthor=C.+Rastelliniauthor=J.+Zhouauthor=R.+S.+Radhakrishnan&title=Enhanced+effects+of+novel+oridonin+analog+CYD0682+for+hepatic+fibrosis&doi=10.1016%2Fj.jss.2015.07.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis</span></div><div class="casAuthors">Bohanon, Fredrick J.; Wang, Xiaofu; Graham, Brittany M.; Ding, Chunyong; Ding, Ye; Radhakrishnan, Geetha L.; Rastellini, Cristiana; Zhou, Jia; Radhakrishnan, Ravi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">JSGRA2</span>;
        ISSN:<span class="NLM_cas:issn">0022-4804</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activated hepatic stellate cells (HSCs) are responsible for excess extracellular matrix (ECM) protein deposition in liver fibrosis.  Previously, our group reported that the natural compd. oridonin induces apoptosis, inhibits cell proliferation, and downregulates ECM proteins in activated HSC.  In this study, the antifibrogenic effects of oridonin deriv. CYD0682 on the activated human LX-2 and rat HSC-T6 stellate cell lines were investigated.Cell proliferation was measured by alamarBlue assay.  Apoptosis was detected by Cell Death ELISA and staining of Yo-Pro-1 and propidium iodide.  Cell cycle was detd. by flow cytometry.  Immunoblot and immunofluorescence staining were performed for cellular protein expression.CYD0682 treatment significantly inhibited LX-2 cell proliferation in a dose- and time-dependent manner with an IC50 value of 0.49 μM for 48 h, ∼10-fold greater potency than oridonin.  Similar results were obsd. in HSC-T6 cells.  In contrast, 2.5 μM of CYD0682 treatment had no significant effects on proliferation of the human hepatocyte cell line C3A.  CYD0682 treatment induced LX-2 cell apoptosis and S-phase cell cycle arrest and was assocd. with activation of p53, p21, and cleaved caspase-3.  The myofibroblast marker protein α-smooth muscle actin and major ECM proteins type I collagen and fibronectin were markedly suppressed in a time- and dose-dependent fashion by CYD0682.  Furthermore, pretreatment with CYD0682 blocked transforming growth factor-β-induced type I collagen and fibronectin prodn.In comparison with oridonin, its novel deriv. CYD0682 may act as a more potent antihepatic fibrosis agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoAhhBJgUujbVg90H21EOLACvtfcHk0lj3kVtnzJ64tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOmt7rF&md5=542b6999c4841430cb08843e16b3f3c3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2015.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2015.07.042%26sid%3Dliteratum%253Aachs%26aulast%3DBohanon%26aufirst%3DF.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGraham%26aufirst%3DB.%2BM.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DRadhakrishnan%26aufirst%3DG.%2BL.%26aulast%3DRastellini%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRadhakrishnan%26aufirst%3DR.%2BS.%26atitle%3DEnhanced%2520effects%2520of%2520novel%2520oridonin%2520analog%2520CYD0682%2520for%2520hepatic%2520fibrosis%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2015%26volume%3D199%26spage%3D441%26epage%3D449%26doi%3D10.1016%2Fj.jss.2015.07.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ester, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8814</span>– <span class="NLM_lpage">8825</span>, <span class="refDoi"> DOI: 10.1021/jm401248x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401248x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8814-8825&author=C.+Dingauthor=Y.+Zhangauthor=H.+Chenauthor=Z.+Yangauthor=C.+Wildauthor=N.+Yeauthor=C.+D.+Esterauthor=A.+Xiongauthor=M.+A.+Whiteauthor=Q.+Shenauthor=J.+Zhou&title=Oridonin+ring+A-based+diverse+constructions+of+enone+functionality%3A+identification+of+novel+dienone+analogues+effective+for+highly+aggressive+breast+cancer+by+inducing+apoptosis&doi=10.1021%2Fjm401248x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin Ring A Based Diverse Constructions of Enone Functionality: Identification of Novel Dienone Analogues Effective for Highly Aggressive Breast Cancer by Inducing Apoptosis</span></div><div class="casAuthors">Ding, Chunyong; Zhang, Yusong; Chen, Haijun; Yang, Zhengduo; Wild, Christopher; Ye, Na; Ester, Corbin D.; Xiong, Ailian; White, Mark A.; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8814-8825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oridonin (I) has attracted considerable attention in recent years because of its unique and safe anticancer pharmacol. profile.  Nevertheless, it exhibits moderate to poor effects against highly aggressive cancers including triple-neg. and drug-resistant breast cancer cells.  Herein, we report the rational design and synthesis of novel dienone derivs. with an addnl. α,β-unsatd. ketone system diversely installed in the A-ring based on this class of natural scaffold that features dense functionalities and stereochem.-rich frameworks.  Efficient and regioselective enone construction strategies have been established.  Meanwhile, a unique 3,7-rearrangement reaction was identified to furnish an unprecedented dienone scaffold.  Intriguingly, these new analogs have been demonstrated to significantly induce apoptosis and inhibit colony formation with superior antitumor effects against aggressive and drug-resistant breast cancer cells in vitro and in vivo while also exhibiting comparable or lower toxicity to normal human mammary epithelial cells in comparison with I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp42KnrzHKFwbVg90H21EOLACvtfcHk0lj3kVtnzJ64tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nJ&md5=467a07903a1d9f8c4df11c5dfa15bfc5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm401248x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401248x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DEster%26aufirst%3DC.%2BD.%26aulast%3DXiong%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DOridonin%2520ring%2520A-based%2520diverse%2520constructions%2520of%2520enone%2520functionality%253A%2520identification%2520of%2520novel%2520dienone%2520analogues%2520effective%2520for%2520highly%2520aggressive%2520breast%2520cancer%2520by%2520inducing%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8814%26epage%3D8825%26doi%3D10.1021%2Fjm401248x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohanon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandathiparampil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastellini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, R.</span></span> <span> </span><span class="NLM_article-title">Suppressive effects of novel oridonin derivative CYD0625 on activated hepatic stellate cells</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">6115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=6115&author=X.+Wangauthor=F.+Bohanonauthor=A.+Kandathiparampilauthor=C.+Rastelliniauthor=C.+Dingauthor=Y.+Dingauthor=J.+Zhouauthor=R.+Radhakrishnan&title=Suppressive+effects+of+novel+oridonin+derivative+CYD0625+on+activated+hepatic+stellate+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBohanon%26aufirst%3DF.%26aulast%3DKandathiparampil%26aufirst%3DA.%26aulast%3DRastellini%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRadhakrishnan%26aufirst%3DR.%26atitle%3DSuppressive%2520effects%2520of%2520novel%2520oridonin%2520derivative%2520CYD0625%2520on%2520activated%2520hepatic%2520stellate%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D6115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5048</span>– <span class="NLM_lpage">5058</span>, <span class="refDoi"> DOI: 10.1021/jm400367n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400367n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVeqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5048-5058&author=C.+Dingauthor=Y.+Zhangauthor=H.+Chenauthor=Z.+Yangauthor=C.+Wildauthor=L.+Chuauthor=H.+Liuauthor=Q.+Shenauthor=J.+Zhou&title=Novel+nitrogen-enriched+oridonin+analogues+with+thiazole-fused+A-ring%3A+protecting+group-free+synthesis%2C+enhanced+anticancer+profile%2C+and+improved+aqueous+solubility&doi=10.1021%2Fjm400367n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Nitrogen-Enriched Oridonin Analogues with Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility</span></div><div class="casAuthors">Ding, Chunyong; Zhang, Yusong; Chen, Haijun; Yang, Zhengduo; Wild, Christopher; Chu, Lili; Liu, Huiling; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5048-5058</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oridonin (I), a complex ent-kaurane diterpenoid isolated from the traditional Chinese herb Isodon rubescens, has demonstrated great potential in the treatment of various human cancers due to its unique and safe anticancer pharmacol. profile.  Nevertheless, the clin. development of oridonin for cancer therapy has been hampered by its relatively moderate potency, limited aq. soly., and poor bioavailability.  Herein, we report the concise synthesis of a series of novel nitrogen-enriched oridonin derivs. with thiazole-fused A-ring through an efficient protecting group-free synthetic strategy.  Most of them, including compds. II [R = Me; R = NR1R2, R1 = Me, CHMe2, n-Bu, cyclohexyl, 2-(piperidin-1-yl)ethyl, allyl], exhibited potent antiproliferative effects against breast, pancreatic, and prostate cancer cells with low micromolar to submicromolar IC50 values as well as markedly enhanced aq. soly.  These new analogs obtained by rationally modifying the natural product have been shown not only to significantly induce the apoptosis and suppress growth of triple-neg. MDA-MB-231 breast cancer both in vitro and in vivo but are also effective against drug-resistant ER-pos. MCF-7 clones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfnEskkayfSLVg90H21EOLACvtfcHk0lg_Q8K3E6M_MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVeqtL0%253D&md5=b7ec95c47f40492b7aea80159cbbe9bb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm400367n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400367n%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DChu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DNovel%2520nitrogen-enriched%2520oridonin%2520analogues%2520with%2520thiazole-fused%2520A-ring%253A%2520protecting%2520group-free%2520synthesis%252C%2520enhanced%2520anticancer%2520profile%252C%2520and%2520improved%2520aqueous%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5048%26epage%3D5058%26doi%3D10.1021%2Fjm400367n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagalowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. T.</span></span> <span> </span><span class="NLM_article-title">Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic oridonin analogues</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">56842</span>– <span class="NLM_lpage">56854</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.18632%2Foncotarget.10863" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=56842-56854&author=W.+Chenauthor=J.+Zhouauthor=K.+Wuauthor=J.+Huangauthor=Y.+Dingauthor=E.+J.+Yunauthor=B.+Wangauthor=C.+Dingauthor=E.+Hernandezauthor=J.+Santoyoauthor=H.+Chenauthor=H.+Linauthor=A.+Sagalowskyauthor=D.+Heauthor=J.+Zhouauthor=J.+T.+Hsieh&title=Targeting+XBP1-mediated+%CE%B2-catenin+expression+associated+with+bladder+cancer+with+newly+synthetic+oridonin+analogues&doi=10.18632%2Foncotarget.10863"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10863%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DHernandez%26aufirst%3DE.%26aulast%3DSantoyo%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSagalowsky%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHsieh%26aufirst%3DJ.%2BT.%26atitle%3DTargeting%2520XBP1-mediated%2520%25CE%25B2-catenin%2520expression%2520associated%2520with%2520bladder%2520cancer%2520with%2520newly%2520synthetic%2520oridonin%2520analogues%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D56842%26epage%3D56854%26doi%3D10.18632%2Foncotarget.10863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.canlet.2016.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27387452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFant7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2016&pages=393-402&author=J.+Wuauthor=Y.+Dingauthor=C.+H.+Chenauthor=Z.+Zhouauthor=C.+Dingauthor=H.+Chenauthor=J.+Zhouauthor=C.+Chen&title=A+new+oridonin+analog+suppresses+triple-negative+breast+cancer+cells+and+tumor+growth+via+the+induction+of+death+receptor+5&doi=10.1016%2Fj.canlet.2016.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5</span></div><div class="casAuthors">Wu, Jing; Ding, Ye; Chen, Chuan-Huizhi; Zhou, Zhongmei; Ding, Chunyong; Chen, Haiying; Zhou, Jia; Chen, Ceshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">393-402</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) remains the leading cause of death among women with breast cancer worldwide.  Oridonin is a natural anti-cancer compd. that is isolated from the traditional Chinese herb Rabdosia rubescens.  However, the antitumor efficacies of oridonin in the treatments of TNBC and other cancers are far from ideal.  In this study, we investigated a series of newly designed oridonin analogs in terms of their actions against HCC1806 and HCC1937 TNBC cell lines and identified CYD-6-28, which significantly inhibits cancer cell proliferation and induces G2/M-phase cell cycle arrest and apoptosis.  CYD-6-28 induces the expression of p21 and the cleavage of caspase-3, -7, -8 and PARP and inhibits the expression levels of Cyclin D1, FLIPL and XIAP.  CYD-6-28 also inhibits the activations of STAT3 and AKT and induces the activation of ERK.  We demonstrated that CYD-6-28 induces apoptosis at least partially by inducing the expression of death receptor 5 (DR5).  Finally, CYD-6-28 significantly suppresses HCC1806 xenograft tumor growth in nude mice at 5 mg/kg without affecting body wt.  Taken together, these results indicate that CYD-6-28 has the potential to be developed as a therapeutic agent to treat TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwRKWDYjI09bVg90H21EOLACvtfcHk0lg_Q8K3E6M_MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFant7%252FO&md5=b550f5511d3bec8d73774cecf290aa81</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DA%2520new%2520oridonin%2520analog%2520suppresses%2520triple-negative%2520breast%2520cancer%2520cells%2520and%2520tumor%2520growth%2520via%2520the%2520induction%2520of%2520death%2520receptor%25205%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D380%26spage%3D393%26epage%3D402%26doi%3D10.1016%2Fj.canlet.2016.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species H2O2 and •OH, but not O2•(−) promote oridonin-induced phagocytosis of apoptotic cells by human histocytic lymphoma U937 cells</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2013.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.intimp.2013.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=23352441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1ShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=414-423&author=L.+Zangauthor=H.+Heauthor=Q.+Xuauthor=Y.+Yuauthor=N.+Zhengauthor=W.+Liuauthor=T.+Hayashiauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Reactive+oxygen+species+H2O2+and+%E2%80%A2OH%2C+but+not+O2%E2%80%A2%28%E2%88%92%29+promote+oridonin-induced+phagocytosis+of+apoptotic+cells+by+human+histocytic+lymphoma+U937+cells&doi=10.1016%2Fj.intimp.2013.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species H2O2 and OH, but not O2- promote oridonin-induced phagocytosis of apoptotic cells by human histocytic lymphoma U937 cells</span></div><div class="casAuthors">Zang, Linghe; He, Hao; Xu, Qian; Yu, Yang; Zheng, Nan; Liu, Weiwei; Hayashi, Toshihiko; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">414-423</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We reported previously that phagocytosis of apoptotic cells by U937 cells was enhanced by the treatment with oridonin that showed high activity to induce the generation of reactive oxygen species (ROS) in many cells.  ROS, important signaling mols., are involved in the immune defenses, cell repair and proliferation.  In this study, oridonin caused modest amt. of ROS generation in U937 cells, with hydrogen peroxide (H2O2) and hydroxyl free radical (OH) as the major types.  Meanwhile, H2O2 and OH were pos. regulators involved in oridonin-enhanced engulfment of apoptotic cells through down-regulating mitochondrial membrane potential (MMP) and inducing autophagy.  The ROS-mediated phagocytosis was independent of cellular ATP (ATP) levels.  H2O2 and OH generation also activated phosphatidylinositol 3-kinases-Akt (PI3K-Akt) and phospholipase C γ-protein kinase C(PLC γ)-Ras-Raf-ERK signaling pathways, which were essential for oridonin-induced engulfment of apoptotic cells.  Phagocytosis, the loss of MMP, autophagy and the activated signaling pathways were all suppressed by ROS scavenger N-acetyl-L-cysteine (NAC), H2O2 scavenger catalase or OH scavenger glutathione (GSH).  However, superoxide anion (O2-) and its scavenger superoxide dismutase (SOD) did not significantly affect these oridonin-induced biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9uUjMukMXJ7Vg90H21EOLACvtfcHk0lg_Q8K3E6M_MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1ShsLg%253D&md5=8f7651560d036dff7a6beb77079aa308</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2013.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2013.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DZang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DReactive%2520oxygen%2520species%2520H2O2%2520and%2520%25E2%2580%25A2OH%252C%2520but%2520not%2520O2%25E2%2580%25A2%2528%25E2%2588%2592%2529%2520promote%2520oridonin-induced%2520phagocytosis%2520of%2520apoptotic%2520cells%2520by%2520human%2520histocytic%2520lymphoma%2520U937%2520cells%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2013%26volume%3D15%26spage%3D414%26epage%3D423%26doi%3D10.1016%2Fj.intimp.2013.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1306</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2008.06864.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1111%2Fj.1742-4658.2008.06864.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=1291-1306&author=Y.+Chengauthor=F.+Qiuauthor=Y.+C.+Yeauthor=Z.+M.+Guoauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Autophagy+inhibits+reactive+oxygen+species-mediated+apoptosis+via+activating+p38-nuclear+factor-kappa+B+survival+pathways+in+oridonin-treated+murine+fibrosarcoma+L929+cells&doi=10.1111%2Fj.1742-4658.2008.06864.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2008.06864.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2008.06864.x%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DY.%2BC.%26aulast%3DGuo%26aufirst%3DZ.%2BM.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DAutophagy%2520inhibits%2520reactive%2520oxygen%2520species-mediated%2520apoptosis%2520via%2520activating%2520p38-nuclear%2520factor-kappa%2520B%2520survival%2520pathways%2520in%2520oridonin-treated%2520murine%2520fibrosarcoma%2520L929%2520cells%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D1291%26epage%3D1306%26doi%3D10.1111%2Fj.1742-4658.2008.06864.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T. L.</span></span> <span> </span><span class="NLM_article-title">Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3327</span>– <span class="NLM_lpage">3344</span>, <span class="refDoi"> DOI: 10.3390/molecules19033327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3390%2Fmolecules19033327" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=3327-3344&author=L.+M.+Kuoauthor=C.+Y.+Kuoauthor=C.+Y.+Linauthor=M.+F.+Hungauthor=J.+J.+Shenauthor=T.+L.+Hwang&title=Intracellular+glutathione+depletion+by+oridonin+leads+to+apoptosis+in+hepatic+stellate+cells&doi=10.3390%2Fmolecules19033327"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3390%2Fmolecules19033327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules19033327%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DL.%2BM.%26aulast%3DKuo%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DHung%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DJ.%2BJ.%26aulast%3DHwang%26aufirst%3DT.%2BL.%26atitle%3DIntracellular%2520glutathione%2520depletion%2520by%2520oridonin%2520leads%2520to%2520apoptosis%2520in%2520hepatic%2520stellate%2520cells%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D3327%26epage%3D3344%26doi%3D10.3390%2Fmolecules19033327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. M.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.3109/10428194.2015.1061127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3109%2F10428194.2015.1061127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26415087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWqurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=888-898&author=Z.+Z.+Xuauthor=W.+B.+Fuauthor=Z.+Jinauthor=P.+Guoauthor=W.+F.+Wangauthor=J.+M.+Li&title=Reactive+oxygen+species+mediate+oridonin-induced+apoptosis+through+DNA+damage+response+and+activation+of+JNK+pathway+in+diffuse+large+B+cell+lymphoma&doi=10.3109%2F10428194.2015.1061127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma</span></div><div class="casAuthors">Xu, Zi-Zhen; Fu, Wan-Bin; Jin, Zhen; Guo, Pei; Wang, Wen-Fang; Li, Jun-Min</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">888-898</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">This study investigated the cytotoxic effect of oridonin (ORI), a diterpenoid isolated from Rabdosia rubescens, in human diffuse large B cell lymphoma (DLBCL) in vitro and in vivo and the potential mol. mechanisms for ORI-induced cell apoptosis.  ORI treatment caused reactive oxygen species (ROS)-mediated oxidative DNA damage response (DDR) and the c-Jun N-terminal kinase (JNK) pathway activation, leading to an induction of intrinsic apoptosis.  ROS abolition blocked ORI-induced apoptosis and attenuated the expression of phospho-histone H2AX and phospho-JNK, indicating that ROS-mediated DNA damage and JNK pathway activation were involved in ORI-induced apoptosis.  The systemic administration of ORI suppressed the growth of human DLBCL xenografts without showing significant toxicity.  These findings suggest that ORI may have promising therapeutic application in DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjsNNhznQ9b7Vg90H21EOLACvtfcHk0lhl2ow36e2fmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWqurrM&md5=4630e1bacf48239e813a01f90aa7091d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3109%2F10428194.2015.1061127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2015.1061127%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%2BZ.%26aulast%3DFu%26aufirst%3DW.%2BB.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%2BF.%26aulast%3DLi%26aufirst%3DJ.%2BM.%26atitle%3DReactive%2520oxygen%2520species%2520mediate%2520oridonin-induced%2520apoptosis%2520through%2520DNA%2520damage%2520response%2520and%2520activation%2520of%2520JNK%2520pathway%2520in%2520diffuse%2520large%2520B%2520cell%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2016%26volume%3D57%26spage%3D888%26epage%3D898%26doi%3D10.3109%2F10428194.2015.1061127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satomura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, T.</span></span> <span> </span><span class="NLM_article-title">Antibacterial activity and chemical structure of diterpenoids</span>. <i>Agric. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1080/00021369.1974.10861320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1080%2F00021369.1974.10861320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADyaE2cXls1eqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1974&pages=1261-1262&author=I.+Kuboauthor=M.+Taniguchiauthor=Y.+Satomuraauthor=T.+Kubota&title=Antibacterial+activity+and+chemical+structure+of+diterpenoids&doi=10.1080%2F00021369.1974.10861320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial activity and chemical structure of diterpenoids</span></div><div class="casAuthors">Kubo, Isao; Taniguchi, Makoto; Satomura, Yukio; Kubota, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Agricultural and Biological Chemistry</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-2</span>CODEN:
                <span class="NLM_cas:coden">ABCHA6</span>;
        ISSN:<span class="NLM_cas:issn">0002-1369</span>.
    </div><div class="casAbstract">The bactericidal activity of the 20 diterpenoids tested appeared to depend on the presence of cylopentanone with a conjugated exocyclic methylene group.  All the tested natural compds. (from various Isodon species) with the exception of one inhibited the growth of Bacillus subtilis.  Their dihydro derivs. were inactive, whereas their acetates showed some activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYEuyCUgQu4rVg90H21EOLACvtfcHk0lhl2ow36e2fmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXls1eqsbw%253D&md5=5ff742b7884d4ed04bde13eaa19e98fe</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F00021369.1974.10861320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00021369.1974.10861320%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DI.%26aulast%3DTaniguchi%26aufirst%3DM.%26aulast%3DSatomura%26aufirst%3DY.%26aulast%3DKubota%26aufirst%3DT.%26atitle%3DAntibacterial%2520activity%2520and%2520chemical%2520structure%2520of%2520diterpenoids%26jtitle%3DAgric.%2520Biol.%2520Chem.%26date%3D1974%26volume%3D38%26spage%3D1261%26epage%3D1262%26doi%3D10.1080%2F00021369.1974.10861320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5022</span>– <span class="NLM_lpage">5034</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2lt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5022-5034&author=S.+Xuauthor=S.+Luoauthor=H.+Yaoauthor=H.+Caiauthor=X.+Miaoauthor=F.+Wuauthor=D.+H.+Yangauthor=X.+Wuauthor=W.+Xieauthor=H.+Yaoauthor=Z.+S.+Chenauthor=J.+Xu&title=Probing+the+anticancer+action+of+oridonin+with+fluorescent+analogues%3A+visualizing+subcellular+localization+to+mitochondria&doi=10.1021%2Facs.jmedchem.6b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria</span></div><div class="casAuthors">Xu, Shengtao; Luo, Shanshan; Yao, Hong; Cai, Hao; Miao, Xiaoming; Wu, Fang; Yang, Dong-Hua; Wu, Xiaoming; Xie, Weijia; Yao, Hequan; Chen, Zhe-Sheng; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5022-5034</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oridonin (1) is a complex ent-kaurane diterpenoid exhibiting remarkable antitumor activity.  However, the detailed mechanism or cellular target that underlies this activity has not yet been identified.  Herein, we report an efficient approach for exploring the anticancer mechanism of oridonin through development of the potent fluorescent analogs.  A series of novel fluorescent oridonin probes linked with coumarin moieties were designed, synthesized, and characterized.  Fluorescence microscopy and confocal imaging studies suggested that fluorescent oridonin probe 17d was rapidly taken up into tumor cells and the mitochondrion was the main site of its accumulation.  Moreover, we confirmed that cytochrome c played an important role in oridonin induced mitochondrion-mediated apoptosis and α,β-unsatd. ketone is the active moiety of oridonin, which is crucial to its uptake, localization, and cytotoxicity.  Our results provide new insights on the mol. mechanism of oridonin and would be useful for its further development into an antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQwh1mki12ZrVg90H21EOLACvtfcHk0lgshumOnV1b_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2lt7s%253D&md5=8017b3f84342c5da185cb84c7effa0d4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00408%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DD.%2BH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520anticancer%2520action%2520of%2520oridonin%2520with%2520fluorescent%2520analogues%253A%2520visualizing%2520subcellular%2520localization%2520to%2520mitochondria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5022%26epage%3D5034%26doi%3D10.1021%2Facs.jmedchem.6b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrowietz, U.</span></span> <span> </span><span class="NLM_article-title">Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-L-cysteine-preparation of S-substituted thiosuccinic acid esters</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.bmc.2006.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=333-342&author=T.+J.+Schmidtauthor=M.+Akauthor=U.+Mrowietz&title=Reactivity+of+dimethyl+fumarate+and+methylhydrogen+fumarate+towards+glutathione+and+N-acetyl-L-cysteine-preparation+of+S-substituted+thiosuccinic+acid+esters&doi=10.1016%2Fj.bmc.2006.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DT.%2BJ.%26aulast%3DAk%26aufirst%3DM.%26aulast%3DMrowietz%26aufirst%3DU.%26atitle%3DReactivity%2520of%2520dimethyl%2520fumarate%2520and%2520methylhydrogen%2520fumarate%2520towards%2520glutathione%2520and%2520N-acetyl-L-cysteine-preparation%2520of%2520S-substituted%2520thiosuccinic%2520acid%2520esters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D333%26epage%3D342%26doi%3D10.1016%2Fj.bmc.2006.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Keap calm, and carry on covalently</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7463</span>– <span class="NLM_lpage">7476</span>, <span class="refDoi"> DOI: 10.1021/jm400224q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400224q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7463-7476&author=A.+J.+Wilsonauthor=J.+K.+Kernsauthor=J.+F.+Callahanauthor=C.+J.+Moody&title=Keap+calm%2C+and+carry+on+covalently&doi=10.1021%2Fjm400224q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Keap Calm, and Carry on Covalently</span></div><div class="casAuthors">Wilson, Anthony J.; Kerns, Jeffrey K.; Callahan, James F.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7463-7476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Nrf2-Keap1 system plays a major role in cellular defense against oxidative stress.  Upon exposure to electrophiles, the cysteine-rich protein Keap1 is covalently modified, and it is this modification of Keap1 that allows the accumulation and subsequent nuclear translocation of Nrf2 where it induces the transcription of over 100 protective genes.  This mechanism can be exploited in drug discovery approaches to diseases such as chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), asthma, and neurodegenerative diseases like multiple sclerosis (MS) and Parkinson's, utilizing the modification of Keap1 by electrophiles, compds. that would not normally be considered useful in drug discovery programs.  This Perspective discusses the development of potential therapies based on potent electrophiles, such as isothiocyanates and Michael acceptors, that, far from being assocd. with toxic events, can actually initiate a range of beneficial protective pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFM-f4P1ElOLVg90H21EOLACvtfcHk0lgshumOnV1b_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE&md5=ea907fb2ccd8c28142ab4fa2776d0195</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm400224q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400224q%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DKeap%2520calm%252C%2520and%2520carry%2520on%2520covalently%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7463%26epage%3D7476%26doi%3D10.1021%2Fjm400224q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2219</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.bmcl.2005.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15837296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2215-2219&author=R.+D.+Couchauthor=R.+G.+Browningauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=D.+L.+Wrightauthor=M.+B.+Spornauthor=A.+C.+Anderson&title=Studies+on+the+reactivity+of+CDDO%2C+a+promising+new+chemopreventive+and+chemotherapeutic+agent%3A+implications+for+a+molecular+mechanism+of+action&doi=10.1016%2Fj.bmcl.2005.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span></div><div class="casAuthors">Couch, Robin D.; Browning, R. Greg; Honda, Tadashi; Gribble, Gordon W.; Wright, Dennis L.; Sporn, Michael B.; Anderson, Amy C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2215-2219</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CDDO, a semi-synthetic triterpenoid derived from oleanolic acid, has the potential to be used as a chemopreventive and chemotherapeutic agent.  The structure of CDDO contains two α,β-unsatd. carbonyl moieties, suggesting a mechanism of action involving a conjugate nucleophilic addn.  Spectroscopic evaluation with thiol nucleophiles illustrates that an addn. does indeed occur, but this addn. is selective and reversible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEly4KE1L3bVg90H21EOLACvtfcHk0lgshumOnV1b_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D&md5=403474a7b33ce6f42e93ad3f9bbd84b0</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DCouch%26aufirst%3DR.%2BD.%26aulast%3DBrowning%26aufirst%3DR.%2BG.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DStudies%2520on%2520the%2520reactivity%2520of%2520CDDO%252C%2520a%2520promising%2520new%2520chemopreventive%2520and%2520chemotherapeutic%2520agent%253A%2520implications%2520for%2520a%2520molecular%2520mechanism%2520of%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2215%26epage%3D2219%26doi%3D10.1016%2Fj.bmcl.2005.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, H.</span></span> <span> </span><span class="NLM_article-title">The antitumor and antibacterial activity of the Isodon diterpenoids</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2118</span>– <span class="NLM_lpage">2127</span>, <span class="refDoi"> DOI: 10.1248/cpb.24.2118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1248%2Fcpb.24.2118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1976&pages=2118-2127&author=E.+Fujitaauthor=Y.+Nagaoauthor=K.+Kanekoauthor=S.+Nakazawaauthor=H.+Kuroda&title=The+antitumor+and+antibacterial+activity+of+the+Isodon+diterpenoids&doi=10.1248%2Fcpb.24.2118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1248%2Fcpb.24.2118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.24.2118%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DE.%26aulast%3DNagao%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DNakazawa%26aufirst%3DS.%26aulast%3DKuroda%26aufirst%3DH.%26atitle%3DThe%2520antitumor%2520and%2520antibacterial%2520activity%2520of%2520the%2520Isodon%2520diterpenoids%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1976%26volume%3D24%26spage%3D2118%26epage%3D2127%26doi%3D10.1248%2Fcpb.24.2118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornwall, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Organocatalytic asymmetric epoxidation and aziridination of olefins and their synthetic applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">8199</span>– <span class="NLM_lpage">8256</span>, <span class="refDoi"> DOI: 10.1021/cr500064w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500064w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1Cntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=8199-8256&author=Y.+Zhuauthor=Q.+Wangauthor=R.+G.+Cornwallauthor=Y.+Shi&title=Organocatalytic+asymmetric+epoxidation+and+aziridination+of+olefins+and+their+synthetic+applications&doi=10.1021%2Fcr500064w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic asymmetric epoxidation and aziridination of olefins and their synthetic applications</span></div><div class="casAuthors">Zhu, Yingguang; Wang, Qian; Cornwall, Richard G.; Shi, Yian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8199-8256</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review highlighted various advances in organocatalytic asym. epoxidn. and aziridination of olefins as well as their synthetic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlHwjm9_i_bVg90H21EOLACvtfcHk0lhrKpzdrx8DDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1Cntro%253D&md5=d9b57d2407d5dd324c7002976c13f842</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fcr500064w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500064w%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DCornwall%26aufirst%3DR.%2BG.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DOrganocatalytic%2520asymmetric%2520epoxidation%2520and%2520aziridination%2520of%2520olefins%2520and%2520their%2520synthetic%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D8199%26epage%3D8256%26doi%3D10.1021%2Fcr500064w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degennaro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luisi, R.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the stereoselective synthesis of aziridines</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7881</span>– <span class="NLM_lpage">7929</span>, <span class="refDoi"> DOI: 10.1021/cr400553c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400553c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVahtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=7881-7929&author=L.+Degennaroauthor=P.+Trincheraauthor=R.+Luisi&title=Recent+advances+in+the+stereoselective+synthesis+of+aziridines&doi=10.1021%2Fcr400553c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the stereoselective synthesis of aziridines</span></div><div class="casAuthors">Degennaro, Leonardo; Trinchera, Piera; Luisi, Renzo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7881-7929</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review reported some recent advances in the field of stereoselective synthesis of aziridines focusing on new methodologies, mechanistic insights, and the scope and limitations of each strategy.  The adjective stereoselective was used in a broad sense to identify synthetic processes creating new stereogenic centers and that occur with a control either on the abs. or relative configuration.  Methodologies developed in the last 10 years were described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIw6kb6If5rLVg90H21EOLACvtfcHk0lhrKpzdrx8DDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVahtLc%253D&md5=6860d33e742e33efdadfa77fcd83d250</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcr400553c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400553c%26sid%3Dliteratum%253Aachs%26aulast%3DDegennaro%26aufirst%3DL.%26aulast%3DTrinchera%26aufirst%3DP.%26aulast%3DLuisi%26aufirst%3DR.%26atitle%3DRecent%2520advances%2520in%2520the%2520stereoselective%2520synthesis%2520of%2520aziridines%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D7881%26epage%3D7929%26doi%3D10.1021%2Fcr400553c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njardarson, J. T.</span></span> <span> </span><span class="NLM_article-title">A scalable rhodium-catalyzed intermolecular aziridination reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4278</span>– <span class="NLM_lpage">4280</span>, <span class="refDoi"> DOI: 10.1002/anie.201400502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.201400502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4278-4280&author=D.+T.+Smithauthor=J.+T.+Njardarson&title=A+scalable+rhodium-catalyzed+intermolecular+aziridination+reaction&doi=10.1002%2Fanie.201400502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.201400502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201400502%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BT.%26aulast%3DNjardarson%26aufirst%3DJ.%2BT.%26atitle%3DA%2520scalable%2520rhodium-catalyzed%2520intermolecular%2520aziridination%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4278%26epage%3D4280%26doi%3D10.1002%2Fanie.201400502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Study on stability of oridonin solution</span>. <i>Zhongguo Zhong Yao Za Zhi</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=19382449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ptFKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=47-49&author=J.+Xuauthor=J.+Zhaoauthor=J.+Wangauthor=N.+Fengauthor=R.+Tanauthor=Y.+Liu&title=Study+on+stability+of+oridonin+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Study on stability of oridonin solution</span></div><div class="casAuthors">Xu Jie; Zhao Jihui; Wang Ju; Feng Nianping; Tan Rong; Liu Ying</div><div class="citationInfo"><span class="NLM_cas:title">Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-9</span>
        ISSN:<span class="NLM_cas:issn">1001-5302</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the stability of oridonin (ORI) solution for research and development of novel ORI prepartions.  METHOD:  The effect of pH on the degradation rate of ORI was evaluated, the pH values of the oridonin solutions were adjusted to the setting pH, with 1 mol x L(-1) HCl or NaOH, respectively, and stored at room temperature for 60 h.  The constant temperature method was applied to evaluate the stability of ORI solution at room temperature and at 4 degrees C.  RESULT:  The pH-rate profile of ORI was V-shaped, and the pHm was 5.  The t90 of ORI solution at room temperature was 53.2 h and 91.5 h at 4 degrees C CONCLUSION: The ORI solution is not stable.  The pH-dependent degradation of ORI solution confirms to specific acid-base catalysis reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4svf8nu1YggaK-_ZudimnfW6udTcc2eaTqpcsaslWZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ptFKnuw%253D%253D&md5=bb3caddd19ed1ef6516bd39121e1fec7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DN.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DStudy%2520on%2520stability%2520of%2520oridonin%2520solution%26jtitle%3DZhongguo%2520Zhong%2520Yao%2520Za%2520Zhi%26date%3D2009%26volume%3D34%26spage%3D47%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jat, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudyal, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousufuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarajan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ess, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kürti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Direct stereospecific synthesis of unprotected N-H and N-Me aziridines from olefins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1126/science.1245727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1126%2Fscience.1245727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=24385626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=61-65&author=J.+L.+Jatauthor=M.+P.+Paudyalauthor=H.+Gaoauthor=Q.+L.+Xuauthor=M.+Yousufuddinauthor=D.+Devarajanauthor=D.+H.+Essauthor=L.+K%C3%BCrtiauthor=J.+R.+Falck&title=Direct+stereospecific+synthesis+of+unprotected+N-H+and+N-Me+aziridines+from+olefins&doi=10.1126%2Fscience.1245727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Stereospecific Synthesis of Unprotected N-H and N-Me Aziridines from Olefins</span></div><div class="casAuthors">Jat, Jawahar L.; Paudyal, Mahesh P.; Gao, Hongyin; Xu, Qing-Long; Yousufuddin, Muhammed; Devarajan, Deepa; Ess, Daniel H.; Kuerti, Laszlo; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6166</span>),
    <span class="NLM_cas:pages">61-65</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Despite the prevalence of the N-H aziridine motif in bioactive natural products and the clear advantages of this unprotected parent structure over N-protected derivs. as a synthetic building block, no practical methods have emerged for direct synthesis of this compd. class from unfunctionalized olefins.  Here, we present a mild, versatile method for the direct stereospecific conversion of structurally diverse mono-, di-, tri-, and tetrasubstituted olefins to N-H aziridines using O-(2,4-dinitrophenyl)hydroxylamine (DPH) via homogeneous rhodium catalysis with no external oxidants.  This method is operationally simple (i.e., one-pot), scalable, and fast at ambient temp., furnishing N-H aziridines in good-to-excellent yields.  Likewise, N-alkyl aziridines are prepd. from N-alkylated DPH derivs.  Quantum-mech. calcns. suggest a plausible Rh-nitrene pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9CgewJPc0vLVg90H21EOLACvtfcHk0lgAnl-a5u7myg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslOh&md5=5f06d6acf464f42fc1d6d1e3cf7355a6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245727%26sid%3Dliteratum%253Aachs%26aulast%3DJat%26aufirst%3DJ.%2BL.%26aulast%3DPaudyal%26aufirst%3DM.%2BP.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DQ.%2BL.%26aulast%3DYousufuddin%26aufirst%3DM.%26aulast%3DDevarajan%26aufirst%3DD.%26aulast%3DEss%26aufirst%3DD.%2BH.%26aulast%3DK%25C3%25BCrti%26aufirst%3DL.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DDirect%2520stereospecific%2520synthesis%2520of%2520unprotected%2520N-H%2520and%2520N-Me%2520aziridines%2520from%2520olefins%26jtitle%3DScience%26date%3D2014%26volume%3D343%26spage%3D61%26epage%3D65%26doi%3D10.1126%2Fscience.1245727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wincewicz, R.</span></span> <span> </span><span class="NLM_article-title">Amine-promoted, organocatalytic aziridination of enones</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1021/ol062852v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol062852v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=351-353&author=A.+Armstrongauthor=C.+A.+Baxterauthor=S.+G.+Lamontauthor=A.+R.+Papeauthor=R.+Wincewicz&title=Amine-promoted%2C+organocatalytic+aziridination+of+enones&doi=10.1021%2Fol062852v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol062852v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol062852v%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DA.%26aulast%3DBaxter%26aufirst%3DC.%2BA.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DPape%26aufirst%3DA.%2BR.%26aulast%3DWincewicz%26aufirst%3DR.%26atitle%3DAmine-promoted%252C%2520organocatalytic%2520aziridination%2520of%2520enones%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D351%26epage%3D353%26doi%3D10.1021%2Fol062852v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">An amine-promoted aziridination of chalcones</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">8005</span>– <span class="NLM_lpage">8008</span>, <span class="refDoi"> DOI: 10.1002/anie.200602586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.200602586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlelu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=8005-8008&author=Y.+M.+Shenauthor=M.+X.+Zhaoauthor=J.+Xuauthor=Y.+Shi&title=An+amine-promoted+aziridination+of+chalcones&doi=10.1002%2Fanie.200602586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">An amine-promoted aziridination of chalcones</span></div><div class="casAuthors">Shen, Yu-Mei; Zhao, Mei-Xin; Xu, Jiaxi; Shi, Yian</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">8005-8008</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Without protection: α-Keto aziridines have been formed in a novel amine-promoted direct aziridination of chalcones using an aminimide generated in situ from a tertiary amine and O-mesitylenesulfonylhydroxylamine in the presence of base.  The aziridination proceeds well using a catalytic amt. of the tertiary amine.  Furthermore, nonracemic aziridines are obtained using a chiral amine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2KTtsPZjQVrVg90H21EOLACvtfcHk0lgAnl-a5u7myg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlelu73N&md5=52966ebec407fbf11c3c492fe83fdc8c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fanie.200602586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200602586%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%2BM.%26aulast%3DZhao%26aufirst%3DM.%2BX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DAn%2520amine-promoted%2520aziridination%2520of%2520chalcones%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D8005%26epage%3D8008%26doi%3D10.1002%2Fanie.200602586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pesciaioli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vincentiis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galzerano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencivenni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzanti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, P.</span></span> <span> </span><span class="NLM_article-title">Organocatalytic asymmetric aziridination of enones</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">8703</span>– <span class="NLM_lpage">8706</span>, <span class="refDoi"> DOI: 10.1002/anie.200803647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.200803647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2ku7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=8703-8706&author=F.+Pesciaioliauthor=F.+De+Vincentiisauthor=P.+Galzeranoauthor=G.+Bencivenniauthor=G.+Bartoliauthor=A.+Mazzantiauthor=P.+Melchiorre&title=Organocatalytic+asymmetric+aziridination+of+enones&doi=10.1002%2Fanie.200803647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic asymmetric aziridination of enones</span></div><div class="casAuthors">Pesciaioli, Fabio; De Vincentiis, Francesco; Galzerano, Patrizia; Bencivenni, Giorgio; Bartoli, Giuseppe; Mazzanti, Andrea; Melchiorre, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8703-8706</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A primary amine derived from cinchona alkaloids as a salt with D-N-Boc phenylglycine is an efficient catalyst for the aziridination of α,β-unsatd. ketones.  This method is effective with both linear and cyclic substrates, leading to chiral aziridines in high yield, with complete diastereoselectivity, and with very high enantioselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbknzeDPaFk7Vg90H21EOLACvtfcHk0lga-a8mxjTGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2ku7%252FO&md5=03662146f9a1beea8c389bb7d663b34e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fanie.200803647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200803647%26sid%3Dliteratum%253Aachs%26aulast%3DPesciaioli%26aufirst%3DF.%26aulast%3DDe%2BVincentiis%26aufirst%3DF.%26aulast%3DGalzerano%26aufirst%3DP.%26aulast%3DBencivenni%26aufirst%3DG.%26aulast%3DBartoli%26aufirst%3DG.%26aulast%3DMazzanti%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DP.%26atitle%3DOrganocatalytic%2520asymmetric%2520aziridination%2520of%2520enones%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D8703%26epage%3D8706%26doi%3D10.1002%2Fanie.200803647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span> <span> </span><span class="NLM_article-title">Reaction of aziridinecarboxylic acids with thiols in aqueous solution. the formation of β-amino acid</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3881</span>– <span class="NLM_lpage">3888</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)81670-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2FS0040-4020%2801%2981670-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=3881-3888&author=Y.+Hataauthor=M.+Watanabe&title=Reaction+of+aziridinecarboxylic+acids+with+thiols+in+aqueous+solution.+the+formation+of+%CE%B2-amino+acid&doi=10.1016%2FS0040-4020%2801%2981670-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2981670-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252981670-7%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DM.%26atitle%3DReaction%2520of%2520aziridinecarboxylic%2520acids%2520with%2520thiols%2520in%2520aqueous%2520solution.%2520the%2520formation%2520of%2520%25CE%25B2-amino%2520acid%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D3881%26epage%3D3888%26doi%3D10.1016%2FS0040-4020%2801%2981670-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3718</span>– <span class="NLM_lpage">3721</span>, <span class="refDoi"> DOI: 10.1021/ol4015865</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol4015865" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=3718-3721&author=C.+Dingauthor=Y.+Zhangauthor=H.+Chenauthor=C.+Wildauthor=T.+Wangauthor=M.+A.+Whiteauthor=Q.+Shenauthor=J.+Zhou&title=Overcoming+synthetic+challenges+of+oridonin+A-ring+structural+diversification%3A+regio-+and+stereoselective+installation+of+azides+and+1%2C2%2C3-triazoles+at+the+C-1%2C+C-2%2C+or+C-3+position&doi=10.1021%2Fol4015865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Synthetic Challenges of Oridonin A-Ring Structural Diversification: Regio- and Stereoselective Installation of Azides and 1,2,3-Triazoles at the C-1, C-2, or C-3 Position</span></div><div class="casAuthors">Ding, Chunyong; Zhang, Yusong; Chen, Haijun; Wild, Christopher; Wang, Tianzhi; White, Mark A.; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3718-3721</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efficient and concise synthetic approaches have been developed for the rapid and diverse installation of azide functionalities at the C-1, C-2, or C-3 positions of oridonin with highly controlled regio- and stereoselectivity, while keeping key reactive pharmacophores intact by utilizing unique preactivation strategies based on the common synthon I.  Further functionalization of these azides through click chem. yielding triazole derivs. successfully provides access to an expanded natural scaffold-based compd. library for potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1L_ezFF5FhrVg90H21EOLACvtfcHk0lga-a8mxjTGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtL%252FN&md5=3471ade39c5ccc1631d2d3cec830414e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fol4015865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol4015865%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DOvercoming%2520synthetic%2520challenges%2520of%2520oridonin%2520A-ring%2520structural%2520diversification%253A%2520regio-%2520and%2520stereoselective%2520installation%2520of%2520azides%2520and%25201%252C2%252C3-triazoles%2520at%2520the%2520C-1%252C%2520C-2%252C%2520or%2520C-3%2520position%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D3718%26epage%3D3721%26doi%3D10.1021%2Fol4015865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">8442</span>– <span class="NLM_lpage">8452</span>, <span class="refDoi"> DOI: 10.1039/C4OB01040J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1039%2FC4OB01040J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=25225052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyht7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=8442-8452&author=C.+Dingauthor=L.+Wangauthor=H.+Chenauthor=C.+Wildauthor=N.+Yeauthor=Y.+Dingauthor=T.+Wangauthor=M.+A.+Whiteauthor=Q.+Shenauthor=J.+Zhou&title=ent-Kaurane-based+regio-+and+stereoselective+inverse+electron+demand+hetero-Diels-Alder+reactions%3A+synthesis+of+dihydropyran-fused+diterpenoids&doi=10.1039%2FC4OB01040J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids</span></div><div class="casAuthors">Ding, Chunyong; Wang, Lili; Chen, Haijun; Wild, Christopher; Ye, Na; Ding, Ye; Wang, Tianzhi; White, Mark A.; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">8442-8452</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A mild and concise approach for the construction of a 3,4-dihydro-2H-pyran ring integrated into the A-ring of the natural product oridonin using an optimized inverse electron demand hetero-Diels-Alder (IED HDA) reaction is reported herein.  A self-dimerization of the exocyclic enone installed in the A-ring through a homo-HDA reaction was identified to exclusively give a dimeric ent-kaurane diterpenoid with the spirochroman core.  Moreover, efficient cross-HDA cycloaddns. of this enone with various vinyl ethers or vinyl sulfides, instead of its own homo-HDA dimerization, were achieved in a regio- and stereoselective manner, thus providing access to novel dihydropyran-fused diterpenoids as potential anticancer agents to overcome chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh8NPnYKmGhbVg90H21EOLACvtfcHk0lg8om_NwSM6xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyht7vN&md5=dc9094f722b6996010db476899842e75</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC4OB01040J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01040J%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3Dent-Kaurane-based%2520regio-%2520and%2520stereoselective%2520inverse%2520electron%2520demand%2520hetero-Diels-Alder%2520reactions%253A%2520synthesis%2520of%2520dihydropyran-fused%2520diterpenoids%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D8442%26epage%3D8452%26doi%3D10.1039%2FC4OB01040J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>489</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2009.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.abb.2009.07.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2009&pages=25-33&author=Y.+Zhangauthor=Y.+Wuauthor=D.+Wuauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=NF-kappab+facilitates+oridonin-induced+apoptosis+and+autophagy+in+HT1080+cells+through+a+p53-mediated+pathway&doi=10.1016%2Fj.abb.2009.07.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DNF-kappab%2520facilitates%2520oridonin-induced%2520apoptosis%2520and%2520autophagy%2520in%2520HT1080%2520cells%2520through%2520a%2520p53-mediated%2520pathway%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D489%26spage%3D25%26epage%3D33%26doi%3D10.1016%2Fj.abb.2009.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijeratne, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilaka, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. M.</span></span> <span> </span><span class="NLM_article-title">Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb rabdosia rubescens</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.09.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.bbrc.2005.09.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=16176802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKis7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2005&pages=224-231&author=T.+C.+Hsiehauthor=E.+K.+Wijeratneauthor=J.+Y.+Liangauthor=A.+L.+Gunatilakaauthor=J.+M.+Wu&title=Differential+control+of+growth%2C+cell+cycle+progression%2C+and+expression+of+NF-kappaB+in+human+breast+cancer+cells+MCF-7%2C+MCF-10A%2C+and+MDA-MB-231+by+ponicidin+and+oridonin%2C+diterpenoids+from+the+Chinese+herb+rabdosia+rubescens&doi=10.1016%2Fj.bbrc.2005.09.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens</span></div><div class="casAuthors">Hsieh, Tze-chen; Wijeratne, E. Kithsiri; Liang, Jing-yu; Gunatilaka, A. Leslie; Wu, Joseph M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-231</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ponicidin and oridonin are novel diterpenoids isolated from Rabdosia rubescens.  We tested their effects in MCF-7 and MDA-MB-231 cells, as representing low and high invasive breast carcinoma, with normal MCF-10A cells.  Clonogenicity and proliferation in MCF-7 cells were inhibited more significantly by ponicidin than oridonin, while the reverse was obsd. in MCF-10A cells.  Ponicidin and oridonin induced S/G2M arrest and G1/S block in MCF-7 cells.  In MCF-10A cells treated with either diterpenoid, induction of apoptosis was obsd.  Moreover, oridonin almost completely blocked MCF-10A progression from S to G2/M phase; in contrast, ponicidin-treated MCF-10A cells showed no discernable changes in cell cycle phase distribution.  Neither diterpenoid affected growth of MDA-MB-231 cells, at the dose range effective for MCF-7 or MCF-10A cells.  Ponicidin-treated MCF-7 cells expressed reduced levels of cyclin B1, cdc2, transcription factor E2F, and Rb including phosphorylation at S780.  Less pronounced effects were found in cells treated with oridonin.  Neither compd. altered cyclin D1 and cdk4 in MCF-7 cells.  In MCF-10A cells, oridonin was more active than ponicidin in inhibiting the expression of cyclin B1, cdc2, S780-phosphorylated Rb, and E2F.  To further investigate induction of apoptosis in MCF-10A cells, we measured changes in NF-κB.  Decreases in p65 or p50 forms of NF-κB and its upstream regulator I-κB were found in oridonin-treated MCF-10A and not MCF-7 cells.  Taken together, these results provide a mechanistic framework for the cellular effects of ponicidin and oridonin in different stage breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTVe4GKsS7PrVg90H21EOLACvtfcHk0lg8om_NwSM6xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKis7%252FI&md5=441c4490b2dc444c65366762a9782fb3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.09.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.09.040%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DT.%2BC.%26aulast%3DWijeratne%26aufirst%3DE.%2BK.%26aulast%3DLiang%26aufirst%3DJ.%2BY.%26aulast%3DGunatilaka%26aufirst%3DA.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BM.%26atitle%3DDifferential%2520control%2520of%2520growth%252C%2520cell%2520cycle%2520progression%252C%2520and%2520expression%2520of%2520NF-kappaB%2520in%2520human%2520breast%2520cancer%2520cells%2520MCF-7%252C%2520MCF-10A%252C%2520and%2520MDA-MB-231%2520by%2520ponicidin%2520and%2520oridonin%252C%2520diterpenoids%2520from%2520the%2520Chinese%2520herb%2520rabdosia%2520rubescens%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D337%26spage%3D224%26epage%3D231%26doi%3D10.1016%2Fj.bbrc.2005.09.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halicka, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traganos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darzynkiewicz, Z.</span></span> <span> </span><span class="NLM_article-title">The cytostatic and cytotoxic effects of oridonin (rubescenin), a diterpenoid from rabdosia rubescens, on tumor cells of different lineage</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.3892/ijo.26.3.579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3892%2Fijo.26.3.579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15703811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVeqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=579-588&author=S.+Chenauthor=J.+Gaoauthor=H.+D.+Halickaauthor=X.+Huangauthor=F.+Traganosauthor=Z.+Darzynkiewicz&title=The+cytostatic+and+cytotoxic+effects+of+oridonin+%28rubescenin%29%2C+a+diterpenoid+from+rabdosia+rubescens%2C+on+tumor+cells+of+different+lineage&doi=10.3892%2Fijo.26.3.579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage</span></div><div class="casAuthors">Chen, Sophie; Gao, Jian; Halicka, H. Dorota; Huang, Xuan; Traganos, Frank; Darzynkiewicz, Zbigniew</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Rabdosia rubescens is a herbal medicine used to treat esophageal cancer in China.  In this study, the sesquiterpene oridonin, an isoprenoid, was isolated from Rabdosia rubescens.  Mass spectroscopy and carbon 13 NMR spectroscopy were used to identify the structure of the purified compd.  It was then evaluated for biol. activity against human cell lines derived from prostate (DU-145, LNCaP), breast (MCF-7), and ovarian (A2780 and PTX10) cancers.  Oridonin exhibited anti-proliferative activity toward all cancer cell lines tested, with an IC50 estd. by the MTT cell viability assay ranging from 5.8±2.3 to 11.72±4.8 μM.  Flow cytometric anal. demonstrated that oridonin induced a G1 phase arrest in androgen receptor-pos. LNCaP cells contg. wt p53, while it blocked the cell cycle at G2 and M phases in androgen receptor-neg. DU-145 cells with mutated p53; the arrest in M was verified by examn. of cell morphol. and by the increased frequency of cells with Ser-10 phosphorylated histone H3.  The increased incidence of apoptosis, identified by characteristic changes in cell morphol., was seen in tumor lines treated with oridonin.  Notably, at concns. that induced apoptosis among tumor cells, oridonin failed to induce apoptosis in cultures of normal human fibroblasts.  Western blot anal. was used to det. the protein expression of cancer suppressor genes, p53 (wt) and Bax, and the proto-oncogene, Bcl-2 in LNCaP cells following treatment with oridonin.  Oridonin up-regulated p53 and Bax and down-regulated Bcl-2 expression in a dose-dependent manner.  To further explore the possible interaction between oridonin and DNA, its absorption spectrum was measured in the presence and absence of double stranded (ds) DNA.  Spectral shifts and an increase in absorption band intensity were obsd. indicating interaction of oridonin with DNA bases.  The nature of the binding is not clear at present though no evidence of histone H2AX phosphorylation on Ser-139 was apparent in DU-145 cells treated with oridonin that would indicate the induction of ds DNA breaks.  In conclusion, oridonin inhibits cancer cell growth in a cell cycle specific manner and shifts the balance between pro- and anti-apoptotic proteins in favor of apoptosis.  The present data suggest that further studies are warranted to assess the potential of oridonin in cancer prevention and/or treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgD-_ukpf-WbVg90H21EOLACvtfcHk0lhL0jf1LAnrCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVeqsLo%253D&md5=945b88283ed80315e970943253914380</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3892%2Fijo.26.3.579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.26.3.579%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHalicka%26aufirst%3DH.%2BD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DTraganos%26aufirst%3DF.%26aulast%3DDarzynkiewicz%26aufirst%3DZ.%26atitle%3DThe%2520cytostatic%2520and%2520cytotoxic%2520effects%2520of%2520oridonin%2520%2528rubescenin%2529%252C%2520a%2520diterpenoid%2520from%2520rabdosia%2520rubescens%252C%2520on%2520tumor%2520cells%2520of%2520different%2520lineage%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2005%26volume%3D26%26spage%3D579%26epage%3D588%26doi%3D10.3892%2Fijo.26.3.579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1254/jphs.FPJ04008X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1254%2Fjphs.FPJ04008X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15492467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=155-163&author=C.+L.+Zhangauthor=L.+J.+Wuauthor=H.+J.+Zuoauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Cytochrome+c+release+from+oridonin-treated+apoptotic+A375-S2+cells+is+dependent+on+p53+and+extracellular+signal-regulated+kinase+activation&doi=10.1254%2Fjphs.FPJ04008X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation</span></div><div class="casAuthors">Zhang, Chun-Ling; Wu, Li-Jun; Zuo, Hai-Jun; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">The authors have reported that oridonin isolated from Rabdosia rubescens induces apoptosis of human melanoma A375-S2 cells within 12 h.  In this study, TUNEL assay and flow cytometric anal. also indicate that one of the causes of A375-S2 cell death induced by oridonin was apoptosis.  The cell death was preceded by the release of cytochrome c from the mitochondria.  Twelve hours after treatment with oridonin, the ratio of Bax/Bcl-xL protein expression was increased and release of cytochrome c was decreased by an extracellular signal-regulated kinase (ERK) MAPK inhibitor (PD98059) and a phosphoinositide 3-kinases (PI3-K) inhibitor (wortmannin).  A mitochondrial permeability transition (MPT) inhibitor, decylubiquinone, suppressed the release of cytochrome c without affecting Bax expression.  The activation of p53 by oridonin was also blocked by wortmannin.  In addn., PD98059 and wortmannin significantly decreased oridonin-induced DNA fragmentation, but the p38 MAPK inhibitor (SB203580) did not alter DNA fragmentation.  Oridonin induced A375-S2 cell apoptosis by activating parallel p53 and ERK pathways, increasing the ratio of Bax/Bcl-xL protein expression, and promoting the release of cytochrome c into the cytosol, resulting in apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjfPu7IVXyQLVg90H21EOLACvtfcHk0lhL0jf1LAnrCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKgt78%253D&md5=d1213d7dc69096134bd06cb1276779af</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FPJ04008X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FPJ04008X%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DL.%2BJ.%26aulast%3DZuo%26aufirst%3DH.%2BJ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DCytochrome%2520c%2520release%2520from%2520oridonin-treated%2520apoptotic%2520A375-S2%2520cells%2520is%2520dependent%2520on%2520p53%2520and%2520extracellular%2520signal-regulated%2520kinase%2520activation%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D96%26spage%3D155%26epage%3D163%26doi%3D10.1254%2Fjphs.FPJ04008X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2009.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.abb.2009.08.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2009&pages=70-75&author=Y.+Chengauthor=F.+Qiuauthor=Y.+C.+Yeauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Oridonin+induces+G2%2FM+arrest+and+apoptosis+via+activating+ERK-p53+apoptotic+pathway+and+inhibiting+PTK-Ras-Raf-JNK+survival+pathway+in+murine+fibrosarcoma+L929+cells&doi=10.1016%2Fj.abb.2009.08.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DY.%2BC.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DOridonin%2520induces%2520G2%252FM%2520arrest%2520and%2520apoptosis%2520via%2520activating%2520ERK-p53%2520apoptotic%2520pathway%2520and%2520inhibiting%2520PTK-Ras-Raf-JNK%2520survival%2520pathway%2520in%2520murine%2520fibrosarcoma%2520L929%2520cells%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D490%26spage%3D70%26epage%3D75%26doi%3D10.1016%2Fj.abb.2009.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Augmentation of oridonin-induced apoptosis observed with reduced autophagy</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1254/jphs.FPJ06003X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1254%2Fjphs.FPJ06003X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=16861822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFalsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=230-239&author=Q.+Cuiauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Augmentation+of+oridonin-induced+apoptosis+observed+with+reduced+autophagy&doi=10.1254%2Fjphs.FPJ06003X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Augmentation of Oridonin-induced apoptosis observed with reduced autophagy</span></div><div class="casAuthors">Cui, Qiao; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-239</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Our previous studies showed that oridonin could induce apoptosis in HeLa cells; and in this study, we further investigated autophagy induced by oridonin in HeLa cells and the relationship between apoptosis and autophagy.  HeLa cells were exposed with oridonin after 3-methyladenine (3-MA) pre-culture, and we evaluated the growth inhibitory ratio, morphol. changes, DNA fragmentation, proteins expression as well as autophagic and apoptotic levels.  Oridonin inhibited the proliferation of HeLa cells in vitro and induced autophagy.  Oligonucleosomal fragementation of DNA as well as increased activities of Bax proteins were induced by oridonin, but the expression of p-Bcl-2 protein was reduced.  In the condition of oridonintreatment, when the inhibitor of phosphoinositide 3-kinase (PI3K), wortmannin, was applied, the autophagic level was significantly decreased, while the apoptotic level was increased, indicating that PI3K is a key regulator of both autophagy and apoptosis.  Akt, down-stream factor of PI3K, was activated in autophagic process but suppressed in apoptosis in this study.  In addn., when autophagy was blocked by 3-MA, the expression of SIRT-1 was decreased, indicating SIRT-1 contributed to autophagy.  Taken together, oridonin simultaneously induced HeLa cell both apoptosis and autophagy in HeLa cells, and inhibition of autophagy contributes to upregulation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnmqdDBZ9UYLVg90H21EOLACvtfcHk0lhL0jf1LAnrCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFalsLw%253D&md5=1e9dd4a14ba3021b72d9653b3335f00e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FPJ06003X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FPJ06003X%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DAugmentation%2520of%2520oridonin-induced%2520apoptosis%2520observed%2520with%2520reduced%2520autophagy%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D101%26spage%3D230%26epage%3D239%26doi%3D10.1254%2Fjphs.FPJ06003X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1248/bpb.30.859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1248%2Fbpb.30.859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=17473426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlKlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=859-864&author=Q.+Cuiauthor=S.+Tashiroauthor=S.+Onoderaauthor=M.+Minamiauthor=T.+Ikejima&title=Autophagy+preceded+apoptosis+in+oridonin-treated+human+breast+cancer+MCF-7+cells&doi=10.1248%2Fbpb.30.859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells</span></div><div class="casAuthors">Cui, Qiao; Tashiro, Shin-ichi; Onodera, Satoshi; Minami, Mutsuhiko; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">859-864</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Recent studies have shown that MCF-7 cells undergo autophagy under some conditions, such as tamoxifen treatment and starvation.  In this study, we investigated autophagy in MCF-7 cells under oridonin treatment and further examd. the relationship between autophagy and apoptosis.  After 3-MA (the specific inhibitor of autophagy) pre-culture, MCF-7 cells were exposed to oridonin, and the growth inhibitory ratio, morphol. changes, DNA fragmentation, proteins expression, autophagic ratio and apoptotic ratio were evaluated.  Oridonin inhibited the proliferation of MCF-7 cells and induced autophagy in vitro.  MDC (a specific dye for autophagosome) recruitment and typical apoptotic features, including apoptotic bodies, membrane blebbing as well as nuclear condensation, were induced by oridonin.  Oridonin downregulated the phosphorylation of ERK, whereas those of JNK and P38 kinase were upregulated.  In the condition of oridonin treatment, 3-MA significantly reduced the autophagic level, and the apoptotic cell ratio was also declined.  Furthermore, combined treatment with oridonin and 3-MA upregulated ERK phosphorylation and downregulated JNK and P38 kinases phosphorylation compared with oridonin alone treatment groups, indicating that autophagy facilitated apoptosis in oridonin-induced MCF-7 cells.  In addn., 3-MA application downregulated DNA ladder and Bax expression but upregulated Bcl-2 expression, compared with oridonin alone treatment.  Taken together, oridonin simultaneously induced MCF-7 cells both apoptosis and autophagy, and in this settings, inhibition of autophagy induced lowered apoptotic level, therefore, autophagy participated in upregulation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxPzyRRDgaMLVg90H21EOLACvtfcHk0lgcbZ3B7-2vAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlKlurY%253D&md5=2829fc94ebb5ea520184720390f93afc</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.859%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DAutophagy%2520preceded%2520apoptosis%2520in%2520oridonin-treated%2520human%2520breast%2520cancer%2520MCF-7%2520cells%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D859%26epage%3D864%26doi%3D10.1248%2Fbpb.30.859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.1248/bpb.27.1527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1248%2Fbpb.27.1527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15467189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSit7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1527-1531&author=C.+L.+Zhangauthor=L.+J.+Wuauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Oridonin+induces+a+caspase-independent+but+mitochondria-+and+MAPK-dependent+cell+death+in+the+murine+fibrosarcoma+cell+line+L929&doi=10.1248%2Fbpb.27.1527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929</span></div><div class="casAuthors">Zhang, Chun-Ling; Wu, Li-Jun; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1527-1531</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Oridonin, an active component isolated from Rabdosia rubescences, has been reported to exhibit antitumor effects, but little is known about its mol. mechanisms of action.  In this study, the growth-inhibitory activity of oridonin for L929 cells is in time- and dose-dependent manner.  After treatment with various concns. of oridonin for 12 h, the majority of L929 cells underwent apoptosis as measured by an LDH activity-based assay.  Although apoptotic bodies were obsd. in oridonin-treated L929 cells, DNA fragmentation as a hallmark of apoptosis was not found.  The pan-caspase inhibitor, z-VAD, and caspase-3 inhibitor, z-DEVD, sensitized L929 cells to oridonin, however, a PARP inhibitor (DPQ) effectively blocked oridonin-induced cell death.  After 12 h treatment, PARP proenzyme was significantly cleaved.  This result indicated that oridonin-induced L929 cell death required PARP degrdn. in a caspase-independent manner.  In addn., an MEK/ERK inhibitor (PD98059) markedly blocked oridonin-induced cell death, whereas a p38 inhibitor (SB203580) and JNK inhibitor (SP600125) weakly protected the cells against death.  Treatment with 41.2 μM oridonin for 12 h induced significant and persistent ERK activation and p38 inactivation in L929 cells without evident changes in the protein levels.  The responsiveness of ERK and p38 to oridonin suggests the involvement of these kinases in this apoptotic process.  Moreover, oridonin increased the ratio of Bax/Bcl-2 protein expression, whereas it had no effect on the expression of Bcl-xL.  These results indicate that regulation of the Bcl-2 and MAPK families maybe the effector mechanisms of oridonin-induced L929 cell death, independent of the caspase pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolRKNoop7647Vg90H21EOLACvtfcHk0lgcbZ3B7-2vAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSit7fN&md5=3d6c91c940184002d3edf4b980f202cd</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1248%2Fbpb.27.1527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.27.1527%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DL.%2BJ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DOridonin%2520induces%2520a%2520caspase-independent%2520but%2520mitochondria-%2520and%2520MAPK-dependent%2520cell%2520death%2520in%2520the%2520murine%2520fibrosarcoma%2520cell%2520line%2520L929%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2004%26volume%3D27%26spage%3D1527%26epage%3D1531%26doi%3D10.1248%2Fbpb.27.1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Barry M. Trost, <span class="NLM_string-name hlFld-ContribAuthor">Chuanle Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Zn-ProPhenol Catalyzed Enantioselective Mannich Reaction of 2H-Azirines with Alkynyl Ketones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (24)
                                     , 9683-9687. <a href="https://doi.org/10.1021/acs.orglett.0c03737" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03737%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DZn-ProPhenol%252BCatalyzed%252BEnantioselective%252BMannich%252BReaction%252Bof%252B2H-Azirines%252Bwith%252BAlkynyl%252BKetones%26aulast%3DTrost%26aufirst%3DBarry%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09112020%26date%3D03122020%26volume%3D22%26issue%3D24%26spage%3D9683%26epage%3D9687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hong Yao, Shaowen Xie, Xiaoqian Ma, Junkai Liu, Hongyu Wu, Aijun Lin, Hequan Yao, Dahong Li, Shengtao Xu, Dong-Hua Yang, Zhe-Sheng Chen, <span class="NLM_string-name hlFld-ContribAuthor">Jinyi Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8157-8178. <a href="https://doi.org/10.1021/acs.jmedchem.0c00408" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00408%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BPotent%252BOridonin%252BAnalogue%252Bfor%252BTreatment%252Bof%252BTriple-Negative%252BBreast%252BCancer%26aulast%3DYao%26aufirst%3DHong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10032020%26date%3D21072020%26date%3D02072020%26volume%3D63%26issue%3D15%26spage%3D8157%26epage%3D8178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rick C. Betori, Yue Liu, Rama K. Mishra, Scott B. Cohen, Stephen J. Kron, <span class="NLM_string-name hlFld-ContribAuthor">Karl A. Scheidt</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibition of Telomerase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (3)
                                     , 706-717. <a href="https://doi.org/10.1021/acschembio.9b00945" title="DOI URL">https://doi.org/10.1021/acschembio.9b00945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00945%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DTargeted%252BCovalent%252BInhibition%252Bof%252BTelomerase%26aulast%3DBetori%26aufirst%3DRick%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D23112019%26date%3D04022020%26date%3D24022020%26date%3D04022020%26volume%3D15%26issue%3D3%26spage%3D706%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lingran Kong, Fan Su, Hang Yu, Zhe Jiang, Yandong Lu, <span class="NLM_string-name hlFld-ContribAuthor">Tuoping Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of (−)-Oridonin: An Interrupted Nazarov Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (51)
                                     , 20048-20052. <a href="https://doi.org/10.1021/jacs.9b12034" title="DOI URL">https://doi.org/10.1021/jacs.9b12034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b12034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b12034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DTotal%252BSynthesis%252Bof%252B%252528%2525E2%252588%252592%252529-Oridonin%25253A%252BAn%252BInterrupted%252BNazarov%252BApproach%26aulast%3DKong%26aufirst%3DLingran%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07112019%26date%3D11122019%26date%3D05122019%26volume%3D141%26issue%3D51%26spage%3D20048%26epage%3D20052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi  Liu</span>, <span class="hlFld-ContribAuthor ">Jimin  Xu</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiang  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance. </span><span class="cited-content_cbyCitation_journal-name">Genes & Diseases</span><span> <strong>2021,</strong> <em>8 </em>
                                    (4)
                                     , 448-462. <a href="https://doi.org/10.1016/j.gendis.2020.06.010" title="DOI URL">https://doi.org/10.1016/j.gendis.2020.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gendis.2020.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gendis.2020.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%2520%2526%2520Diseases%26atitle%3DOridonin%252Band%252Bits%252Bderivatives%252Bfor%252Bcancer%252Btreatment%252Band%252Bovercoming%252Btherapeutic%252Bresistance%26aulast%3DLiu%26aufirst%3DXi%26date%3D2021%26volume%3D8%26issue%3D4%26spage%3D448%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabien  Emmetiere</span>, <span class="hlFld-ContribAuthor ">Ranjala  Ratnayake</span>, <span class="hlFld-ContribAuthor ">Henry A. M.  Schares</span>, <span class="hlFld-ContribAuthor ">Katherine F. M.  Jones</span>, <span class="hlFld-ContribAuthor ">Emily  Bevan–Smith</span>, <span class="hlFld-ContribAuthor ">Hendrik  Luesch</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Harki</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Grenning</span>. </span><span class="cited-content_cbyCitation_article-title">Function‐Oriented and Modular (+/−)‐
              cis
              ‐Pseudoguaianolide Synthesis: Discovery of New Nrf2 Activators and NF‐κB Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (17)
                                     , 5564-5571. <a href="https://doi.org/10.1002/chem.202100038" title="DOI URL">https://doi.org/10.1002/chem.202100038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100038%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFunction%2525E2%252580%252590Oriented%252Band%252BModular%252B%252528%25252B%25252F%2525E2%252588%252592%252529%2525E2%252580%252590%252Bcis%252B%2525E2%252580%252590Pseudoguaianolide%252BSynthesis%25253A%252BDiscovery%252Bof%252BNew%252BNrf2%252BActivators%252Band%252BNF%2525E2%252580%252590%2525CE%2525BAB%252BInhibitors%26aulast%3DEmmetiere%26aufirst%3DFabien%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D17%26spage%3D5564%26epage%3D5571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Xiaobin  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanan  Qiao</span>, <span class="hlFld-ContribAuthor ">Yuliang  Xu</span>, <span class="hlFld-ContribAuthor ">Yong  Sun</span>, <span class="hlFld-ContribAuthor ">Lilin  Qian</span>, <span class="hlFld-ContribAuthor ">Zhaopeng  Liu</span>, <span class="hlFld-ContribAuthor ">Aiguo  Ji</span>, <span class="hlFld-ContribAuthor ">Hongxiang  Lou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112896. <a href="https://doi.org/10.1016/j.ejmech.2020.112896" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112896%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Blysosome-targeted%252Bcovalent%252Banticancer%252Bagents%252Bbased%252Bon%252Bisosteviol%252Bskeleton%26aulast%3DLiu%26aufirst%3DJun%26date%3D2021%26volume%3D209%26spage%3D112896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Linghe  Zang</span>, <span class="hlFld-ContribAuthor ">Yan  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (6)
                                     , 483-497. <a href="https://doi.org/10.2174/1389557519666191029121809" title="DOI URL">https://doi.org/10.2174/1389557519666191029121809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557519666191029121809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557519666191029121809%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bof%252BOridonin%252Band%252BIts%252BDerivatives%252Bfor%252Bthe%252BTreatment%252Bof%252BAcute%252BMyelogenous%252BLeukemia%26aulast%3DHu%26aufirst%3DXu%26date%3D2020%26volume%3D20%26issue%3D6%26spage%3D483%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Jian  Song</span>, <span class="hlFld-ContribAuthor ">Ting  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Pang</span>, <span class="hlFld-ContribAuthor ">Sheng-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Jun-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Zi</span>, <span class="hlFld-ContribAuthor ">Sai-Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112153. <a href="https://doi.org/10.1016/j.ejmech.2020.112153" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112153%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Btertiary%252Bamide%252Bderivatives%252Bas%252BNEDDylation%252Bpathway%252Bactivators%252Bto%252Binhibit%252Bthe%252Btumor%252Bprogression%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2020%26volume%3D192%26spage%3D112153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Wang</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Dai</span>, <span class="hlFld-ContribAuthor ">Jijuan  Nai</span>, <span class="hlFld-ContribAuthor ">Liqiao  Zhu</span>, <span class="hlFld-ContribAuthor ">Huagang  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Solubility and Bioavailability Enhancement of Oridonin: A Review. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 332. <a href="https://doi.org/10.3390/molecules25020332" title="DOI URL">https://doi.org/10.3390/molecules25020332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25020332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25020332%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSolubility%252Band%252BBioavailability%252BEnhancement%252Bof%252BOridonin%25253A%252BA%252BReview%26aulast%3DZhang%26aufirst%3DYuanyuan%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma K  Davison</span>, <span class="hlFld-ContribAuthor ">Margaret A  Brimble</span>. </span><span class="cited-content_cbyCitation_article-title">Natural product derived privileged scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2019,</strong> <em>52 </em>, 1-8. <a href="https://doi.org/10.1016/j.cbpa.2018.12.007" title="DOI URL">https://doi.org/10.1016/j.cbpa.2018.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2018.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2018.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DNatural%252Bproduct%252Bderived%252Bprivileged%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DDavison%26aufirst%3DEmma%2BK%26date%3D2019%26volume%3D52%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Tao  Yin</span>, <span class="hlFld-ContribAuthor ">Hyejin  Kim</span>, <span class="hlFld-ContribAuthor ">Chunyong  Ding</span>, <span class="hlFld-ContribAuthor ">Zhuo  Yu</span>, <span class="hlFld-ContribAuthor ">Hong  Wang</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Ruping  Yan</span>, <span class="hlFld-ContribAuthor ">Eric A.  Wold</span>, <span class="hlFld-ContribAuthor ">Hao  Zou</span>, <span class="hlFld-ContribAuthor ">Xi  Liu</span>, <span class="hlFld-ContribAuthor ">Ye  Ding</span>, <span class="hlFld-ContribAuthor ">Qiang  Shen</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 589-605. <a href="https://doi.org/10.1016/j.ejmech.2019.06.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bstudies%252Bon%252BBax%252Bactivator%252BSMBA1%252Bfor%252Bthe%252Btreatment%252Bof%252BER-positive%252Band%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DLiu%26aufirst%3DGang%26date%3D2019%26volume%3D178%26spage%3D589%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Qiuju  Fan</span>, <span class="hlFld-ContribAuthor ">Lin  Su</span>, <span class="hlFld-ContribAuthor ">Hongtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 935-947. <a href="https://doi.org/10.2174/1871520619666190118121439" title="DOI URL">https://doi.org/10.2174/1871520619666190118121439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666190118121439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666190118121439%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BOridonin%252BDerivatives%252Bvia%252BMizoroki-Heck%252BReaction%252Band%252BClick%252BChemistry%252Bfor%252BCytotoxic%252BActivity%26aulast%3DHou%26aufirst%3DWei%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D935%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Kun  Shen</span>, <span class="hlFld-ContribAuthor ">Hao  Deng</span>, <span class="hlFld-ContribAuthor ">Shi-Ben  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Shun  Tian</span>, <span class="hlFld-ContribAuthor ">Zhe-Shan  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>173 </em>, 15-31. <a href="https://doi.org/10.1016/j.ejmech.2019.04.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Band%252Bevaluation%252Bof%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Banticancer%252Bactivity%252Bof%252B14-substituted%252Boridonin%252Banalogs%25253A%252BA%252Bnovel%252Band%252Bpotent%252Bcell%252Bcycle%252Barrest%252Band%252Bapoptosis%252Binducer%252Bthrough%252Bthe%252Bp53-MDM2%252Bpathway%26aulast%3DShen%26aufirst%3DQing-Kun%26date%3D2019%26volume%3D173%26spage%3D15%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Ziyi  Bai</span>, <span class="hlFld-ContribAuthor ">Jian  Qiao</span>, <span class="hlFld-ContribAuthor ">Haonan  Li</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Xianhua  Wang</span>, <span class="hlFld-ContribAuthor ">Yongnan  Xu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 169-179. <a href="https://doi.org/10.1016/j.ejmech.2019.03.046" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffective%252Benmein-type%252Bmimics%252Bof%252Bclinical%252Bcandidate%252BHAO472%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DHu%26aufirst%3DXu%26date%3D2019%26volume%3D171%26spage%3D169%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weizhi  Ge</span>, <span class="hlFld-ContribAuthor ">Xin  Hao</span>, <span class="hlFld-ContribAuthor ">Fangzhi  Han</span>, <span class="hlFld-ContribAuthor ">Zhongquan  Liu</span>, <span class="hlFld-ContribAuthor ">Tianpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Yahui  Ding</span>, <span class="hlFld-ContribAuthor ">Yue  Chen</span>, <span class="hlFld-ContribAuthor ">Quan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 445-469. <a href="https://doi.org/10.1016/j.ejmech.2019.01.058" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.058%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudies%252Bof%252Bparthenolide%252Bderivatives%252Bas%252Bpotential%252Banti-triple%252Bnegative%252Bbreast%252Bcancer%252Bagents%26aulast%3DGe%26aufirst%3DWeizhi%26date%3D2019%26volume%3D166%26spage%3D445%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dengfeng  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Wang</span>, <span class="hlFld-ContribAuthor ">Ye  Ding</span>, <span class="hlFld-ContribAuthor ">Ziwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi  Zheng</span>, <span class="hlFld-ContribAuthor ">Jiabin  Dong</span>, <span class="hlFld-ContribAuthor ">Hyejin  Kim</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Meng</span>, <span class="hlFld-ContribAuthor ">Qianjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Lin  Fang</span>, <span class="hlFld-ContribAuthor ">Qiang  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2018,</strong> <em>424 </em>, 97-108. <a href="https://doi.org/10.1016/j.canlet.2018.03.029" title="DOI URL">https://doi.org/10.1016/j.canlet.2018.03.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2018.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2018.03.029%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DTargeting%252Bthe%252BNRF-2%25252FRHOA%25252FROCK%252Bsignaling%252Bpathway%252Bwith%252Ba%252Bnovel%252Baziridonin%25252C%252BYD0514%25252C%252Bto%252Bsuppress%252Bbreast%252Bcancer%252Bprogression%252Band%252Blung%252Bmetastasis%26aulast%3DLi%26aufirst%3DDengfeng%26date%3D2018%26volume%3D424%26spage%3D97%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Representative molecules bearing covalent warheads enamide and ynamide (highlighted in red). (B) Representative molecules with covalent warheads epoxide and aziridine (highlighted in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reactivity of oridonin with GSH determined by <sup>1</sup>H NMR analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plausible reaction mechanism for Rh<sub>2</sub>(esp)<sub>2</sub> catalyzed regio- and stereospecific aziridination of oridonin-like substrates. (A) Analysis of the reactive substructure and substrate participating in the aziridination. (B) The structures of Rh<sub>2</sub>(esp)<sub>2</sub>. (C, D) The comparison of two different substrates (C) <b>33</b> vs (D) <b>21</b>, assisted by the neighboring oxygen group participation in the Rh<sub>2</sub>(esp)<sub>2</sub>-promoted regio- and stereospecific aziridination.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Aziridinated Oridonin Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5% HCl (aq), MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 15 min, 28∼62%; (b) Fmoc chloride, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 0 °C → rt, 12 h, 34%; (c) 5% HCl (aq), MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 15 min, 75%; (d) PyHBr<sub>3</sub>, THF, 0 °C, 2 h, 82%; (e) <i>N</i>-allylthiourea, EtOH, reflux, 5 h, 44%; (f) piperidine, DMF, rt, 1 h, 82%; (g) acrylic acid, HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 12 h, 33%; (h) propionic acid, HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 12 h, 74%.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reactivity of aziridinated oridonin analogue <b>25</b> with GSH determined by <sup>1</sup>H NMR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Reactivity of aziridinated oridonin analogue <b>44</b> with GSH determined by <sup>1</sup>H NMR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Growth inhibitory effects of <b>44</b> against MDA-MB-231, SK-BR3, MDA-MB-468, and MCF-7 breast cancer cells. (A) <b>44</b> significantly inhibits colony formation of MDA-MB-231, SK-BR3, MDA-MB-468, and MCF-7 cells. (B) <b>44</b> suppresses the proliferation of MDA-MB-231, SK-BR3, MDA-MB-468, and MCF-7 cells. Data are presented as the mean ± SD of at least three independent experiments. Significance between different groups was determined by using one-way ANOVA; <i>p</i> = 0.0003 (MDA-MB-231), <i>p</i> = 0.0002 (MDA-MB-468), <i>p</i> < 0.0001 (SK-BR3), and <i>p</i> = 0.0012 (MCF-7).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Induction of apoptosis in MDA-MB-231 breast cancer cells by <b>44</b>. (A) Flow-cytometry analysis of apoptotic MDA-MB-231 breast cancer cells induced by <b>44</b> at different concentrations. (B) Apoptotic ratio of different concentrations of <b>44</b> in MDA-MB-231 breast cancer cells. The values are means ± SD of at least three independent experiments. A single asterisk represents <i>p</i> < 0.05, two asterisks represent <i>p</i> < 0.01, and three asterisks represent <i>p</i> < 0.001 to 0 μM group (DMSO, vehicle control). (C) Western-blot analysis of biomarkers for apoptosis induced by <b>44</b> in MDA-MB-231 breast cancer cells at different concentrations (48 h).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>44</b> and oridonin on normal mammary epithelial cells (MCF-10A) proliferation. MCF-10A cells were treated with varying concentrations of <b>44</b> and oridonin for 48 h. Values are mean ± SD of three independent experiments. Statistical significance was determined using a Student <i>t</i>-test, in comparison to the corresponding value of oridonin treatment at the same concentration. ns indicates not significant, a single asterisk indicates <i>p</i> < 0.05, triple asterisks indicate <i>p</i> < 0.001, and quadruple asterisks indicate <i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/medium/jm-2017-01514r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In vivo efficacy of <b>44</b> in suppressing the xenograft tumor growth of triple-negative breast cancer. The breast cancer cell line MDA-MB-231 was used to generate xenograft tumors in nude mice for 10 and 15 mg/kg doses via intraperitoneal injection, respectively. Data are presented as the mean ± SEM of tumor volume at each time point. Significance between different groups was determined by using one-way ANOVA; <i>p</i> = 0.0023.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01514/20180406/images/large/jm-2017-01514r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01514&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span> <span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lj4DPHYmy_wMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaptein, A.</span></span> <span> </span><span class="NLM_article-title">Irreversible protein kinase inhibitors: balancing the benefits and risks</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6243</span>– <span class="NLM_lpage">6262</span>, <span class="refDoi"> DOI: 10.1021/jm3003203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6243-6262&author=T.+Barfauthor=A.+Kaptein&title=Irreversible+protein+kinase+inhibitors%3A+balancing+the+benefits+and+risks&doi=10.1021%2Fjm3003203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks</span></div><div class="casAuthors">Barf, Tjeerd; Kaptein, Allard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6243-6262</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Not applicable for a Perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4PLlisO0OVbVg90H21EOLACvtfcHk0lj4DPHYmy_wMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVerur8%253D&md5=5d87850857d37faab02e6037ef8140a4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm3003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003203%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DKaptein%26aufirst%3DA.%26atitle%3DIrreversible%2520protein%2520kinase%2520inhibitors%253A%2520balancing%2520the%2520benefits%2520and%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6243%26epage%3D6262%26doi%3D10.1021%2Fjm3003203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Developing irreversible inhibitors of the protein kinase cysteinome</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.chembiol.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=23438744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=146-159&author=Q.+Liuauthor=Y.+Sabnisauthor=Z.+Zhaoauthor=T.+Zhangauthor=S.+J.+Buhrlageauthor=L.+H.+Jonesauthor=N.+S.+Gray&title=Developing+irreversible+inhibitors+of+the+protein+kinase+cysteinome&doi=10.1016%2Fj.chembiol.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome</span></div><div class="casAuthors">Liu, Qingsong; Sabnis, Yogesh; Zhao, Zheng; Zhang, Tinghu; Buhrlage, Sara J.; Jones, Lyn H.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-159</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a large family of approx. 530 highly conserved enzymes that transfer a γ-phosphate group from ATP to a variety of amino acid residues, such as tyrosine, serine, and threonine, that serves as a ubiquitous mechanism for cellular signal transduction.  The clin. success of a no. of kinase-directed drugs and the frequent observation of disease causing mutations in protein kinases suggest that a large no. of kinases may represent therapeutically relevant targets.  To date, the majority of clin. and preclin. kinase inhibitors are ATP competitive, noncovalent inhibitors that achieve selectivity through recognition of unique features of particular protein kinases.  Recently, there has been renewed interest in the development of irreversible inhibitors that form covalent bonds with cysteine or other nucleophilic residues in the ATP-binding pocket.  Irreversible kinase inhibitors have a no. of potential advantages including prolonged pharmacodynamics, suitability for rational design, high potency, and ability to validate pharmacol. specificity through mutation of the reactive cysteine residue.  Here, we review recent efforts to develop cysteine-targeted irreversible protein kinase inhibitors and discuss their modes of recognizing the ATP-binding pocket and their biol. activity profiles.  In addn., we provided an informatics assessment of the potential "kinase cysteinome" and discuss strategies for the efficient development of new covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGD7TX3oIeLVg90H21EOLACvtfcHk0lhmBdgzlEJh5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D&md5=cef80823123bae88362e816a0a638133</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSabnis%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDeveloping%2520irreversible%2520inhibitors%2520of%2520the%2520protein%2520kinase%2520cysteinome%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D146%26epage%3D159%26doi%3D10.1016%2Fj.chembiol.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8249</span>– <span class="NLM_lpage">8267</span>, <span class="refDoi"> DOI: 10.1021/jm500973a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500973a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8249-8267&author=M.+R.+Finlayauthor=M.+Andertonauthor=S.+Ashtonauthor=P.+Ballardauthor=P.+A.+Bethelauthor=M.+R.+Boxauthor=R.+H.+Bradburyauthor=S.+J.+Brownauthor=S.+Butterworthauthor=A.+Campbellauthor=C.+Chorleyauthor=N.+Colcloughauthor=D.+A.+Crossauthor=G.+S.+Currieauthor=M.+Gristauthor=L.+Hassallauthor=G.+B.+Hillauthor=D.+Jamesauthor=M.+Jamesauthor=P.+Kemmittauthor=T.+Klinowskaauthor=G.+Lamontauthor=S.+G.+Lamontauthor=N.+Martinauthor=H.+L.+McFarlandauthor=M.+J.+Mellorauthor=J.+P.+Ormeauthor=D.+Perkinsauthor=P.+Perkinsauthor=G.+Richmondauthor=P.+Smithauthor=R.+A.+Wardauthor=M.+J.+Waringauthor=D.+Whittakerauthor=S.+Wellsauthor=G.+L.+Wrigley&title=Discovery+of+a+potent+and+selective+EGFR+inhibitor+%28AZD9291%29+of+both+sensitizing+and+T790M+resistance+mutations+that+spares+the+wild+type+form+of+the+receptor&doi=10.1021%2Fjm500973a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor</span></div><div class="casAuthors">Finlay, M. Raymond V.; Anderton, Mark; Ashton, Susan; Ballard, Peter; Bethel, Paul A.; Box, Matthew R.; Bradbury, Robert H.; Brown, Simon J.; Butterworth, Sam; Campbell, Andrew; Chorley, Christopher; Colclough, Nicola; Cross, Darren A. E.; Currie, Gordon S.; Grist, Matthew; Hassall, Lorraine; Hill, George B.; James, Daniel; James, Michael; Kemmitt, Paul; Klinowska, Teresa; Lamont, Gillian; Lamont, Scott G.; Martin, Nathaniel; McFarland, Heather L.; Mellor, Martine J.; Orme, Jonathon P.; Perkins, David; Perkins, Paula; Richmond, Graham; Smith, Peter; Ward, Richard A.; Waring, Michael J.; Whittaker, David; Wells, Stuart; Wrigley, Gail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8249-8267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) inhibitors have been used clin. in the treatment of nonsmall-cell lung cancer (NSCLC) patients harboring sensitizing (or activating) mutations for a no. of years.  Despite encouraging clin. efficacy with these agents, in many patients resistance develops leading to disease progression.  In most cases, this resistance is in the form of the T790M mutation.  In addn., EGFR wild type receptor inhibition inherent with these agents can lead to dose limiting toxicities of rash and diarrhea.  The authors describe herein the evolution of an early, mutant selective lead to the clin. candidate AZD9291 I, an irreversible inhibitor of both EGFR sensitizing (EGFRm+) and T790M resistance mutations with selectivity over the wild type form of the receptor.  Following observations of significant tumor inhibition in preclin. models, the clin. candidate was administered clin. to patients with T790M pos. EGFR-TKI resistant NSCLC and early efficacy has been obsd., accompanied by an encouraging safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouPAWG9N0Ro7Vg90H21EOLACvtfcHk0lhmBdgzlEJh5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI&md5=db9db624bb4324c2e22b1ab12035263b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm500973a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500973a%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DAnderton%26aufirst%3DM.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%2BR.%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DChorley%26aufirst%3DC.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DKemmitt%26aufirst%3DP.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DG.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMcFarland%26aufirst%3DH.%2BL.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DRichmond%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DWrigley%26aufirst%3DG.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520EGFR%2520inhibitor%2520%2528AZD9291%2529%2520of%2520both%2520sensitizing%2520and%2520T790M%2520resistance%2520mutations%2520that%2520spares%2520the%2520wild%2520type%2520form%2520of%2520the%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8249%26epage%3D8267%26doi%3D10.1021%2Fjm500973a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getlik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Termathe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lategahn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer-Wrangowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grütter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlenbrock, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaumann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eppmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kibies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffgaard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menninger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Cuaran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuckmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinnefeld, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahedi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz-Fademrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kast, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span> <span> </span><span class="NLM_article-title">Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6844</span>– <span class="NLM_lpage">6863</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCjsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6844-6863&author=J.+Engelauthor=A.+Richtersauthor=M.+Getlikauthor=S.+Tomassiauthor=M.+Keulauthor=M.+Termatheauthor=J.+Lategahnauthor=C.+Beckerauthor=S.+Mayer-Wrangowskiauthor=C.+Gr%C3%BCtterauthor=N.+Uhlenbrockauthor=J.+Kr%C3%BCllauthor=N.+Schaumannauthor=S.+Eppmannauthor=P.+Kibiesauthor=F.+Hoffgaardauthor=J.+Heilauthor=S.+Menningerauthor=S.+Ortiz-Cuaranauthor=J.+M.+Heuckmannauthor=V.+Tinnefeldauthor=R.+P.+Zahediauthor=M.+L.+Sosauthor=C.+Schultz-Fademrechtauthor=R.+K.+Thomasauthor=S.+M.+Kastauthor=D.+Rauh&title=Targeting+drug+resistance+in+EGFR+with+covalent+inhibitors%3A+a+structure-based+design+approach&doi=10.1021%2Facs.jmedchem.5b01082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach</span></div><div class="casAuthors">Engel, Julian; Richters, Andre; Getlik, Matthaeus; Tomassi, Stefano; Keul, Marina; Termathe, Martin; Lategahn, Jonas; Becker, Christian; Mayer-Wrangowski, Svenja; Gruetter, Christian; Uhlenbrock, Niklas; Kruell, Jasmin; Schaumann, Niklas; Eppmann, Simone; Kibies, Patrick; Hoffgaard, Franziska; Heil, Jochen; Menninger, Sascha; Ortiz-Cuaran, Sandra; Heuckmann, Johannes M.; Tinnefeld, Verena; Zahedi, Rene P.; Sos, Martin L.; Schultz-Fademrecht, Carsten; Thomas, Roman K.; Kast, Stefan M.; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6844-6863</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Receptor tyrosine kinases represent one of the prime targets in cancer therapy, as the dysregulation of these elementary transducers of extracellular signals, like the epidermal growth factor receptor (EGFR), contributes to the onset of cancer, such as non-small cell lung cancer (NSCLC).  Strong efforts were directed to the development of irreversible inhibitors and led to compd. CO-1686, which takes advantage of increased residence time at EGFR by alkylating Cys797 and thereby preventing toxic effects.  Here, the authors present a structure-based approach, rationalized by subsequent computational anal. of conformational ligand ensembles in soln., to design novel and irreversible EGFR inhibitors based on a screening hit that was identified in a phenotype screen of 80 NSCLC cell lines against approx. 1500 compds.  Using protein x-ray crystallog., the authors deciphered the binding mode in engineered cSrc (T338M/S345C), a validated model system for EGFR-T790M, which constituted the basis for further rational design approaches.  Chem. synthesis led to further compd. collections that revealed increased biochem. potency and, in part, selectivity toward mutated (L858R and L858R/T790M) vs. nonmutated EGFR.  Further cell-based and kinetic studies were performed to substantiate the authors initial findings.  Utilizing proteolytic digestion and nano-LC-MS/MS anal., the authors confirmed the alkylation of Cys797.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGJPIuqoVObVg90H21EOLACvtfcHk0livqh5GA8vE9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCjsrvM&md5=d5264a2a99d7752af0e587f23aeb7723</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01082%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DRichters%26aufirst%3DA.%26aulast%3DGetlik%26aufirst%3DM.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DKeul%26aufirst%3DM.%26aulast%3DTermathe%26aufirst%3DM.%26aulast%3DLategahn%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DC.%26aulast%3DUhlenbrock%26aufirst%3DN.%26aulast%3DKr%25C3%25BCll%26aufirst%3DJ.%26aulast%3DSchaumann%26aufirst%3DN.%26aulast%3DEppmann%26aufirst%3DS.%26aulast%3DKibies%26aufirst%3DP.%26aulast%3DHoffgaard%26aufirst%3DF.%26aulast%3DHeil%26aufirst%3DJ.%26aulast%3DMenninger%26aufirst%3DS.%26aulast%3DOrtiz-Cuaran%26aufirst%3DS.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DTinnefeld%26aufirst%3DV.%26aulast%3DZahedi%26aufirst%3DR.%2BP.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DKast%26aufirst%3DS.%2BM.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DTargeting%2520drug%2520resistance%2520in%2520EGFR%2520with%2520covalent%2520inhibitors%253A%2520a%2520structure-based%2520design%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6844%26epage%3D6863%26doi%3D10.1021%2Facs.jmedchem.5b01082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span> <span> </span><span class="NLM_article-title">Challenges and perspectives on the development of small-molecule EGFR inhibitors against T790M-mediated resistance in non-small-cell lung cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6580</span>– <span class="NLM_lpage">6594</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00840</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00840" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6580-6594&author=Z.+Songauthor=Y.+Geauthor=C.+Wangauthor=S.+Huangauthor=X.+Shuauthor=K.+Liuauthor=Y.+Zhouauthor=X.+Ma&title=Challenges+and+perspectives+on+the+development+of+small-molecule+EGFR+inhibitors+against+T790M-mediated+resistance+in+non-small-cell+lung+cancer&doi=10.1021%2Facs.jmedchem.5b00840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer</span></div><div class="casAuthors">Song, Zhendong; Ge, Yang; Wang, Changyuan; Huang, Shanshan; Shu, Xiaohong; Liu, Kexin; Zhou, Youwen; Ma, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6580-6594</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the development of drug-resistance mutations, particularly the "gatekeeper" threonine790-to-methionine790 (T790M) mutation in the ATP-binding pocket of the epidermal growth factor receptor (EGFR), the current generation of EGFR tyrosine kinase inhibitors lost their clin. efficacy.  Recently, a large no. of small-mol. inhibitors with striking inhibitory potency against EGFR mutants with the T790M change have been identified.  In particular, the inhibitors rociletinib and osimertinib, which can selectively target both sensitizing mutations and the T790M resistance while sparing the wild-type (WT) form of the receptor, have been designated as breakthrough therapies in the treatment of mutant non-small-cell lung cancer (NSCLC) by the U.S.  FDA in 2014.  We hope that this review on the small-mol. EGFR T790M inhibitors, along with their discovery strategies, will assist in the design of future T790M-contg. EGFR inhibitors with high levels of selectivity over WT EGFR, broad kinase selectivity, and desirable physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcAydAIVpNbVg90H21EOLACvtfcHk0livqh5GA8vE9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGntbo%253D&md5=2112d52e116494f61b1c8bd3f8f383d9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00840%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%26atitle%3DChallenges%2520and%2520perspectives%2520on%2520the%2520development%2520of%2520small-molecule%2520EGFR%2520inhibitors%2520against%2520T790M-mediated%2520resistance%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6580%26epage%3D6594%26doi%3D10.1021%2Facs.jmedchem.5b00840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzmic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolanos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1073/pnas.1313733111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1073%2Fpnas.1313733111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=24347635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=173-178&author=P.+A.+Schwartzauthor=P.+Kuzmicauthor=J.+Solowiejauthor=S.+Bergqvistauthor=B.+Bolanosauthor=C.+Almadenauthor=A.+Nagataauthor=K.+Ryanauthor=J.+Fengauthor=D.+Dalvieauthor=J.+C.+Kathauthor=M.+Xuauthor=R.+Waniauthor=B.+W.+Murray&title=Covalent+EGFR+inhibitor+analysis+reveals+importance+of+reversible+interactions+to+potency+and+mechanisms+of+drug+resistance&doi=10.1073%2Fpnas.1313733111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span></div><div class="casAuthors">Schwartz, Phillip A.; Kuzmic, Petr; Solowiej, James; Bergqvist, Simon; Bolanos, Ben; Almaden, Chau; Nagata, Asako; Ryan, Kevin; Feng, Junli; Dalvie, Deepak; Kath, John C.; Xu, Meirong; Wani, Revati; Murray, Brion William</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-178</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Covalent inhibition is a reemerging paradigm in kinase drug design, but the roles of inhibitor binding affinity and chem. reactivity in overall potency are not well-understood.  To characterize the underlying mol. processes at a microscopic level and det. the appropriate kinetic consts., specialized exptl. design and advanced numerical integration of differential equations are developed.  Previously uncharacterized investigational covalent drugs reported here are shown to be extremely effective epidermal growth factor receptor (EGFR) inhibitors (kinact/Ki in the range 105-107 M-1s-1), despite their low specific reactivity (kinact ≤ 2.1 × 10-3 s-1), which is compensated for by high binding affinities (Ki < 1 nM).  For inhibitors relying on reactivity to achieve potency, noncovalent enzyme-inhibitor complex partitioning between inhibitor dissocn. and bond formation is central.  Interestingly, reversible binding affinity of EGFR covalent inhibitors is highly correlated with antitumor cell potency.  Furthermore, cellular potency for a subset of covalent inhibitors can be accounted for solely through reversible interactions.  One reversible interaction is between EGFR-Cys797 nucleophile and the inhibitor's reactive group, which may also contribute to drug resistance.  Because covalent inhibitors target a cysteine residue, the effects of its oxidn. on enzyme catalysis and inhibitor pharmacol. are characterized.  Oxidn. of the EGFR cysteine nucleophile does not alter catalysis but has widely varied effects on inhibitor potency depending on the EGFR context (e.g., oncogenic mutations), type of oxidn. (sulfinylation or glutathiolation), and inhibitor architecture.  These methods, parameters, and insights provide a rational framework for assessing and designing effective covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTpPuRq8MwCLVg90H21EOLACvtfcHk0livqh5GA8vE9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D&md5=47197c5e7876a238eefb2e8e7de305ea</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1313733111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1313733111%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DKuzmic%26aufirst%3DP.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWani%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DCovalent%2520EGFR%2520inhibitor%2520analysis%2520reveals%2520importance%2520of%2520reversible%2520interactions%2520to%2520potency%2520and%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D173%26epage%3D178%26doi%3D10.1073%2Fpnas.1313733111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Páez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanning, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijaro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide covalent ligand discovery in native biological systems</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>534</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1038/nature18002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1038%2Fnature18002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27309814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2016&pages=570-574&author=K.+M.+Backusauthor=B.+E.+Correiaauthor=K.+M.+Lumauthor=S.+Forliauthor=B.+D.+Horningauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=S.+Chatterjeeauthor=B.+R.+Lanningauthor=J.+R.+Teijaroauthor=A.+J.+Olsonauthor=D.+W.+Wolanauthor=B.+F.+Cravatt&title=Proteome-wide+covalent+ligand+discovery+in+native+biological+systems&doi=10.1038%2Fnature18002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-wide covalent ligand discovery in native biological systems</span></div><div class="casAuthors">Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Forli, Stefano; Horning, Benjamin D.; Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Lanning, Bryan R.; Teijaro, John R.; Olson, Arthur J.; Wolan, Dennis W.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">7608</span>),
    <span class="NLM_cas:pages">570-574</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small mols. are powerful tools for investigating protein function and can serve as leads for new therapeutics.  Most human proteins, however, lack small-mol. ligands, and entire protein classes are considered 'undruggable'.  Fragment-based ligand discovery can identify small-mol. probes for proteins that have proven difficult to target using high-throughput screening of complex compd. libraries.  Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-mol. probes, including those that can access regions of proteins that are difficult to target through binding affinity alone.  Here we report a quant. anal. of cysteine-reactive small-mol. fragments screened against thousands of proteins in human proteomes and cells.  Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chem. probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins.  Among the atypical ligand-protein interactions discovered were compds. that react preferentially with pro- (inactive) caspases.  We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines vs. primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10.  Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compds. that can illuminate protein functions in native biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNJ88KALeSLVg90H21EOLACvtfcHk0ljKdFgbQQ07SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN&md5=6fab087c042de735f8a5931e9f5b946c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature18002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18002%26sid%3Dliteratum%253Aachs%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHorning%26aufirst%3DB.%2BD.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DLanning%26aufirst%3DB.%2BR.%26aulast%3DTeijaro%26aufirst%3DJ.%2BR.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520covalent%2520ligand%2520discovery%2520in%2520native%2520biological%2520systems%26jtitle%3DNature%26date%3D2016%26volume%3D534%26spage%3D570%26epage%3D574%26doi%3D10.1038%2Fnature18002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppenheimer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span> <span> </span><span class="NLM_article-title">Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10072</span>– <span class="NLM_lpage">10079</span>, <span class="refDoi"> DOI: 10.1021/jm501412a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501412a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10072-10079&author=M.+E.+Flanaganauthor=J.+A.+Abramiteauthor=D.+P.+Andersonauthor=A.+Aulabaughauthor=U.+P.+Dahalauthor=A.+M.+Gilbertauthor=C.+Liauthor=J.+Montgomeryauthor=S.+R.+Oppenheimerauthor=T.+Ryderauthor=B.+P.+Schuffauthor=D.+P.+Uccelloauthor=G.+S.+Walkerauthor=Y.+Wuauthor=M.+F.+Brownauthor=J.+M.+Chenauthor=M.+M.+Haywardauthor=M.+C.+Noeauthor=R.+S.+Obachauthor=L.+Philippeauthor=V.+Shanmugasundaramauthor=M.+J.+Shapiroauthor=J.+Starrauthor=J.+Strohauthor=Y.+Che&title=Chemical+and+computational+methods+for+the+characterization+of+covalent+reactive+groups+for+the+prospective+design+of+irreversible+inhibitors&doi=10.1021%2Fjm501412a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors</span></div><div class="casAuthors">Flanagan, Mark E.; Abramite, Joseph A.; Anderson, Dennis P.; Aulabaugh, Ann; Dahal, Upendra P.; Gilbert, Adam M.; Li, Chao; Montgomery, Justin; Oppenheimer, Stacey R.; Ryder, Tim; Schuff, Brandon P.; Uccello, Daniel P.; Walker, Gregory S.; Wu, Yan; Brown, Matthew F.; Chen, Jinshan M.; Hayward, Matthew M.; Noe, Mark C.; Obach, R. Scott; Philippe, Laurence; Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Starr, Jeremy; Stroh, Justin; Che, Ye</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10072-10079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interest in drugs that covalently modify their target is driven by the desire for enhanced efficacy that can result from the silencing of enzymic activity until protein resynthesis can occur, along with the potential for increased selectivity by targeting uniquely positioned nucleophilic residues in the protein.  However, covalent approaches carry addnl. risk for toxicities or hypersensitivity reactions that can result from covalent modification of unintended targets.  Here we describe methods for measuring the reactivity of covalent reactive groups (CRGs) with a biol. relevant nucleophile, glutathione (GSH), along with kinetic data for a broad array of electrophiles.  We also describe a computational method for predicting electrophilic reactivity, which taken together can be applied to the prospective design of thiol-reactive covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzTSCv_Nj6bVg90H21EOLACvtfcHk0ljKdFgbQQ07SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM&md5=3ccf59ab7a494655185e5eb5becf8c48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501412a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501412a%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DOppenheimer%26aufirst%3DS.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DSchuff%26aufirst%3DB.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DJ.%26aulast%3DChe%26aufirst%3DY.%26atitle%3DChemical%2520and%2520computational%2520methods%2520for%2520the%2520characterization%2520of%2520covalent%2520reactive%2520groups%2520for%2520the%2520prospective%2520design%2520of%2520irreversible%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10072%26epage%3D10079%26doi%3D10.1021%2Fjm501412a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Systematic study of the glutathione (GSH) reactivity of N-arylacrylamides: 1. effects of aryl substitution</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9171</span>– <span class="NLM_lpage">9178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9171-9178&author=V.+J.+Ceeauthor=L.+P.+Volakauthor=Y.+Chenauthor=M.+D.+Bartbergerauthor=C.+Tegleyauthor=T.+Arvedsonauthor=J.+McCarterauthor=A.+S.+Taskerauthor=C.+Fotsch&title=Systematic+study+of+the+glutathione+%28GSH%29+reactivity+of+N-arylacrylamides%3A+1.+effects+of+aryl+substitution&doi=10.1021%2Facs.jmedchem.5b01018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution</span></div><div class="casAuthors">Cee, Victor J.; Volak, Laurie P.; Chen, Yuping; Bartberger, Michael D.; Tegley, Chris; Arvedson, Tara; McCarter, John; Tasker, Andrew S.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9171-9178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Success in the design of targeted covalent inhibitors depends in part on a knowledge of the factors influencing electrophile reactivity.  In an effort to further develop an understanding of structure-reactivity relations among N-arylacrylamides, the authors detd. glutathione (GSH) reaction rates for a family of N-arylacrylamides independently substituted at ortho-, meta-, and para-positions with 11 different groups common to inhibitor design.  Substituent effects on reaction rates show a linear Hammett correlation for ortho-, meta-, and para-substitution.  The authors note a correlation between 1H and 13C NMR chem. shifts of the acrylamide with GSH reaction rates, suggesting that NMR chem. shifts may be a convenient surrogate measure of relative acrylamide reactivity.  D. functional theory calcns. reveal a correlation between computed activation parameters and exptl. detd. reaction rates, validating the use of such methodol. for the screening of synthetic candidates in a prospective fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAoYRfo0lRj7Vg90H21EOLACvtfcHk0ljKdFgbQQ07SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN&md5=2f3a816446dd73d5be061ad8d2195e2d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01018%26sid%3Dliteratum%253Aachs%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DTegley%26aufirst%3DC.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DSystematic%2520study%2520of%2520the%2520glutathione%2520%2528GSH%2529%2520reactivity%2520of%2520N-arylacrylamides%253A%25201.%2520effects%2520of%2520aryl%2520substitution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9171%26epage%3D9178%26doi%3D10.1021%2Facs.jmedchem.5b01018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7025</span>– <span class="NLM_lpage">7048</span>, <span class="refDoi"> DOI: 10.1021/jm400822z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400822z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CltL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7025-7048&author=R.+A.+Wardauthor=M.+J.+Andertonauthor=S.+Ashtonauthor=P.+A.+Bethelauthor=M.+Boxauthor=S.+Butterworthauthor=N.+Colcloughauthor=C.+G.+Chorleyauthor=C.+Chuaquiauthor=D.+A.+Crossauthor=L.+A.+Dakinauthor=J.+%C3%89.+Debreczeniauthor=C.+Eberleinauthor=M.+R.+Finlayauthor=G.+B.+Hillauthor=M.+Gristauthor=T.+C.+Klinowskaauthor=C.+Laneauthor=S.+Martinauthor=J.+P.+Ormeauthor=P.+Smithauthor=F.+Wangauthor=M.+J.+Waring&title=Structure-+and+reactivity-based+development+of+covalent+inhibitors+of+the+activating+and+gatekeeper+mutant+forms+of+the+epidermal+growth+factor+receptor+%28EGFR%29&doi=10.1021%2Fjm400822z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)</span></div><div class="casAuthors">Ward, Richard A.; Anderton, Mark J.; Ashton, Susan; Bethel, Paul A.; Box, Matthew; Butterworth, Sam; Colclough, Nicola; Chorley, Christopher G.; Chuaqui, Claudio; Cross, Darren A. E.; Dakin, Les A.; Debreczeni, Judit E.; Eberlein, Cath; Finlay, M. Raymond V.; Hill, George B.; Grist, Matthew; Klinowska, Teresa C. M.; Lane, Clare; Martin, Scott; Orme, Jonathon P.; Smith, Peter; Wang, Fengjiang; Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7025-7048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of small-mol. inhibitors has been developed to target the double mutant form of the epidermal growth factor receptor (EGFR) tyrosine kinase, which is resistant to treatment with gefitinib and erlotinib.  Our reported compds. also show selectivity over wild-type EGFR.  Guided by mol. modeling, this series was evolved to target a cysteine residue in the ATP binding site via covalent bond formation and demonstrates high levels of activity in cellular models of the double mutant form of EGFR.  In addn., these compds. show significant activity against the activating mutations, which gefitinib and erlotinib target and inhibition of which gives rise to their obsd. clin. efficacy.  A glutathione (GSH)-based assay was used to measure thiol reactivity toward the electrophilic functionality of the inhibitor series, enabling both the identification of a suitable reactivity window for their potency and the development of a reactivity quant. structure-property relationship (QSPR) to support design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKi6oNvtQPEbVg90H21EOLACvtfcHk0litqKnqpjQAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CltL%252FN&md5=59c86415d71ac2abe5c6d4486e5d2517</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm400822z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400822z%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DChorley%26aufirst%3DC.%2BG.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDebreczeni%26aufirst%3DJ.%2B%25C3%2589.%26aulast%3DEberlein%26aufirst%3DC.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DKlinowska%26aufirst%3DT.%2BC.%26aulast%3DLane%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DStructure-%2520and%2520reactivity-based%2520development%2520of%2520covalent%2520inhibitors%2520of%2520the%2520activating%2520and%2520gatekeeper%2520mutant%2520forms%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7025%26epage%3D7048%26doi%3D10.1021%2Fjm400822z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palkowitz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of diverse N-acryloyl azetidines and evaluation of their enhanced thiol reactivities</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2270</span>– <span class="NLM_lpage">2273</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=2270-2273&author=M.+D.+Palkowitzauthor=B.+Tanauthor=H.+Huauthor=K.+Rothauthor=R.+A.+Bauer&title=Synthesis+of+diverse+N-acryloyl+azetidines+and+evaluation+of+their+enhanced+thiol+reactivities&doi=10.1021%2Facs.orglett.7b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span></div><div class="casAuthors">Palkowitz, Maximilian D.; Tan, Bo; Hu, Haitao; Roth, Kenneth; Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2270-2273</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl azetidines exhibit nonplanar hybridization, leading to lower amide-like character of the corresponding (O)C-N bonds.  This impacts N-acryloyl azetidines by producing enhanced electrophilicy at appended Michael acceptors.  Herein, reactivity data are reported in the presence of glutathione (GSH) in phosphate buffer (pH 7.4) at 37 °C.  Wide reactivity ranges are obsd. by varying substitution at the Michael acceptor or by modulating the electron-withdrawing character of substituents at the C3 position of the azetidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUFdHgOWgc7Vg90H21EOLACvtfcHk0litqKnqpjQAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D&md5=d65414bda2976c07bc76cd0df6d4a38d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPalkowitz%26aufirst%3DM.%2BD.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520of%2520diverse%2520N-acryloyl%2520azetidines%2520and%2520evaluation%2520of%2520their%2520enhanced%2520thiol%2520reactivities%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D2270%26epage%3D2273%26doi%3D10.1021%2Facs.orglett.7b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kathman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statsyuk, A. V.</span></span> <span> </span><span class="NLM_article-title">A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4969</span>– <span class="NLM_lpage">4974</span>, <span class="refDoi"> DOI: 10.1021/jm500345q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500345q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4969-4974&author=S.+G.+Kathmanauthor=Z.+Xuauthor=A.+V.+Statsyuk&title=A+fragment-based+method+to+discover+irreversible+covalent+inhibitors+of+cysteine+proteases&doi=10.1021%2Fjm500345q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases</span></div><div class="casAuthors">Kathman, Stefan G.; Xu, Ziyang; Statsyuk, Alexander V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4969-4974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel fragment-based drug discovery approach is reported which irreversibly tethers drug-like fragments to catalytic cysteines.  Acrylamides, acylaminoacrylates, vinylsulfonamides, and acylaminopropenyl sulfones were prepd. and the dependence of their rates of reaction with N-acetylcysteine Me ester on their structure was detd.; of the compds. tested, the rate of Michael addn. of N-acetylcysteine Me ester to acylaminoacrylates depended least on the acyl moiety.  A library of 100 fragment-substituted acylaminoacrylates was prepd.; addn. of subsets of the library to papain followed by mass spectrometric anal. identified three acylaminoacrylates which selectively reacted with the cysteine protease papain.  The kinetics of the inhibition of papain by the acylaminoacrylates, the effect of known inhibitors of papain on its inhibition by the acylaminoacrylates, and the lack of inhibition of other cysteine proteases (human rhinovirus 3C protease, the catalytic domain of the deubiquitinase USP08, and the E2 ubiquitin-conjugating enzyme UbcH7) by the acylaminoacrylates supported their identification as selective and irreversible papain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXt6xtGfQ_w7Vg90H21EOLACvtfcHk0ljBJy6vG35Eig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWiur0%253D&md5=39dee964ac1ba26ed373eedbd86102ac</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm500345q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500345q%26sid%3Dliteratum%253Aachs%26aulast%3DKathman%26aufirst%3DS.%2BG.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DStatsyuk%26aufirst%3DA.%2BV.%26atitle%3DA%2520fragment-based%2520method%2520to%2520discover%2520irreversible%2520covalent%2520inhibitors%2520of%2520cysteine%2520proteases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4969%26epage%3D4974%26doi%3D10.1021%2Fjm500345q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q.</span></span> <span> </span><span class="NLM_article-title">Haem-activated promiscuous targeting of artemisinin in plasmodium falciparum</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10111</span>, <span class="refDoi"> DOI: 10.1038/ncomms10111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1038%2Fncomms10111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26694030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10111&author=J.+Wangauthor=C.+J.+Zhangauthor=W.+N.+Chiaauthor=C.+C.+Lohauthor=Z.+Liauthor=Y.+M.+Leeauthor=Y.+Heauthor=L.+X.+Yuanauthor=T.+K.+Limauthor=M.+Liuauthor=C.+X.+Liewauthor=Y.+Q.+Leeauthor=J.+Zhangauthor=N.+Luauthor=C.+T.+Limauthor=Z.+C.+Huaauthor=B.+Liuauthor=H.+M.+Shenauthor=K.+S.+Tanauthor=Q.+Lin&title=Haem-activated+promiscuous+targeting+of+artemisinin+in+plasmodium+falciparum&doi=10.1038%2Fncomms10111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Jigang; Zhang, Chong-Jing; Chia, Wan Ni; Loh, Cheryl C. Y.; Li, Zhengjun; Lee, Yew Mun; He, Yingke; Yuan, Li-Xia; Lim, Teck Kwang; Liu, Min; Liew, Chin Xia; Lee, Yan Quan; Zhang, Jianbin; Lu, Nianci; Lim, Chwee Teck; Hua, Zi-Chun; Liu, Bin; Shen, Han-Ming; Tan, Kevin S. W.; Lin, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10111</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of action of artemisinin and its derivs., the most potent of the anti-malarial drugs, is not completely understood.  Here we present an unbiased chem. proteomics anal. to directly explore this mechanism in Plasmodium falciparum.  We use an alkyne-tagged artemisinin analog coupled with biotin to identify 124 artemisinin covalent binding protein targets, many of which are involved in the essential biol. processes of the parasite.  Such a broad targeting spectrum disrupts the biochem. landscape of the parasite and causes its death.  Furthermore, using alkyne-tagged artemisinin coupled with a fluorescent dye to monitor protein binding, we show that haem, rather than free ferrous iron, is predominantly responsible for artemisinin activation.  The haem derives primarily from the parasite's haem biosynthesis pathway at the early ring stage and from Hb digestion at the latter stages.  Our results support a unifying model to explain the action and specificity of artemisinin in parasite killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsYEHWprDdeLVg90H21EOLACvtfcHk0ljBJy6vG35Eig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO&md5=a532a76cdd2f33b0ca23e733e6247a0c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncomms10111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DChia%26aufirst%3DW.%2BN.%26aulast%3DLoh%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DL.%2BX.%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiew%26aufirst%3DC.%2BX.%26aulast%3DLee%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DC.%2BT.%26aulast%3DHua%26aufirst%3DZ.%2BC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DH.%2BM.%26aulast%3DTan%26aufirst%3DK.%2BS.%26aulast%3DLin%26aufirst%3DQ.%26atitle%3DHaem-activated%2520promiscuous%2520targeting%2520of%2520artemisinin%2520in%2520plasmodium%2520falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10111%26doi%3D10.1038%2Fncomms10111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Targeted covalent inhibitors for drug design</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1002/anie.201601091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.201601091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2-17&author=T.+A.+Baillie&title=Targeted+covalent+inhibitors+for+drug+design&doi=10.1002%2Fanie.201601091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601091%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DTargeted%2520covalent%2520inhibitors%2520for%2520drug%2520design%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2016%26volume%3D55%26spage%3D2%26epage%3D17%26doi%3D10.1002%2Fanie.201601091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copple, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of irreversible analogues of bardoxolone methyl for the identification of pharmacologically relevant targets and interaction sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2396</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2396-2409&author=M.+H.+Wongauthor=H.+K.+Bryanauthor=I.+M.+Coppleauthor=R.+E.+Jenkinsauthor=P.+H.+Chiuauthor=J.+Bibbyauthor=N.+G.+Berryauthor=N.+R.+Kitteringhamauthor=C.+E.+Goldringauthor=P.+M.+O%E2%80%99Neillauthor=B.+K.+Park&title=Design+and+synthesis+of+irreversible+analogues+of+bardoxolone+methyl+for+the+identification+of+pharmacologically+relevant+targets+and+interaction+sites&doi=10.1021%2Facs.jmedchem.5b01292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites</span></div><div class="casAuthors">Wong, Michael H. L.; Bryan, Holly K.; Copple, Ian M.; Jenkins, Rosalind E.; Chiu, Pak Him; Bibby, Jaclyn; Berry, Neil G.; Kitteringham, Neil R.; Goldring, Christopher E.; O'Neill, Paul M.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2396-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Semisynthetic triterpenoids such as bardoxolone Me (methyl-2-cyano 3,12-dioxooleano-1,9-dien-28-oate; CDDO-Me) (I) are potent inducers of antioxidant and anti-inflammatory signaling pathways, including those regulated by the transcription factor Nrf2.  However, the reversible nature of the interaction between triterpenoids and thiols has hindered attempts to identify pharmacol. relevant targets and characterize the sites of interaction.  Here, we report a shortened synthesis and SAR profiling of I, enabling the design of analogs that react irreversibly with model thiols, as well as the model protein glutathione S-transferase P1, in vitro.  We show that one of these analogs, CDDO-epoxide (II), is comparable to I in terms of cytotoxicity and potency toward Nrf2 in rat hepatoma cells and stably modifies specific cysteine residues (namely, Cys-257, -273, -288, -434, -489, and -613) within Keap1, the major repressor of Nrf2, both in vitro and in living cells.  Supported by mol. modeling, these data demonstrate the value of II for identifying site(s) of interaction with pharmacol. relevant targets and informing the continuing development of triterpenoids as novel drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjC_Ca8KocPLVg90H21EOLACvtfcHk0ljRxTMJOmAb0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCis7k%253D&md5=eb2c0d997a2b22ceb41b75c203bb27fc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01292%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DBryan%26aufirst%3DH.%2BK.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DChiu%26aufirst%3DP.%2BH.%26aulast%3DBibby%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520irreversible%2520analogues%2520of%2520bardoxolone%2520methyl%2520for%2520the%2520identification%2520of%2520pharmacologically%2520relevant%2520targets%2520and%2520interaction%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2396%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.5b01292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Federspiel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codreanu, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albertolle, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span> <span> </span><span class="NLM_article-title">Specificity of protein covalent modification by the electrophilic proteasome inhibitor carfilzomib in human cells</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3233</span>– <span class="NLM_lpage">3242</span>, <span class="refDoi"> DOI: 10.1074/mcp.M116.059709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1074%2Fmcp.M116.059709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27503896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=3233-3242&author=J.+D.+Federspielauthor=S.+G.+Codreanuauthor=S.+Goyalauthor=M.+E.+Albertolleauthor=E.+Loweauthor=J.+Teagueauthor=H.+L.+Wongauthor=F.+P.+Guengerichauthor=D.+C.+Liebler&title=Specificity+of+protein+covalent+modification+by+the+electrophilic+proteasome+inhibitor+carfilzomib+in+human+cells&doi=10.1074%2Fmcp.M116.059709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of protein covalent modification by the electrophilic proteasome inhibitor carfilzomib in human cells</span></div><div class="casAuthors">Federspiel, Joel D.; Codreanu, Simona G.; Goyal, Sandeep; Albertolle, Matthew E.; Lowe, Eric; Teague, Juli; Wong, Hansen; Guengerich, F. Peter; Liebler, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3233-3242</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Carfilzomib (CFZ) is a second-generation proteasome inhibitor that is Food and Drug Administration and European Commission approved for the treatment of relapsed or refractory multiple myeloma.  CFZ is an epoxomicin deriv. with an epoxyketone electrophilic warhead that irreversibly adducts the catalytic threonine residue of the β5 subunit of the proteasome.  Although CFZ produces a highly potent, sustained inactivation of the proteasome, the electrophilic nature of the drug could potentially produce off-target protein adduction.  To address this possibility, we synthesized an alkynyl analog of CFZ and investigated protein adduction by this analog in HepG2 cells.  Using click chem. coupled with streptavidin based IP and shotgun tandem mass spectrometry (MS/MS), we identified two off-target proteins, cytochrome P 450 27A1 (CYP27A1) and glutathione S-transferase omega 1 (GSTO1), as targets of the alkynyl CFZ probe.  We confirmed the adduction of CYP27A1 and GSTO1 by streptavidin capture and immunoblotting methodol. and then site-specifically mapped the adducts with targeted MS/MS methods.  Although CFZ adduction of CYP27A1 and GSTO1 in vitro decreased the activities of these enzymes, the small fraction of these proteins modified by CFZ in intact cells should limit the impact of these offtarget modifications.  The data support the high selectivity of CFZ for covalent modification of its therapeutic targets, despite the presence of a reactive electrophile.  The approach we describe offers a generalizable method to evaluate the safety profile of covalent protein-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1MWDdlf62B7Vg90H21EOLACvtfcHk0ljRxTMJOmAb0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCnsLs%253D&md5=ff2d31854362ad6b6c7f8ea2129acdc8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M116.059709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M116.059709%26sid%3Dliteratum%253Aachs%26aulast%3DFederspiel%26aufirst%3DJ.%2BD.%26aulast%3DCodreanu%26aufirst%3DS.%2BG.%26aulast%3DGoyal%26aufirst%3DS.%26aulast%3DAlbertolle%26aufirst%3DM.%2BE.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%2BL.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26atitle%3DSpecificity%2520of%2520protein%2520covalent%2520modification%2520by%2520the%2520electrophilic%2520proteasome%2520inhibitor%2520carfilzomib%2520in%2520human%2520cells%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2016%26volume%3D15%26spage%3D3233%26epage%3D3242%26doi%3D10.1074%2Fmcp.M116.059709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span> <span> </span><span class="NLM_article-title">Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1061</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.drudis.2015.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26002380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=1061-1073&author=R.+A.+Bauer&title=Covalent+inhibitors+in+drug+discovery%3A+from+accidental+discoveries+to+avoided+liabilities+and+designed+therapies&doi=10.1016%2Fj.drudis.2015.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies</span></div><div class="casAuthors">Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1061-1073</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Drugs that covalently bond to their biol. targets have a long history in drug discovery.  A look at drug approvals in recent years suggests that covalent drugs will continue to make impacts on human health for years to come.  Although fraught with concerns about toxicity, the high potencies and prolonged effects achievable with covalent drugs may result in less-frequent drug dosing and in wide therapeutic margins for patients.  Covalent inhibition can also dissoc. drug pharmacodynamics (PD) from pharmacokinetics (PK), which can result in desired drug efficacy for inhibitors that have short systemic exposure.  Evidence suggests that there is a reduced risk for the development of resistance against covalent drugs, which is a major challenge in areas such as oncol. and infectious disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkBDsUEu4arVg90H21EOLACvtfcHk0ljRxTMJOmAb0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOnu7s%253D&md5=6ba5b016d2804c7d56838a2724b9a0b9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DCovalent%2520inhibitors%2520in%2520drug%2520discovery%253A%2520from%2520accidental%2520discoveries%2520to%2520avoided%2520liabilities%2520and%2520designed%2520therapies%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D1061%26epage%3D1073%26doi%3D10.1016%2Fj.drudis.2015.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, J. K.</span></span> <span> </span><span class="NLM_article-title">Oridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">701</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2011.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.biocel.2011.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=21295154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=701-704&author=C.+Y.+Liauthor=E.+Q.+Wangauthor=Y.+Chengauthor=J.+K.+Bao&title=Oridonin%3A+an+active+diterpenoid+targeting+cell+cycle+arrest%2C+apoptotic+and+autophagic+pathways+for+cancer+therapeutics&doi=10.1016%2Fj.biocel.2011.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics</span></div><div class="casAuthors">Li, Chun-yang; Wang, En-qin; Cheng, Yan; Bao, Jin-ku</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">701-704</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is well-known that cell cycle arrest and/or death play a pivotal role in tumor progression, which has drawn a rising attention for cancer biologists due to their complex and intricate relationships.  In this review, we demonstrate the recent research on oridonin, an active diterpenoid with remarkable anti-proliferative activities, and then further explore its mol. mechanisms of cell cycle arrest, apoptosis, autophagy and their cross-talks in various cancer cells, which may provide a new perspective of oridonin as a candidate anti-neoplastic drug for future cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy8n0E52UccrVg90H21EOLACvtfcHk0ljRxTMJOmAb0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSmsL0%253D&md5=9e899aba27ef93235c383f30e2ddc436</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2011.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2011.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DJ.%2BK.%26atitle%3DOridonin%253A%2520an%2520active%2520diterpenoid%2520targeting%2520cell%2520cycle%2520arrest%252C%2520apoptotic%2520and%2520autophagic%2520pathways%2520for%2520cancer%2520therapeutics%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2011%26volume%3D43%26spage%3D701%26epage%3D704%26doi%3D10.1016%2Fj.biocel.2011.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">474</span>, <span class="refDoi"> DOI: 10.3390/molecules23020474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3390%2Fmolecules23020474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OhsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=474&author=J.+Xuauthor=E.+A.+Woldauthor=Y.+Dingauthor=Q.+Shenauthor=J.+Zhou&title=Therapeutic+potential+of+oridonin+and+its+analogs%3A+from+anticancer+and+antiinflammation+to+neuroprotection&doi=10.3390%2Fmolecules23020474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection</span></div><div class="casAuthors">Xu, Jimin; Wold, Eric A.; Ding, Ye; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">474/1-474/16</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Oridonin, a diterpenoid natural product commonly used in East Asian herbal medicine, is garnering increased attention in the biomedical community due to its extensive biol. activities that include antitumor, anti-inflammatory, antimicrobial, hepatic fibrosis prevention, and neurol. effects.  Over the past decade, significant progress has been made in structure activity relationship and mechanism of action studies of oridonin for the treatment of cancer and other diseases.  This review provides a brief summary on oridonin and its analogs in cancer drug discovery and antiinflammation and highlights its emerging therapeutic potential in neuroprotection applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgkNPnZO0SgrVg90H21EOLACvtfcHk0ljW2dWCvflzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OhsrvN&md5=022222bcdebc4dac9f398d7c0dea99ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020474%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DTherapeutic%2520potential%2520of%2520oridonin%2520and%2520its%2520analogs%253A%2520from%2520anticancer%2520and%2520antiinflammation%2520to%2520neuroprotection%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D474%26doi%3D10.3390%2Fmolecules23020474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of natural product oridonin-inspired anticancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.ejmech.2016.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27344488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=102-117&author=Y.+Dingauthor=C.+Dingauthor=N.+Yeauthor=Z.+Liuauthor=E.+A.+Woldauthor=H.+Chenauthor=C.+Wildauthor=Q.+Shenauthor=J.+Zhou&title=Discovery+and+development+of+natural+product+oridonin-inspired+anticancer+agents&doi=10.1016%2Fj.ejmech.2016.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of natural product oridonin-inspired anticancer agents</span></div><div class="casAuthors">Ding, Ye; Ding, Chunyong; Ye, Na; Liu, Zhiqing; Wold, Eric A.; Chen, Haiying; Wild, Christopher; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Natural products have historically been, and continue to be, an invaluable source for the discovery of various therapeutic agents.  Oridonin, a natural diterpenoid widely applied in traditional Chinese medicines, exhibits a broad range of biol. effects including anticancer and anti-inflammatory activities.  To further improve its potency, aq. soly. and bioavailability, the oridonin template serves as an exciting platform for drug discovery to yield better candidates with unique targets and enhanced drug properties.  A no. of oridonin derivs. (e.g. HAO472) have been designed and synthesized, and have contributed to substantial progress in the identification of new agents and relevant mol. mechanistic studies toward the treatment of human cancers and other diseases.  This review summarizes the recent advances in medicinal chem. on the explorations of novel oridonin analogs as potential anticancer therapeutics, and provides a detailed discussion of future directions for the development and progression of this class of mols. into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv6x0p1uhEt7Vg90H21EOLACvtfcHk0ljW2dWCvflzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsL3E&md5=0cce14ee999e3e59fe48cf6a1249d90b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520development%2520of%2520natural%2520product%2520oridonin-inspired%2520anticancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D122%26spage%3D102%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2016.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span> <span> </span><span class="NLM_article-title">ent-Kaurane diterpenoids from Chinese liverworts and their antitumor activities through Michael addition as detected in situ by a fluorescence probe</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3944</span>– <span class="NLM_lpage">3956</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3944-3956&author=Z.+Linauthor=Y.+Guoauthor=Y.+Gaoauthor=S.+Wangauthor=X.+Wangauthor=Z.+Xieauthor=H.+Niuauthor=W.+Changauthor=L.+Liuauthor=H.+Yuanauthor=H.+Lou&title=ent-Kaurane+diterpenoids+from+Chinese+liverworts+and+their+antitumor+activities+through+Michael+addition+as+detected+in+situ+by+a+fluorescence+probe&doi=10.1021%2Facs.jmedchem.5b00208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ent-Kaurane Diterpenoids from Chinese Liverworts and Their Antitumor Activities through Michael Addition As Detected in Situ by a Fluorescence Probe</span></div><div class="casAuthors">Lin, Zhaomin; Guo, Yanxia; Gao, Yanhui; Wang, Shuqi; Wang, Xiaoning; Xie, Zhiyu; Niu, Huanmin; Chang, Wenqiang; Liu, Lei; Yuan, Huiqing; Lou, Hongxiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3944-3956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is generally accepted that the origin of the cytotoxicity of ent-kaurane diterpenoids is due to the formation of reactive oxygen species (ROS) and that the α,β-unsatd. carbonyl is a pivotal moiety.  Herein we demonstrate the isolation of 32 new and 12 known ent-kaurane diterpenoids from two Chinese liverworts.  These compds. and three semisynthesized derivs. were screened against human cancer cell lines.  The results revealed that their anticancer activities are caused by ROS formation through Michael modification of the protein thiols and depletion of glutathione unselectively.  We also found that N-acetylcysteine reverses the cytotoxicity of these diterpenoids by forming Michael adducts, not through a well-recognized ROS scavenging pathway as previously reported.  In situ intracellular thiol detection helped us visualize the intracellular distribution of the diterpenoids and det. the potency of their cytotoxicity.  An alk. analog was found to be more selective because of the altered subcellular distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f8oGSL_Bz7Vg90H21EOLACvtfcHk0ljW2dWCvflzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2nsLo%253D&md5=18fd5c20f9f34fd87ef4c31058efe107</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00208%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLou%26aufirst%3DH.%26atitle%3Dent-Kaurane%2520diterpenoids%2520from%2520Chinese%2520liverworts%2520and%2520their%2520antitumor%2520activities%2520through%2520Michael%2520addition%2520as%2520detected%2520in%2520situ%2520by%2520a%2520fluorescence%2520probe%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3944%26epage%3D3956%26doi%3D10.1021%2Facs.jmedchem.5b00208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nan, F. J.</span>; <span class="NLM_string-name">Zhang, Y. M.</span>; <span class="NLM_string-name">Liu, H. N.</span>; <span class="NLM_string-name">Ding, J.</span>; <span class="NLM_string-name">Meng, L.
H.</span>; <span class="NLM_string-name">Xu, C. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Derivatization of an ent-Kaurane Diterpenoid</span>.  <i>Chinese Patent</i> <span class="NLM_patent">CN102584760A</span>, <span class="NLM_year">01/13/2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=01%2F13%2F2011&author=F.+J.+Nan&author=Y.+M.+Zhang&author=H.+N.+Liu&author=J.+Ding&author=L.%0AH.+Meng&author=C.+H.+Xu&title=Synthesis+and+Derivatization+of+an+ent-Kaurane+Diterpenoid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNan%26aufirst%3DF.%2BJ.%26atitle%3DSynthesis%2520and%2520Derivatization%2520of%2520an%2520ent-Kaurane%2520Diterpenoid%26jtitle%3DChinese%2520Patent%26date%3D01%252F13%252F2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response</span>. <i>Environ. Health Persp.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1289/ehp.11464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1289%2Fehp.11464" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2008&pages=1154-1161&author=Y.+Duauthor=N.+F.+Villeneuveauthor=X.+J.+Wangauthor=Z.+Sunauthor=W.+Chenauthor=J.+Liauthor=H.+Louauthor=P.+K.+Wongauthor=D.+D.+Zhang&title=Oridonin+confers+protection+against+arsenic-induced+toxicity+through+activation+of+the+Nrf2-mediated+defensive+response&doi=10.1289%2Fehp.11464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1289%2Fehp.11464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.11464%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DP.%2BK.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DOridonin%2520confers%2520protection%2520against%2520arsenic-induced%2520toxicity%2520through%2520activation%2520of%2520the%2520Nrf2-mediated%2520defensive%2520response%26jtitle%3DEnviron.%2520Health%2520Persp.%26date%3D2008%26volume%3D116%26spage%3D1154%26epage%3D1161%26doi%3D10.1289%2Fehp.11464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">127ra38</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1126%2Fscitranslmed.3003562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=22461642" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=127ra38&author=T.+Zhenauthor=C.+F.+Wuauthor=P.+Liuauthor=H.+Y.+Wuauthor=G.+B.+Zhouauthor=Y.+Luauthor=J.+X.+Liuauthor=Y.+Liangauthor=K.+K.+Liauthor=Y.+Y.+Wangauthor=Y.+Y.+Xieauthor=M.+M.+Heauthor=H.+M.+Caoauthor=W.+N.+Zhangauthor=L.+M.+Chenauthor=K.+Petrieauthor=S.+J.+Chenauthor=Z.+Chen&title=Targeting+of+AML1-ETO+in+t%288%3B21%29+leukemia+by+oridonin+generates+a+tumor+suppressor-like+protein&doi=10.1126%2Fscitranslmed.3003562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003562%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DC.%2BF.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DZhou%26aufirst%3DG.%2BB.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BY.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHe%26aufirst%3DM.%2BM.%26aulast%3DCao%26aufirst%3DH.%2BM.%26aulast%3DZhang%26aufirst%3DW.%2BN.%26aulast%3DChen%26aufirst%3DL.%2BM.%26aulast%3DPetrie%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DTargeting%2520of%2520AML1-ETO%2520in%2520t%25288%253B21%2529%2520leukemia%2520by%2520oridonin%2520generates%2520a%2520tumor%2520suppressor-like%2520protein%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D127ra38%26doi%3D10.1126%2Fscitranslmed.3003562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3441</span>– <span class="NLM_lpage">3450</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-06-032250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1182%2Fblood-2006-06-032250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=17197433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=3441-3450&author=G.+B.+Zhouauthor=H.+Kangauthor=L.+Wangauthor=L.+Gaoauthor=P.+Liuauthor=J.+Xieauthor=F.+X.+Zhangauthor=X.+Q.+Wengauthor=Z.+X.+Shenauthor=J.+Chenauthor=L.+J.+Guauthor=M.+Yanauthor=D.+E.+Zhangauthor=S.+J.+Chenauthor=Z.+Y.+Wangauthor=Z.+Chen&title=Oridonin%2C+a+diterpenoid+extracted+from+medicinal+herbs%2C+targets+AML1-ETO+fusion+protein+and+shows+potent+antitumor+activity+with+low+adverse+effects+on+t%288%3B21%29+leukemia+in+vitro+and+in+vivo&doi=10.1182%2Fblood-2006-06-032250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo</span></div><div class="casAuthors">Zhou, Guang-Biao; Kang, Hui; Wang, Lan; Gao, Li; Liu, Ping; Xie, Jun; Zhang, Feng-Xiang; Weng, Xiang-Qin; Shen, Zhi-Xiang; Chen, Jue; Gu, Long-Jun; Yan, Ming; Zhang, Dong-Er; Chen, Sai-Juan; Wang, Zhen-Yi; Chen, Zhu</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3441-3450</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Studies have documented the potential antitumor activities of oridonin, a compd. extd. from medicinal herbs.  However, whether oridonin can be used in the selected setting of hematol./oncol. remains obscure.  Here, we reported that oridonin induced apoptosis of t(8;21) acute myeloid leukemic (AML) cells.  Intriguingly, the t(8;21) product AML1-ETO (AE) fusion protein, which plays a crit. role in leukemogenesis, was degraded with generation of a catabolic fragment, while the expression pattern of AE target genes investigated could be reprogrammed.  The ectopic expression of AE enhanced the apoptotic effect of oridonin in U937 cells.  Preincubation with caspase inhibitors blocked oridonin-triggered cleavage of AE, while substitution of Ala for Asp at residues 188 in ETO moiety of the fusion abrogated AE degrdn.  Furthermore, oridonin prolonged lifespan of C57 mice bearing truncated AE-expressing leukemic cells without suppression of bone marrow or redn. of body wt. of animals, and exerted synergic effects while combined with cytosine arabinoside.  Oridonin also inhibited tumor growth in nude mice inoculated with t(8;21)-harboring Kasumi-1 cells.  These results suggest that oridonin may be a potential antileukemia agent that targets AE oncoprotein at residue D188 with low adverse effect, and may be helpful for the treatment of patients with t(8;21) AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_wey2HaXwrVg90H21EOLACvtfcHk0liYY_lnR2yFRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWhsrw%253D&md5=9cf2b38066ec9c39b8e6ac6280e35d3b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-06-032250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-06-032250%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%2BB.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%2BX.%26aulast%3DWeng%26aufirst%3DX.%2BQ.%26aulast%3DShen%26aufirst%3DZ.%2BX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DL.%2BJ.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DD.%2BE.%26aulast%3DChen%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DOridonin%252C%2520a%2520diterpenoid%2520extracted%2520from%2520medicinal%2520herbs%252C%2520targets%2520AML1-ETO%2520fusion%2520protein%2520and%2520shows%2520potent%2520antitumor%2520activity%2520with%2520low%2520adverse%2520effects%2520on%2520t%25288%253B21%2529%2520leukemia%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D3441%26epage%3D3450%26doi%3D10.1182%2Fblood-2006-06-032250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, K. M.</span></span> <span> </span><span class="NLM_article-title">Inflammatory aortitis controlled by the Chinese herbal remedy Donglingcao Pian</span>. <i>Rheumatology (Oxford, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1259</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/ken209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1093%2Frheumatology%2Fken209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=18577551" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1257-1259&author=C.+De%0ASilvaauthor=R.+Stevensauthor=K.+M.+Jordan&title=Inflammatory+aortitis+controlled+by+the+Chinese+herbal+remedy+Donglingcao+Pian&doi=10.1093%2Frheumatology%2Fken209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fken209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fken209%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSilva%26aufirst%3DC.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DK.%2BM.%26atitle%3DInflammatory%2520aortitis%2520controlled%2520by%2520the%2520Chinese%2520herbal%2520remedy%2520Donglingcao%2520Pian%26jtitle%3DRheumatology%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2008%26volume%3D47%26spage%3D1257%26epage%3D1259%26doi%3D10.1093%2Frheumatology%2Fken209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. W.</span></span> <span> </span><span class="NLM_article-title">Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B</span>. <i>J. Dig. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1111/1751-2980.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1111%2F1751-2980.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26718746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVCqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=104-112&author=Q.+Q.+Liuauthor=H.+L.+Wangauthor=K.+Chenauthor=S.+B.+Wangauthor=Y.+Xuauthor=Q.+Yeauthor=Y.+W.+Sun&title=Oridonin+derivative+ameliorates+experimental+colitis+by+inhibiting+activated+T-cells+and+translocation+of+nuclear+factor-kappa+B&doi=10.1111%2F1751-2980.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B</span></div><div class="casAuthors">Liu, Qian Qian; Wang, Hai Li; Chen, Ke; Wang, Shu Bei; Xu, Ying; Ye, Qiao; Sun, Yun Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Digestive Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">JDDOA9</span>;
        ISSN:<span class="NLM_cas:issn">1751-2972</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Objective : To confirm the potential therapeutic efficacy of HAO472 against inflammatory bowel disease (IBD), we investigated the modulatory functions of HAO472 in a mouse model of trinitrobenzene sulfonic acid (TNBS)-induced colitis.  Methods : Colitis was induced via an intrarectal injection of TNBS in mice.  HAO472 (5.0 mg/kg or 7.5 mg/kg) or 1 mg/kg dexamethasone (DX) was injected i.p. into the mice after the TNBS administration.  Behavioral and wt. changes, macroscopic and histol. assessments of colon, the expressions of tumor necrosis factor (TNF)-α, interferon (IFN)-γ and interleukin (IL)-17A, cyclooxygenase (COX)-2, inducible nitric oxide synthase (iNOS) and nuclear factor-kappa B (NF-κB) in the colonic tissues were evaluated.  The effect of HAO472 on NF-κB signaling pathway in lymphocytes was also investigated.  Results : HAO472 significantly ameliorated the clin. symptoms, reduced the severity of the inflammation and decreased mortality in the mouse model.  HAO472 also reduced TNF-α, IFN-γ, IL-17A, iNOS/COX-2 and lymphocyte proliferation.  These changes were assocd. with a significant decrease in NF-κB p65 expression and activity.  Conclusion : HAO472 has pos. effects on TNBS-induced colitis by modulating the subsets and functions of lymphocytes, suppressing inflammation and inhibiting the nuclear translocation of NF-κB p65 subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrPHOzXBkHmrVg90H21EOLACvtfcHk0lieCq15MshYNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVCqsrk%253D&md5=11a1af379ed95a81222dbb1e0e517211</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2F1751-2980.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1751-2980.12314%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%2BQ.%26aulast%3DWang%26aufirst%3DH.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%2BW.%26atitle%3DOridonin%2520derivative%2520ameliorates%2520experimental%2520colitis%2520by%2520inhibiting%2520activated%2520T-cells%2520and%2520translocation%2520of%2520nuclear%2520factor-kappa%2520B%26jtitle%3DJ.%2520Dig.%2520Dis.%26date%3D2016%26volume%3D17%26spage%3D104%26epage%3D112%26doi%3D10.1111%2F1751-2980.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P. Y.</span>; <span class="NLM_string-name">Wu, G.
L.</span>; <span class="NLM_string-name">Qiu, Z. J.</span>; <span class="NLM_string-name">Chen, Y. J.</span></span> <span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-alanine-(14-oridonin) Ester Trifluoroacetate as well as Preparation Method and Application</span>.  <i>Chinese Patent</i> <span class="NLM_patent">CN104017000A</span>, <span class="NLM_year">09/03/2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=09%2F03%2F2014&author=P.+Y.+Sun&author=G.%0AL.+Wu&author=Z.+J.+Qiu&author=Y.+J.+Chen&title=l-alanine-%2814-oridonin%29+Ester+Trifluoroacetate+as+well+as+Preparation+Method+and+Application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DP.%2BY.%26atitle%3Dl-alanine-%252814-oridonin%2529%2520Ester%2520Trifluoroacetate%2520as%2520well%2520as%2520Preparation%2520Method%2520and%2520Application%26jtitle%3DChinese%2520Patent%26date%3D09%252F03%252F2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohanon, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastellini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, R. S.</span></span> <span> </span><span class="NLM_article-title">Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis</span>. <i>J. Surg. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>199</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1016/j.jss.2015.07.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.jss.2015.07.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26409288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOmt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2015&pages=441-449&author=F.+J.+Bohanonauthor=X.+Wangauthor=B.+M.+Grahamauthor=C.+Dingauthor=Y.+Dingauthor=G.+L.+Radhakrishnanauthor=C.+Rastelliniauthor=J.+Zhouauthor=R.+S.+Radhakrishnan&title=Enhanced+effects+of+novel+oridonin+analog+CYD0682+for+hepatic+fibrosis&doi=10.1016%2Fj.jss.2015.07.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis</span></div><div class="casAuthors">Bohanon, Fredrick J.; Wang, Xiaofu; Graham, Brittany M.; Ding, Chunyong; Ding, Ye; Radhakrishnan, Geetha L.; Rastellini, Cristiana; Zhou, Jia; Radhakrishnan, Ravi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">JSGRA2</span>;
        ISSN:<span class="NLM_cas:issn">0022-4804</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activated hepatic stellate cells (HSCs) are responsible for excess extracellular matrix (ECM) protein deposition in liver fibrosis.  Previously, our group reported that the natural compd. oridonin induces apoptosis, inhibits cell proliferation, and downregulates ECM proteins in activated HSC.  In this study, the antifibrogenic effects of oridonin deriv. CYD0682 on the activated human LX-2 and rat HSC-T6 stellate cell lines were investigated.Cell proliferation was measured by alamarBlue assay.  Apoptosis was detected by Cell Death ELISA and staining of Yo-Pro-1 and propidium iodide.  Cell cycle was detd. by flow cytometry.  Immunoblot and immunofluorescence staining were performed for cellular protein expression.CYD0682 treatment significantly inhibited LX-2 cell proliferation in a dose- and time-dependent manner with an IC50 value of 0.49 μM for 48 h, ∼10-fold greater potency than oridonin.  Similar results were obsd. in HSC-T6 cells.  In contrast, 2.5 μM of CYD0682 treatment had no significant effects on proliferation of the human hepatocyte cell line C3A.  CYD0682 treatment induced LX-2 cell apoptosis and S-phase cell cycle arrest and was assocd. with activation of p53, p21, and cleaved caspase-3.  The myofibroblast marker protein α-smooth muscle actin and major ECM proteins type I collagen and fibronectin were markedly suppressed in a time- and dose-dependent fashion by CYD0682.  Furthermore, pretreatment with CYD0682 blocked transforming growth factor-β-induced type I collagen and fibronectin prodn.In comparison with oridonin, its novel deriv. CYD0682 may act as a more potent antihepatic fibrosis agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoAhhBJgUujbVg90H21EOLACvtfcHk0lieCq15MshYNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOmt7rF&md5=542b6999c4841430cb08843e16b3f3c3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2015.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2015.07.042%26sid%3Dliteratum%253Aachs%26aulast%3DBohanon%26aufirst%3DF.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGraham%26aufirst%3DB.%2BM.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DRadhakrishnan%26aufirst%3DG.%2BL.%26aulast%3DRastellini%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRadhakrishnan%26aufirst%3DR.%2BS.%26atitle%3DEnhanced%2520effects%2520of%2520novel%2520oridonin%2520analog%2520CYD0682%2520for%2520hepatic%2520fibrosis%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2015%26volume%3D199%26spage%3D441%26epage%3D449%26doi%3D10.1016%2Fj.jss.2015.07.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ester, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8814</span>– <span class="NLM_lpage">8825</span>, <span class="refDoi"> DOI: 10.1021/jm401248x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401248x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8814-8825&author=C.+Dingauthor=Y.+Zhangauthor=H.+Chenauthor=Z.+Yangauthor=C.+Wildauthor=N.+Yeauthor=C.+D.+Esterauthor=A.+Xiongauthor=M.+A.+Whiteauthor=Q.+Shenauthor=J.+Zhou&title=Oridonin+ring+A-based+diverse+constructions+of+enone+functionality%3A+identification+of+novel+dienone+analogues+effective+for+highly+aggressive+breast+cancer+by+inducing+apoptosis&doi=10.1021%2Fjm401248x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin Ring A Based Diverse Constructions of Enone Functionality: Identification of Novel Dienone Analogues Effective for Highly Aggressive Breast Cancer by Inducing Apoptosis</span></div><div class="casAuthors">Ding, Chunyong; Zhang, Yusong; Chen, Haijun; Yang, Zhengduo; Wild, Christopher; Ye, Na; Ester, Corbin D.; Xiong, Ailian; White, Mark A.; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8814-8825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oridonin (I) has attracted considerable attention in recent years because of its unique and safe anticancer pharmacol. profile.  Nevertheless, it exhibits moderate to poor effects against highly aggressive cancers including triple-neg. and drug-resistant breast cancer cells.  Herein, we report the rational design and synthesis of novel dienone derivs. with an addnl. α,β-unsatd. ketone system diversely installed in the A-ring based on this class of natural scaffold that features dense functionalities and stereochem.-rich frameworks.  Efficient and regioselective enone construction strategies have been established.  Meanwhile, a unique 3,7-rearrangement reaction was identified to furnish an unprecedented dienone scaffold.  Intriguingly, these new analogs have been demonstrated to significantly induce apoptosis and inhibit colony formation with superior antitumor effects against aggressive and drug-resistant breast cancer cells in vitro and in vivo while also exhibiting comparable or lower toxicity to normal human mammary epithelial cells in comparison with I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp42KnrzHKFwbVg90H21EOLACvtfcHk0lieCq15MshYNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nJ&md5=467a07903a1d9f8c4df11c5dfa15bfc5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm401248x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401248x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DEster%26aufirst%3DC.%2BD.%26aulast%3DXiong%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DOridonin%2520ring%2520A-based%2520diverse%2520constructions%2520of%2520enone%2520functionality%253A%2520identification%2520of%2520novel%2520dienone%2520analogues%2520effective%2520for%2520highly%2520aggressive%2520breast%2520cancer%2520by%2520inducing%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8814%26epage%3D8825%26doi%3D10.1021%2Fjm401248x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohanon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandathiparampil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastellini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, R.</span></span> <span> </span><span class="NLM_article-title">Suppressive effects of novel oridonin derivative CYD0625 on activated hepatic stellate cells</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">6115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=6115&author=X.+Wangauthor=F.+Bohanonauthor=A.+Kandathiparampilauthor=C.+Rastelliniauthor=C.+Dingauthor=Y.+Dingauthor=J.+Zhouauthor=R.+Radhakrishnan&title=Suppressive+effects+of+novel+oridonin+derivative+CYD0625+on+activated+hepatic+stellate+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBohanon%26aufirst%3DF.%26aulast%3DKandathiparampil%26aufirst%3DA.%26aulast%3DRastellini%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRadhakrishnan%26aufirst%3DR.%26atitle%3DSuppressive%2520effects%2520of%2520novel%2520oridonin%2520derivative%2520CYD0625%2520on%2520activated%2520hepatic%2520stellate%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D6115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5048</span>– <span class="NLM_lpage">5058</span>, <span class="refDoi"> DOI: 10.1021/jm400367n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400367n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVeqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5048-5058&author=C.+Dingauthor=Y.+Zhangauthor=H.+Chenauthor=Z.+Yangauthor=C.+Wildauthor=L.+Chuauthor=H.+Liuauthor=Q.+Shenauthor=J.+Zhou&title=Novel+nitrogen-enriched+oridonin+analogues+with+thiazole-fused+A-ring%3A+protecting+group-free+synthesis%2C+enhanced+anticancer+profile%2C+and+improved+aqueous+solubility&doi=10.1021%2Fjm400367n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Nitrogen-Enriched Oridonin Analogues with Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility</span></div><div class="casAuthors">Ding, Chunyong; Zhang, Yusong; Chen, Haijun; Yang, Zhengduo; Wild, Christopher; Chu, Lili; Liu, Huiling; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5048-5058</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oridonin (I), a complex ent-kaurane diterpenoid isolated from the traditional Chinese herb Isodon rubescens, has demonstrated great potential in the treatment of various human cancers due to its unique and safe anticancer pharmacol. profile.  Nevertheless, the clin. development of oridonin for cancer therapy has been hampered by its relatively moderate potency, limited aq. soly., and poor bioavailability.  Herein, we report the concise synthesis of a series of novel nitrogen-enriched oridonin derivs. with thiazole-fused A-ring through an efficient protecting group-free synthetic strategy.  Most of them, including compds. II [R = Me; R = NR1R2, R1 = Me, CHMe2, n-Bu, cyclohexyl, 2-(piperidin-1-yl)ethyl, allyl], exhibited potent antiproliferative effects against breast, pancreatic, and prostate cancer cells with low micromolar to submicromolar IC50 values as well as markedly enhanced aq. soly.  These new analogs obtained by rationally modifying the natural product have been shown not only to significantly induce the apoptosis and suppress growth of triple-neg. MDA-MB-231 breast cancer both in vitro and in vivo but are also effective against drug-resistant ER-pos. MCF-7 clones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfnEskkayfSLVg90H21EOLACvtfcHk0lhkAzy1tXPuVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVeqtL0%253D&md5=b7ec95c47f40492b7aea80159cbbe9bb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm400367n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400367n%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DChu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DNovel%2520nitrogen-enriched%2520oridonin%2520analogues%2520with%2520thiazole-fused%2520A-ring%253A%2520protecting%2520group-free%2520synthesis%252C%2520enhanced%2520anticancer%2520profile%252C%2520and%2520improved%2520aqueous%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5048%26epage%3D5058%26doi%3D10.1021%2Fjm400367n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagalowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. T.</span></span> <span> </span><span class="NLM_article-title">Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic oridonin analogues</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">56842</span>– <span class="NLM_lpage">56854</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.18632%2Foncotarget.10863" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=56842-56854&author=W.+Chenauthor=J.+Zhouauthor=K.+Wuauthor=J.+Huangauthor=Y.+Dingauthor=E.+J.+Yunauthor=B.+Wangauthor=C.+Dingauthor=E.+Hernandezauthor=J.+Santoyoauthor=H.+Chenauthor=H.+Linauthor=A.+Sagalowskyauthor=D.+Heauthor=J.+Zhouauthor=J.+T.+Hsieh&title=Targeting+XBP1-mediated+%CE%B2-catenin+expression+associated+with+bladder+cancer+with+newly+synthetic+oridonin+analogues&doi=10.18632%2Foncotarget.10863"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10863%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DHernandez%26aufirst%3DE.%26aulast%3DSantoyo%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSagalowsky%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHsieh%26aufirst%3DJ.%2BT.%26atitle%3DTargeting%2520XBP1-mediated%2520%25CE%25B2-catenin%2520expression%2520associated%2520with%2520bladder%2520cancer%2520with%2520newly%2520synthetic%2520oridonin%2520analogues%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D56842%26epage%3D56854%26doi%3D10.18632%2Foncotarget.10863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.canlet.2016.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=27387452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFant7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2016&pages=393-402&author=J.+Wuauthor=Y.+Dingauthor=C.+H.+Chenauthor=Z.+Zhouauthor=C.+Dingauthor=H.+Chenauthor=J.+Zhouauthor=C.+Chen&title=A+new+oridonin+analog+suppresses+triple-negative+breast+cancer+cells+and+tumor+growth+via+the+induction+of+death+receptor+5&doi=10.1016%2Fj.canlet.2016.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5</span></div><div class="casAuthors">Wu, Jing; Ding, Ye; Chen, Chuan-Huizhi; Zhou, Zhongmei; Ding, Chunyong; Chen, Haiying; Zhou, Jia; Chen, Ceshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">393-402</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) remains the leading cause of death among women with breast cancer worldwide.  Oridonin is a natural anti-cancer compd. that is isolated from the traditional Chinese herb Rabdosia rubescens.  However, the antitumor efficacies of oridonin in the treatments of TNBC and other cancers are far from ideal.  In this study, we investigated a series of newly designed oridonin analogs in terms of their actions against HCC1806 and HCC1937 TNBC cell lines and identified CYD-6-28, which significantly inhibits cancer cell proliferation and induces G2/M-phase cell cycle arrest and apoptosis.  CYD-6-28 induces the expression of p21 and the cleavage of caspase-3, -7, -8 and PARP and inhibits the expression levels of Cyclin D1, FLIPL and XIAP.  CYD-6-28 also inhibits the activations of STAT3 and AKT and induces the activation of ERK.  We demonstrated that CYD-6-28 induces apoptosis at least partially by inducing the expression of death receptor 5 (DR5).  Finally, CYD-6-28 significantly suppresses HCC1806 xenograft tumor growth in nude mice at 5 mg/kg without affecting body wt.  Taken together, these results indicate that CYD-6-28 has the potential to be developed as a therapeutic agent to treat TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwRKWDYjI09bVg90H21EOLACvtfcHk0lhkAzy1tXPuVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFant7%252FO&md5=b550f5511d3bec8d73774cecf290aa81</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DA%2520new%2520oridonin%2520analog%2520suppresses%2520triple-negative%2520breast%2520cancer%2520cells%2520and%2520tumor%2520growth%2520via%2520the%2520induction%2520of%2520death%2520receptor%25205%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D380%26spage%3D393%26epage%3D402%26doi%3D10.1016%2Fj.canlet.2016.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species H2O2 and •OH, but not O2•(−) promote oridonin-induced phagocytosis of apoptotic cells by human histocytic lymphoma U937 cells</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2013.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.intimp.2013.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=23352441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1ShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=414-423&author=L.+Zangauthor=H.+Heauthor=Q.+Xuauthor=Y.+Yuauthor=N.+Zhengauthor=W.+Liuauthor=T.+Hayashiauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Reactive+oxygen+species+H2O2+and+%E2%80%A2OH%2C+but+not+O2%E2%80%A2%28%E2%88%92%29+promote+oridonin-induced+phagocytosis+of+apoptotic+cells+by+human+histocytic+lymphoma+U937+cells&doi=10.1016%2Fj.intimp.2013.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species H2O2 and OH, but not O2- promote oridonin-induced phagocytosis of apoptotic cells by human histocytic lymphoma U937 cells</span></div><div class="casAuthors">Zang, Linghe; He, Hao; Xu, Qian; Yu, Yang; Zheng, Nan; Liu, Weiwei; Hayashi, Toshihiko; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">414-423</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We reported previously that phagocytosis of apoptotic cells by U937 cells was enhanced by the treatment with oridonin that showed high activity to induce the generation of reactive oxygen species (ROS) in many cells.  ROS, important signaling mols., are involved in the immune defenses, cell repair and proliferation.  In this study, oridonin caused modest amt. of ROS generation in U937 cells, with hydrogen peroxide (H2O2) and hydroxyl free radical (OH) as the major types.  Meanwhile, H2O2 and OH were pos. regulators involved in oridonin-enhanced engulfment of apoptotic cells through down-regulating mitochondrial membrane potential (MMP) and inducing autophagy.  The ROS-mediated phagocytosis was independent of cellular ATP (ATP) levels.  H2O2 and OH generation also activated phosphatidylinositol 3-kinases-Akt (PI3K-Akt) and phospholipase C γ-protein kinase C(PLC γ)-Ras-Raf-ERK signaling pathways, which were essential for oridonin-induced engulfment of apoptotic cells.  Phagocytosis, the loss of MMP, autophagy and the activated signaling pathways were all suppressed by ROS scavenger N-acetyl-L-cysteine (NAC), H2O2 scavenger catalase or OH scavenger glutathione (GSH).  However, superoxide anion (O2-) and its scavenger superoxide dismutase (SOD) did not significantly affect these oridonin-induced biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9uUjMukMXJ7Vg90H21EOLACvtfcHk0lgNTEmISPVneA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1ShsLg%253D&md5=8f7651560d036dff7a6beb77079aa308</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2013.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2013.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DZang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DReactive%2520oxygen%2520species%2520H2O2%2520and%2520%25E2%2580%25A2OH%252C%2520but%2520not%2520O2%25E2%2580%25A2%2528%25E2%2588%2592%2529%2520promote%2520oridonin-induced%2520phagocytosis%2520of%2520apoptotic%2520cells%2520by%2520human%2520histocytic%2520lymphoma%2520U937%2520cells%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2013%26volume%3D15%26spage%3D414%26epage%3D423%26doi%3D10.1016%2Fj.intimp.2013.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1306</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2008.06864.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1111%2Fj.1742-4658.2008.06864.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=1291-1306&author=Y.+Chengauthor=F.+Qiuauthor=Y.+C.+Yeauthor=Z.+M.+Guoauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Autophagy+inhibits+reactive+oxygen+species-mediated+apoptosis+via+activating+p38-nuclear+factor-kappa+B+survival+pathways+in+oridonin-treated+murine+fibrosarcoma+L929+cells&doi=10.1111%2Fj.1742-4658.2008.06864.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2008.06864.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2008.06864.x%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DY.%2BC.%26aulast%3DGuo%26aufirst%3DZ.%2BM.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DAutophagy%2520inhibits%2520reactive%2520oxygen%2520species-mediated%2520apoptosis%2520via%2520activating%2520p38-nuclear%2520factor-kappa%2520B%2520survival%2520pathways%2520in%2520oridonin-treated%2520murine%2520fibrosarcoma%2520L929%2520cells%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D1291%26epage%3D1306%26doi%3D10.1111%2Fj.1742-4658.2008.06864.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T. L.</span></span> <span> </span><span class="NLM_article-title">Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3327</span>– <span class="NLM_lpage">3344</span>, <span class="refDoi"> DOI: 10.3390/molecules19033327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3390%2Fmolecules19033327" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=3327-3344&author=L.+M.+Kuoauthor=C.+Y.+Kuoauthor=C.+Y.+Linauthor=M.+F.+Hungauthor=J.+J.+Shenauthor=T.+L.+Hwang&title=Intracellular+glutathione+depletion+by+oridonin+leads+to+apoptosis+in+hepatic+stellate+cells&doi=10.3390%2Fmolecules19033327"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3390%2Fmolecules19033327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules19033327%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DL.%2BM.%26aulast%3DKuo%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DHung%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DJ.%2BJ.%26aulast%3DHwang%26aufirst%3DT.%2BL.%26atitle%3DIntracellular%2520glutathione%2520depletion%2520by%2520oridonin%2520leads%2520to%2520apoptosis%2520in%2520hepatic%2520stellate%2520cells%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D3327%26epage%3D3344%26doi%3D10.3390%2Fmolecules19033327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. M.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.3109/10428194.2015.1061127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3109%2F10428194.2015.1061127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=26415087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWqurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=888-898&author=Z.+Z.+Xuauthor=W.+B.+Fuauthor=Z.+Jinauthor=P.+Guoauthor=W.+F.+Wangauthor=J.+M.+Li&title=Reactive+oxygen+species+mediate+oridonin-induced+apoptosis+through+DNA+damage+response+and+activation+of+JNK+pathway+in+diffuse+large+B+cell+lymphoma&doi=10.3109%2F10428194.2015.1061127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma</span></div><div class="casAuthors">Xu, Zi-Zhen; Fu, Wan-Bin; Jin, Zhen; Guo, Pei; Wang, Wen-Fang; Li, Jun-Min</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">888-898</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">This study investigated the cytotoxic effect of oridonin (ORI), a diterpenoid isolated from Rabdosia rubescens, in human diffuse large B cell lymphoma (DLBCL) in vitro and in vivo and the potential mol. mechanisms for ORI-induced cell apoptosis.  ORI treatment caused reactive oxygen species (ROS)-mediated oxidative DNA damage response (DDR) and the c-Jun N-terminal kinase (JNK) pathway activation, leading to an induction of intrinsic apoptosis.  ROS abolition blocked ORI-induced apoptosis and attenuated the expression of phospho-histone H2AX and phospho-JNK, indicating that ROS-mediated DNA damage and JNK pathway activation were involved in ORI-induced apoptosis.  The systemic administration of ORI suppressed the growth of human DLBCL xenografts without showing significant toxicity.  These findings suggest that ORI may have promising therapeutic application in DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjsNNhznQ9b7Vg90H21EOLACvtfcHk0lgNTEmISPVneA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWqurrM&md5=4630e1bacf48239e813a01f90aa7091d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3109%2F10428194.2015.1061127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2015.1061127%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%2BZ.%26aulast%3DFu%26aufirst%3DW.%2BB.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%2BF.%26aulast%3DLi%26aufirst%3DJ.%2BM.%26atitle%3DReactive%2520oxygen%2520species%2520mediate%2520oridonin-induced%2520apoptosis%2520through%2520DNA%2520damage%2520response%2520and%2520activation%2520of%2520JNK%2520pathway%2520in%2520diffuse%2520large%2520B%2520cell%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2016%26volume%3D57%26spage%3D888%26epage%3D898%26doi%3D10.3109%2F10428194.2015.1061127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satomura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, T.</span></span> <span> </span><span class="NLM_article-title">Antibacterial activity and chemical structure of diterpenoids</span>. <i>Agric. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1080/00021369.1974.10861320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1080%2F00021369.1974.10861320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADyaE2cXls1eqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1974&pages=1261-1262&author=I.+Kuboauthor=M.+Taniguchiauthor=Y.+Satomuraauthor=T.+Kubota&title=Antibacterial+activity+and+chemical+structure+of+diterpenoids&doi=10.1080%2F00021369.1974.10861320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial activity and chemical structure of diterpenoids</span></div><div class="casAuthors">Kubo, Isao; Taniguchi, Makoto; Satomura, Yukio; Kubota, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Agricultural and Biological Chemistry</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-2</span>CODEN:
                <span class="NLM_cas:coden">ABCHA6</span>;
        ISSN:<span class="NLM_cas:issn">0002-1369</span>.
    </div><div class="casAbstract">The bactericidal activity of the 20 diterpenoids tested appeared to depend on the presence of cylopentanone with a conjugated exocyclic methylene group.  All the tested natural compds. (from various Isodon species) with the exception of one inhibited the growth of Bacillus subtilis.  Their dihydro derivs. were inactive, whereas their acetates showed some activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYEuyCUgQu4rVg90H21EOLACvtfcHk0lgmpBYDwfoS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXls1eqsbw%253D&md5=5ff742b7884d4ed04bde13eaa19e98fe</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F00021369.1974.10861320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00021369.1974.10861320%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DI.%26aulast%3DTaniguchi%26aufirst%3DM.%26aulast%3DSatomura%26aufirst%3DY.%26aulast%3DKubota%26aufirst%3DT.%26atitle%3DAntibacterial%2520activity%2520and%2520chemical%2520structure%2520of%2520diterpenoids%26jtitle%3DAgric.%2520Biol.%2520Chem.%26date%3D1974%26volume%3D38%26spage%3D1261%26epage%3D1262%26doi%3D10.1080%2F00021369.1974.10861320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5022</span>– <span class="NLM_lpage">5034</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2lt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5022-5034&author=S.+Xuauthor=S.+Luoauthor=H.+Yaoauthor=H.+Caiauthor=X.+Miaoauthor=F.+Wuauthor=D.+H.+Yangauthor=X.+Wuauthor=W.+Xieauthor=H.+Yaoauthor=Z.+S.+Chenauthor=J.+Xu&title=Probing+the+anticancer+action+of+oridonin+with+fluorescent+analogues%3A+visualizing+subcellular+localization+to+mitochondria&doi=10.1021%2Facs.jmedchem.6b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria</span></div><div class="casAuthors">Xu, Shengtao; Luo, Shanshan; Yao, Hong; Cai, Hao; Miao, Xiaoming; Wu, Fang; Yang, Dong-Hua; Wu, Xiaoming; Xie, Weijia; Yao, Hequan; Chen, Zhe-Sheng; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5022-5034</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oridonin (1) is a complex ent-kaurane diterpenoid exhibiting remarkable antitumor activity.  However, the detailed mechanism or cellular target that underlies this activity has not yet been identified.  Herein, we report an efficient approach for exploring the anticancer mechanism of oridonin through development of the potent fluorescent analogs.  A series of novel fluorescent oridonin probes linked with coumarin moieties were designed, synthesized, and characterized.  Fluorescence microscopy and confocal imaging studies suggested that fluorescent oridonin probe 17d was rapidly taken up into tumor cells and the mitochondrion was the main site of its accumulation.  Moreover, we confirmed that cytochrome c played an important role in oridonin induced mitochondrion-mediated apoptosis and α,β-unsatd. ketone is the active moiety of oridonin, which is crucial to its uptake, localization, and cytotoxicity.  Our results provide new insights on the mol. mechanism of oridonin and would be useful for its further development into an antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQwh1mki12ZrVg90H21EOLACvtfcHk0lgmpBYDwfoS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2lt7s%253D&md5=8017b3f84342c5da185cb84c7effa0d4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00408%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DD.%2BH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520anticancer%2520action%2520of%2520oridonin%2520with%2520fluorescent%2520analogues%253A%2520visualizing%2520subcellular%2520localization%2520to%2520mitochondria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5022%26epage%3D5034%26doi%3D10.1021%2Facs.jmedchem.6b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrowietz, U.</span></span> <span> </span><span class="NLM_article-title">Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-L-cysteine-preparation of S-substituted thiosuccinic acid esters</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.bmc.2006.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=333-342&author=T.+J.+Schmidtauthor=M.+Akauthor=U.+Mrowietz&title=Reactivity+of+dimethyl+fumarate+and+methylhydrogen+fumarate+towards+glutathione+and+N-acetyl-L-cysteine-preparation+of+S-substituted+thiosuccinic+acid+esters&doi=10.1016%2Fj.bmc.2006.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DT.%2BJ.%26aulast%3DAk%26aufirst%3DM.%26aulast%3DMrowietz%26aufirst%3DU.%26atitle%3DReactivity%2520of%2520dimethyl%2520fumarate%2520and%2520methylhydrogen%2520fumarate%2520towards%2520glutathione%2520and%2520N-acetyl-L-cysteine-preparation%2520of%2520S-substituted%2520thiosuccinic%2520acid%2520esters%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D333%26epage%3D342%26doi%3D10.1016%2Fj.bmc.2006.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Keap calm, and carry on covalently</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7463</span>– <span class="NLM_lpage">7476</span>, <span class="refDoi"> DOI: 10.1021/jm400224q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400224q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7463-7476&author=A.+J.+Wilsonauthor=J.+K.+Kernsauthor=J.+F.+Callahanauthor=C.+J.+Moody&title=Keap+calm%2C+and+carry+on+covalently&doi=10.1021%2Fjm400224q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Keap Calm, and Carry on Covalently</span></div><div class="casAuthors">Wilson, Anthony J.; Kerns, Jeffrey K.; Callahan, James F.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7463-7476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Nrf2-Keap1 system plays a major role in cellular defense against oxidative stress.  Upon exposure to electrophiles, the cysteine-rich protein Keap1 is covalently modified, and it is this modification of Keap1 that allows the accumulation and subsequent nuclear translocation of Nrf2 where it induces the transcription of over 100 protective genes.  This mechanism can be exploited in drug discovery approaches to diseases such as chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), asthma, and neurodegenerative diseases like multiple sclerosis (MS) and Parkinson's, utilizing the modification of Keap1 by electrophiles, compds. that would not normally be considered useful in drug discovery programs.  This Perspective discusses the development of potential therapies based on potent electrophiles, such as isothiocyanates and Michael acceptors, that, far from being assocd. with toxic events, can actually initiate a range of beneficial protective pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFM-f4P1ElOLVg90H21EOLACvtfcHk0lgmpBYDwfoS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE&md5=ea907fb2ccd8c28142ab4fa2776d0195</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm400224q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400224q%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DKeap%2520calm%252C%2520and%2520carry%2520on%2520covalently%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7463%26epage%3D7476%26doi%3D10.1021%2Fjm400224q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2219</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.bmcl.2005.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15837296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2215-2219&author=R.+D.+Couchauthor=R.+G.+Browningauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=D.+L.+Wrightauthor=M.+B.+Spornauthor=A.+C.+Anderson&title=Studies+on+the+reactivity+of+CDDO%2C+a+promising+new+chemopreventive+and+chemotherapeutic+agent%3A+implications+for+a+molecular+mechanism+of+action&doi=10.1016%2Fj.bmcl.2005.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span></div><div class="casAuthors">Couch, Robin D.; Browning, R. Greg; Honda, Tadashi; Gribble, Gordon W.; Wright, Dennis L.; Sporn, Michael B.; Anderson, Amy C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2215-2219</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CDDO, a semi-synthetic triterpenoid derived from oleanolic acid, has the potential to be used as a chemopreventive and chemotherapeutic agent.  The structure of CDDO contains two α,β-unsatd. carbonyl moieties, suggesting a mechanism of action involving a conjugate nucleophilic addn.  Spectroscopic evaluation with thiol nucleophiles illustrates that an addn. does indeed occur, but this addn. is selective and reversible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEly4KE1L3bVg90H21EOLACvtfcHk0liwyhq9dKdAtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D&md5=403474a7b33ce6f42e93ad3f9bbd84b0</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DCouch%26aufirst%3DR.%2BD.%26aulast%3DBrowning%26aufirst%3DR.%2BG.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DStudies%2520on%2520the%2520reactivity%2520of%2520CDDO%252C%2520a%2520promising%2520new%2520chemopreventive%2520and%2520chemotherapeutic%2520agent%253A%2520implications%2520for%2520a%2520molecular%2520mechanism%2520of%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2215%26epage%3D2219%26doi%3D10.1016%2Fj.bmcl.2005.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, H.</span></span> <span> </span><span class="NLM_article-title">The antitumor and antibacterial activity of the Isodon diterpenoids</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2118</span>– <span class="NLM_lpage">2127</span>, <span class="refDoi"> DOI: 10.1248/cpb.24.2118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1248%2Fcpb.24.2118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1976&pages=2118-2127&author=E.+Fujitaauthor=Y.+Nagaoauthor=K.+Kanekoauthor=S.+Nakazawaauthor=H.+Kuroda&title=The+antitumor+and+antibacterial+activity+of+the+Isodon+diterpenoids&doi=10.1248%2Fcpb.24.2118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1248%2Fcpb.24.2118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.24.2118%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DE.%26aulast%3DNagao%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DNakazawa%26aufirst%3DS.%26aulast%3DKuroda%26aufirst%3DH.%26atitle%3DThe%2520antitumor%2520and%2520antibacterial%2520activity%2520of%2520the%2520Isodon%2520diterpenoids%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1976%26volume%3D24%26spage%3D2118%26epage%3D2127%26doi%3D10.1248%2Fcpb.24.2118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornwall, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Organocatalytic asymmetric epoxidation and aziridination of olefins and their synthetic applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">8199</span>– <span class="NLM_lpage">8256</span>, <span class="refDoi"> DOI: 10.1021/cr500064w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500064w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1Cntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=8199-8256&author=Y.+Zhuauthor=Q.+Wangauthor=R.+G.+Cornwallauthor=Y.+Shi&title=Organocatalytic+asymmetric+epoxidation+and+aziridination+of+olefins+and+their+synthetic+applications&doi=10.1021%2Fcr500064w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic asymmetric epoxidation and aziridination of olefins and their synthetic applications</span></div><div class="casAuthors">Zhu, Yingguang; Wang, Qian; Cornwall, Richard G.; Shi, Yian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8199-8256</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review highlighted various advances in organocatalytic asym. epoxidn. and aziridination of olefins as well as their synthetic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlHwjm9_i_bVg90H21EOLACvtfcHk0liwyhq9dKdAtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1Cntro%253D&md5=d9b57d2407d5dd324c7002976c13f842</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fcr500064w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500064w%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DCornwall%26aufirst%3DR.%2BG.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DOrganocatalytic%2520asymmetric%2520epoxidation%2520and%2520aziridination%2520of%2520olefins%2520and%2520their%2520synthetic%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D8199%26epage%3D8256%26doi%3D10.1021%2Fcr500064w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degennaro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luisi, R.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the stereoselective synthesis of aziridines</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7881</span>– <span class="NLM_lpage">7929</span>, <span class="refDoi"> DOI: 10.1021/cr400553c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400553c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVahtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=7881-7929&author=L.+Degennaroauthor=P.+Trincheraauthor=R.+Luisi&title=Recent+advances+in+the+stereoselective+synthesis+of+aziridines&doi=10.1021%2Fcr400553c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the stereoselective synthesis of aziridines</span></div><div class="casAuthors">Degennaro, Leonardo; Trinchera, Piera; Luisi, Renzo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7881-7929</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review reported some recent advances in the field of stereoselective synthesis of aziridines focusing on new methodologies, mechanistic insights, and the scope and limitations of each strategy.  The adjective stereoselective was used in a broad sense to identify synthetic processes creating new stereogenic centers and that occur with a control either on the abs. or relative configuration.  Methodologies developed in the last 10 years were described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIw6kb6If5rLVg90H21EOLACvtfcHk0liwyhq9dKdAtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVahtLc%253D&md5=6860d33e742e33efdadfa77fcd83d250</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcr400553c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400553c%26sid%3Dliteratum%253Aachs%26aulast%3DDegennaro%26aufirst%3DL.%26aulast%3DTrinchera%26aufirst%3DP.%26aulast%3DLuisi%26aufirst%3DR.%26atitle%3DRecent%2520advances%2520in%2520the%2520stereoselective%2520synthesis%2520of%2520aziridines%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D7881%26epage%3D7929%26doi%3D10.1021%2Fcr400553c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njardarson, J. T.</span></span> <span> </span><span class="NLM_article-title">A scalable rhodium-catalyzed intermolecular aziridination reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4278</span>– <span class="NLM_lpage">4280</span>, <span class="refDoi"> DOI: 10.1002/anie.201400502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.201400502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4278-4280&author=D.+T.+Smithauthor=J.+T.+Njardarson&title=A+scalable+rhodium-catalyzed+intermolecular+aziridination+reaction&doi=10.1002%2Fanie.201400502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.201400502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201400502%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BT.%26aulast%3DNjardarson%26aufirst%3DJ.%2BT.%26atitle%3DA%2520scalable%2520rhodium-catalyzed%2520intermolecular%2520aziridination%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4278%26epage%3D4280%26doi%3D10.1002%2Fanie.201400502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Study on stability of oridonin solution</span>. <i>Zhongguo Zhong Yao Za Zhi</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=19382449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ptFKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=47-49&author=J.+Xuauthor=J.+Zhaoauthor=J.+Wangauthor=N.+Fengauthor=R.+Tanauthor=Y.+Liu&title=Study+on+stability+of+oridonin+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Study on stability of oridonin solution</span></div><div class="casAuthors">Xu Jie; Zhao Jihui; Wang Ju; Feng Nianping; Tan Rong; Liu Ying</div><div class="citationInfo"><span class="NLM_cas:title">Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-9</span>
        ISSN:<span class="NLM_cas:issn">1001-5302</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the stability of oridonin (ORI) solution for research and development of novel ORI prepartions.  METHOD:  The effect of pH on the degradation rate of ORI was evaluated, the pH values of the oridonin solutions were adjusted to the setting pH, with 1 mol x L(-1) HCl or NaOH, respectively, and stored at room temperature for 60 h.  The constant temperature method was applied to evaluate the stability of ORI solution at room temperature and at 4 degrees C.  RESULT:  The pH-rate profile of ORI was V-shaped, and the pHm was 5.  The t90 of ORI solution at room temperature was 53.2 h and 91.5 h at 4 degrees C CONCLUSION: The ORI solution is not stable.  The pH-dependent degradation of ORI solution confirms to specific acid-base catalysis reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4svf8nu1YggaK-_ZudimnfW6udTcc2eY1IxlhSS30krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ptFKnuw%253D%253D&md5=bb3caddd19ed1ef6516bd39121e1fec7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DN.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DStudy%2520on%2520stability%2520of%2520oridonin%2520solution%26jtitle%3DZhongguo%2520Zhong%2520Yao%2520Za%2520Zhi%26date%3D2009%26volume%3D34%26spage%3D47%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jat, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudyal, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousufuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarajan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ess, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kürti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Direct stereospecific synthesis of unprotected N-H and N-Me aziridines from olefins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1126/science.1245727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1126%2Fscience.1245727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=24385626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=61-65&author=J.+L.+Jatauthor=M.+P.+Paudyalauthor=H.+Gaoauthor=Q.+L.+Xuauthor=M.+Yousufuddinauthor=D.+Devarajanauthor=D.+H.+Essauthor=L.+K%C3%BCrtiauthor=J.+R.+Falck&title=Direct+stereospecific+synthesis+of+unprotected+N-H+and+N-Me+aziridines+from+olefins&doi=10.1126%2Fscience.1245727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Stereospecific Synthesis of Unprotected N-H and N-Me Aziridines from Olefins</span></div><div class="casAuthors">Jat, Jawahar L.; Paudyal, Mahesh P.; Gao, Hongyin; Xu, Qing-Long; Yousufuddin, Muhammed; Devarajan, Deepa; Ess, Daniel H.; Kuerti, Laszlo; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6166</span>),
    <span class="NLM_cas:pages">61-65</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Despite the prevalence of the N-H aziridine motif in bioactive natural products and the clear advantages of this unprotected parent structure over N-protected derivs. as a synthetic building block, no practical methods have emerged for direct synthesis of this compd. class from unfunctionalized olefins.  Here, we present a mild, versatile method for the direct stereospecific conversion of structurally diverse mono-, di-, tri-, and tetrasubstituted olefins to N-H aziridines using O-(2,4-dinitrophenyl)hydroxylamine (DPH) via homogeneous rhodium catalysis with no external oxidants.  This method is operationally simple (i.e., one-pot), scalable, and fast at ambient temp., furnishing N-H aziridines in good-to-excellent yields.  Likewise, N-alkyl aziridines are prepd. from N-alkylated DPH derivs.  Quantum-mech. calcns. suggest a plausible Rh-nitrene pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9CgewJPc0vLVg90H21EOLACvtfcHk0ljqyp8nEmN0dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslOh&md5=5f06d6acf464f42fc1d6d1e3cf7355a6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245727%26sid%3Dliteratum%253Aachs%26aulast%3DJat%26aufirst%3DJ.%2BL.%26aulast%3DPaudyal%26aufirst%3DM.%2BP.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DQ.%2BL.%26aulast%3DYousufuddin%26aufirst%3DM.%26aulast%3DDevarajan%26aufirst%3DD.%26aulast%3DEss%26aufirst%3DD.%2BH.%26aulast%3DK%25C3%25BCrti%26aufirst%3DL.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DDirect%2520stereospecific%2520synthesis%2520of%2520unprotected%2520N-H%2520and%2520N-Me%2520aziridines%2520from%2520olefins%26jtitle%3DScience%26date%3D2014%26volume%3D343%26spage%3D61%26epage%3D65%26doi%3D10.1126%2Fscience.1245727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wincewicz, R.</span></span> <span> </span><span class="NLM_article-title">Amine-promoted, organocatalytic aziridination of enones</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1021/ol062852v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol062852v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=351-353&author=A.+Armstrongauthor=C.+A.+Baxterauthor=S.+G.+Lamontauthor=A.+R.+Papeauthor=R.+Wincewicz&title=Amine-promoted%2C+organocatalytic+aziridination+of+enones&doi=10.1021%2Fol062852v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol062852v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol062852v%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DA.%26aulast%3DBaxter%26aufirst%3DC.%2BA.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DPape%26aufirst%3DA.%2BR.%26aulast%3DWincewicz%26aufirst%3DR.%26atitle%3DAmine-promoted%252C%2520organocatalytic%2520aziridination%2520of%2520enones%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D351%26epage%3D353%26doi%3D10.1021%2Fol062852v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">An amine-promoted aziridination of chalcones</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">8005</span>– <span class="NLM_lpage">8008</span>, <span class="refDoi"> DOI: 10.1002/anie.200602586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.200602586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlelu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=8005-8008&author=Y.+M.+Shenauthor=M.+X.+Zhaoauthor=J.+Xuauthor=Y.+Shi&title=An+amine-promoted+aziridination+of+chalcones&doi=10.1002%2Fanie.200602586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">An amine-promoted aziridination of chalcones</span></div><div class="casAuthors">Shen, Yu-Mei; Zhao, Mei-Xin; Xu, Jiaxi; Shi, Yian</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">8005-8008</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Without protection: α-Keto aziridines have been formed in a novel amine-promoted direct aziridination of chalcones using an aminimide generated in situ from a tertiary amine and O-mesitylenesulfonylhydroxylamine in the presence of base.  The aziridination proceeds well using a catalytic amt. of the tertiary amine.  Furthermore, nonracemic aziridines are obtained using a chiral amine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2KTtsPZjQVrVg90H21EOLACvtfcHk0ljqyp8nEmN0dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlelu73N&md5=52966ebec407fbf11c3c492fe83fdc8c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fanie.200602586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200602586%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%2BM.%26aulast%3DZhao%26aufirst%3DM.%2BX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DAn%2520amine-promoted%2520aziridination%2520of%2520chalcones%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D8005%26epage%3D8008%26doi%3D10.1002%2Fanie.200602586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pesciaioli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vincentiis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galzerano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencivenni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzanti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, P.</span></span> <span> </span><span class="NLM_article-title">Organocatalytic asymmetric aziridination of enones</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">8703</span>– <span class="NLM_lpage">8706</span>, <span class="refDoi"> DOI: 10.1002/anie.200803647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1002%2Fanie.200803647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2ku7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=8703-8706&author=F.+Pesciaioliauthor=F.+De+Vincentiisauthor=P.+Galzeranoauthor=G.+Bencivenniauthor=G.+Bartoliauthor=A.+Mazzantiauthor=P.+Melchiorre&title=Organocatalytic+asymmetric+aziridination+of+enones&doi=10.1002%2Fanie.200803647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic asymmetric aziridination of enones</span></div><div class="casAuthors">Pesciaioli, Fabio; De Vincentiis, Francesco; Galzerano, Patrizia; Bencivenni, Giorgio; Bartoli, Giuseppe; Mazzanti, Andrea; Melchiorre, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8703-8706</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A primary amine derived from cinchona alkaloids as a salt with D-N-Boc phenylglycine is an efficient catalyst for the aziridination of α,β-unsatd. ketones.  This method is effective with both linear and cyclic substrates, leading to chiral aziridines in high yield, with complete diastereoselectivity, and with very high enantioselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbknzeDPaFk7Vg90H21EOLACvtfcHk0lgXBY1c3VAEwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2ku7%252FO&md5=03662146f9a1beea8c389bb7d663b34e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fanie.200803647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200803647%26sid%3Dliteratum%253Aachs%26aulast%3DPesciaioli%26aufirst%3DF.%26aulast%3DDe%2BVincentiis%26aufirst%3DF.%26aulast%3DGalzerano%26aufirst%3DP.%26aulast%3DBencivenni%26aufirst%3DG.%26aulast%3DBartoli%26aufirst%3DG.%26aulast%3DMazzanti%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DP.%26atitle%3DOrganocatalytic%2520asymmetric%2520aziridination%2520of%2520enones%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D8703%26epage%3D8706%26doi%3D10.1002%2Fanie.200803647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span> <span> </span><span class="NLM_article-title">Reaction of aziridinecarboxylic acids with thiols in aqueous solution. the formation of β-amino acid</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3881</span>– <span class="NLM_lpage">3888</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)81670-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2FS0040-4020%2801%2981670-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=3881-3888&author=Y.+Hataauthor=M.+Watanabe&title=Reaction+of+aziridinecarboxylic+acids+with+thiols+in+aqueous+solution.+the+formation+of+%CE%B2-amino+acid&doi=10.1016%2FS0040-4020%2801%2981670-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2981670-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252981670-7%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DM.%26atitle%3DReaction%2520of%2520aziridinecarboxylic%2520acids%2520with%2520thiols%2520in%2520aqueous%2520solution.%2520the%2520formation%2520of%2520%25CE%25B2-amino%2520acid%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D3881%26epage%3D3888%26doi%3D10.1016%2FS0040-4020%2801%2981670-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3718</span>– <span class="NLM_lpage">3721</span>, <span class="refDoi"> DOI: 10.1021/ol4015865</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol4015865" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=3718-3721&author=C.+Dingauthor=Y.+Zhangauthor=H.+Chenauthor=C.+Wildauthor=T.+Wangauthor=M.+A.+Whiteauthor=Q.+Shenauthor=J.+Zhou&title=Overcoming+synthetic+challenges+of+oridonin+A-ring+structural+diversification%3A+regio-+and+stereoselective+installation+of+azides+and+1%2C2%2C3-triazoles+at+the+C-1%2C+C-2%2C+or+C-3+position&doi=10.1021%2Fol4015865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Synthetic Challenges of Oridonin A-Ring Structural Diversification: Regio- and Stereoselective Installation of Azides and 1,2,3-Triazoles at the C-1, C-2, or C-3 Position</span></div><div class="casAuthors">Ding, Chunyong; Zhang, Yusong; Chen, Haijun; Wild, Christopher; Wang, Tianzhi; White, Mark A.; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3718-3721</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efficient and concise synthetic approaches have been developed for the rapid and diverse installation of azide functionalities at the C-1, C-2, or C-3 positions of oridonin with highly controlled regio- and stereoselectivity, while keeping key reactive pharmacophores intact by utilizing unique preactivation strategies based on the common synthon I.  Further functionalization of these azides through click chem. yielding triazole derivs. successfully provides access to an expanded natural scaffold-based compd. library for potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1L_ezFF5FhrVg90H21EOLACvtfcHk0lgXBY1c3VAEwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtL%252FN&md5=3471ade39c5ccc1631d2d3cec830414e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fol4015865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol4015865%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DOvercoming%2520synthetic%2520challenges%2520of%2520oridonin%2520A-ring%2520structural%2520diversification%253A%2520regio-%2520and%2520stereoselective%2520installation%2520of%2520azides%2520and%25201%252C2%252C3-triazoles%2520at%2520the%2520C-1%252C%2520C-2%252C%2520or%2520C-3%2520position%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D3718%26epage%3D3721%26doi%3D10.1021%2Fol4015865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">8442</span>– <span class="NLM_lpage">8452</span>, <span class="refDoi"> DOI: 10.1039/C4OB01040J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1039%2FC4OB01040J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=25225052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyht7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=8442-8452&author=C.+Dingauthor=L.+Wangauthor=H.+Chenauthor=C.+Wildauthor=N.+Yeauthor=Y.+Dingauthor=T.+Wangauthor=M.+A.+Whiteauthor=Q.+Shenauthor=J.+Zhou&title=ent-Kaurane-based+regio-+and+stereoselective+inverse+electron+demand+hetero-Diels-Alder+reactions%3A+synthesis+of+dihydropyran-fused+diterpenoids&doi=10.1039%2FC4OB01040J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids</span></div><div class="casAuthors">Ding, Chunyong; Wang, Lili; Chen, Haijun; Wild, Christopher; Ye, Na; Ding, Ye; Wang, Tianzhi; White, Mark A.; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">8442-8452</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A mild and concise approach for the construction of a 3,4-dihydro-2H-pyran ring integrated into the A-ring of the natural product oridonin using an optimized inverse electron demand hetero-Diels-Alder (IED HDA) reaction is reported herein.  A self-dimerization of the exocyclic enone installed in the A-ring through a homo-HDA reaction was identified to exclusively give a dimeric ent-kaurane diterpenoid with the spirochroman core.  Moreover, efficient cross-HDA cycloaddns. of this enone with various vinyl ethers or vinyl sulfides, instead of its own homo-HDA dimerization, were achieved in a regio- and stereoselective manner, thus providing access to novel dihydropyran-fused diterpenoids as potential anticancer agents to overcome chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh8NPnYKmGhbVg90H21EOLACvtfcHk0lgXBY1c3VAEwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyht7vN&md5=dc9094f722b6996010db476899842e75</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC4OB01040J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01040J%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3Dent-Kaurane-based%2520regio-%2520and%2520stereoselective%2520inverse%2520electron%2520demand%2520hetero-Diels-Alder%2520reactions%253A%2520synthesis%2520of%2520dihydropyran-fused%2520diterpenoids%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D8442%26epage%3D8452%26doi%3D10.1039%2FC4OB01040J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>489</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2009.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.abb.2009.07.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2009&pages=25-33&author=Y.+Zhangauthor=Y.+Wuauthor=D.+Wuauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=NF-kappab+facilitates+oridonin-induced+apoptosis+and+autophagy+in+HT1080+cells+through+a+p53-mediated+pathway&doi=10.1016%2Fj.abb.2009.07.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DNF-kappab%2520facilitates%2520oridonin-induced%2520apoptosis%2520and%2520autophagy%2520in%2520HT1080%2520cells%2520through%2520a%2520p53-mediated%2520pathway%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D489%26spage%3D25%26epage%3D33%26doi%3D10.1016%2Fj.abb.2009.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijeratne, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilaka, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. M.</span></span> <span> </span><span class="NLM_article-title">Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb rabdosia rubescens</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.09.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.bbrc.2005.09.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=16176802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKis7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2005&pages=224-231&author=T.+C.+Hsiehauthor=E.+K.+Wijeratneauthor=J.+Y.+Liangauthor=A.+L.+Gunatilakaauthor=J.+M.+Wu&title=Differential+control+of+growth%2C+cell+cycle+progression%2C+and+expression+of+NF-kappaB+in+human+breast+cancer+cells+MCF-7%2C+MCF-10A%2C+and+MDA-MB-231+by+ponicidin+and+oridonin%2C+diterpenoids+from+the+Chinese+herb+rabdosia+rubescens&doi=10.1016%2Fj.bbrc.2005.09.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens</span></div><div class="casAuthors">Hsieh, Tze-chen; Wijeratne, E. Kithsiri; Liang, Jing-yu; Gunatilaka, A. Leslie; Wu, Joseph M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-231</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ponicidin and oridonin are novel diterpenoids isolated from Rabdosia rubescens.  We tested their effects in MCF-7 and MDA-MB-231 cells, as representing low and high invasive breast carcinoma, with normal MCF-10A cells.  Clonogenicity and proliferation in MCF-7 cells were inhibited more significantly by ponicidin than oridonin, while the reverse was obsd. in MCF-10A cells.  Ponicidin and oridonin induced S/G2M arrest and G1/S block in MCF-7 cells.  In MCF-10A cells treated with either diterpenoid, induction of apoptosis was obsd.  Moreover, oridonin almost completely blocked MCF-10A progression from S to G2/M phase; in contrast, ponicidin-treated MCF-10A cells showed no discernable changes in cell cycle phase distribution.  Neither diterpenoid affected growth of MDA-MB-231 cells, at the dose range effective for MCF-7 or MCF-10A cells.  Ponicidin-treated MCF-7 cells expressed reduced levels of cyclin B1, cdc2, transcription factor E2F, and Rb including phosphorylation at S780.  Less pronounced effects were found in cells treated with oridonin.  Neither compd. altered cyclin D1 and cdk4 in MCF-7 cells.  In MCF-10A cells, oridonin was more active than ponicidin in inhibiting the expression of cyclin B1, cdc2, S780-phosphorylated Rb, and E2F.  To further investigate induction of apoptosis in MCF-10A cells, we measured changes in NF-κB.  Decreases in p65 or p50 forms of NF-κB and its upstream regulator I-κB were found in oridonin-treated MCF-10A and not MCF-7 cells.  Taken together, these results provide a mechanistic framework for the cellular effects of ponicidin and oridonin in different stage breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTVe4GKsS7PrVg90H21EOLACvtfcHk0ljIW2Ic_zg95g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKis7%252FI&md5=441c4490b2dc444c65366762a9782fb3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.09.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.09.040%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DT.%2BC.%26aulast%3DWijeratne%26aufirst%3DE.%2BK.%26aulast%3DLiang%26aufirst%3DJ.%2BY.%26aulast%3DGunatilaka%26aufirst%3DA.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BM.%26atitle%3DDifferential%2520control%2520of%2520growth%252C%2520cell%2520cycle%2520progression%252C%2520and%2520expression%2520of%2520NF-kappaB%2520in%2520human%2520breast%2520cancer%2520cells%2520MCF-7%252C%2520MCF-10A%252C%2520and%2520MDA-MB-231%2520by%2520ponicidin%2520and%2520oridonin%252C%2520diterpenoids%2520from%2520the%2520Chinese%2520herb%2520rabdosia%2520rubescens%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D337%26spage%3D224%26epage%3D231%26doi%3D10.1016%2Fj.bbrc.2005.09.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halicka, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traganos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darzynkiewicz, Z.</span></span> <span> </span><span class="NLM_article-title">The cytostatic and cytotoxic effects of oridonin (rubescenin), a diterpenoid from rabdosia rubescens, on tumor cells of different lineage</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.3892/ijo.26.3.579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.3892%2Fijo.26.3.579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15703811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVeqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=579-588&author=S.+Chenauthor=J.+Gaoauthor=H.+D.+Halickaauthor=X.+Huangauthor=F.+Traganosauthor=Z.+Darzynkiewicz&title=The+cytostatic+and+cytotoxic+effects+of+oridonin+%28rubescenin%29%2C+a+diterpenoid+from+rabdosia+rubescens%2C+on+tumor+cells+of+different+lineage&doi=10.3892%2Fijo.26.3.579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage</span></div><div class="casAuthors">Chen, Sophie; Gao, Jian; Halicka, H. Dorota; Huang, Xuan; Traganos, Frank; Darzynkiewicz, Zbigniew</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Rabdosia rubescens is a herbal medicine used to treat esophageal cancer in China.  In this study, the sesquiterpene oridonin, an isoprenoid, was isolated from Rabdosia rubescens.  Mass spectroscopy and carbon 13 NMR spectroscopy were used to identify the structure of the purified compd.  It was then evaluated for biol. activity against human cell lines derived from prostate (DU-145, LNCaP), breast (MCF-7), and ovarian (A2780 and PTX10) cancers.  Oridonin exhibited anti-proliferative activity toward all cancer cell lines tested, with an IC50 estd. by the MTT cell viability assay ranging from 5.8±2.3 to 11.72±4.8 μM.  Flow cytometric anal. demonstrated that oridonin induced a G1 phase arrest in androgen receptor-pos. LNCaP cells contg. wt p53, while it blocked the cell cycle at G2 and M phases in androgen receptor-neg. DU-145 cells with mutated p53; the arrest in M was verified by examn. of cell morphol. and by the increased frequency of cells with Ser-10 phosphorylated histone H3.  The increased incidence of apoptosis, identified by characteristic changes in cell morphol., was seen in tumor lines treated with oridonin.  Notably, at concns. that induced apoptosis among tumor cells, oridonin failed to induce apoptosis in cultures of normal human fibroblasts.  Western blot anal. was used to det. the protein expression of cancer suppressor genes, p53 (wt) and Bax, and the proto-oncogene, Bcl-2 in LNCaP cells following treatment with oridonin.  Oridonin up-regulated p53 and Bax and down-regulated Bcl-2 expression in a dose-dependent manner.  To further explore the possible interaction between oridonin and DNA, its absorption spectrum was measured in the presence and absence of double stranded (ds) DNA.  Spectral shifts and an increase in absorption band intensity were obsd. indicating interaction of oridonin with DNA bases.  The nature of the binding is not clear at present though no evidence of histone H2AX phosphorylation on Ser-139 was apparent in DU-145 cells treated with oridonin that would indicate the induction of ds DNA breaks.  In conclusion, oridonin inhibits cancer cell growth in a cell cycle specific manner and shifts the balance between pro- and anti-apoptotic proteins in favor of apoptosis.  The present data suggest that further studies are warranted to assess the potential of oridonin in cancer prevention and/or treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgD-_ukpf-WbVg90H21EOLACvtfcHk0ljIW2Ic_zg95g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVeqsLo%253D&md5=945b88283ed80315e970943253914380</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3892%2Fijo.26.3.579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.26.3.579%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHalicka%26aufirst%3DH.%2BD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DTraganos%26aufirst%3DF.%26aulast%3DDarzynkiewicz%26aufirst%3DZ.%26atitle%3DThe%2520cytostatic%2520and%2520cytotoxic%2520effects%2520of%2520oridonin%2520%2528rubescenin%2529%252C%2520a%2520diterpenoid%2520from%2520rabdosia%2520rubescens%252C%2520on%2520tumor%2520cells%2520of%2520different%2520lineage%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2005%26volume%3D26%26spage%3D579%26epage%3D588%26doi%3D10.3892%2Fijo.26.3.579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1254/jphs.FPJ04008X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1254%2Fjphs.FPJ04008X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15492467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=155-163&author=C.+L.+Zhangauthor=L.+J.+Wuauthor=H.+J.+Zuoauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Cytochrome+c+release+from+oridonin-treated+apoptotic+A375-S2+cells+is+dependent+on+p53+and+extracellular+signal-regulated+kinase+activation&doi=10.1254%2Fjphs.FPJ04008X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation</span></div><div class="casAuthors">Zhang, Chun-Ling; Wu, Li-Jun; Zuo, Hai-Jun; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">The authors have reported that oridonin isolated from Rabdosia rubescens induces apoptosis of human melanoma A375-S2 cells within 12 h.  In this study, TUNEL assay and flow cytometric anal. also indicate that one of the causes of A375-S2 cell death induced by oridonin was apoptosis.  The cell death was preceded by the release of cytochrome c from the mitochondria.  Twelve hours after treatment with oridonin, the ratio of Bax/Bcl-xL protein expression was increased and release of cytochrome c was decreased by an extracellular signal-regulated kinase (ERK) MAPK inhibitor (PD98059) and a phosphoinositide 3-kinases (PI3-K) inhibitor (wortmannin).  A mitochondrial permeability transition (MPT) inhibitor, decylubiquinone, suppressed the release of cytochrome c without affecting Bax expression.  The activation of p53 by oridonin was also blocked by wortmannin.  In addn., PD98059 and wortmannin significantly decreased oridonin-induced DNA fragmentation, but the p38 MAPK inhibitor (SB203580) did not alter DNA fragmentation.  Oridonin induced A375-S2 cell apoptosis by activating parallel p53 and ERK pathways, increasing the ratio of Bax/Bcl-xL protein expression, and promoting the release of cytochrome c into the cytosol, resulting in apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjfPu7IVXyQLVg90H21EOLACvtfcHk0ligJtne4FYYaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKgt78%253D&md5=d1213d7dc69096134bd06cb1276779af</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FPJ04008X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FPJ04008X%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DL.%2BJ.%26aulast%3DZuo%26aufirst%3DH.%2BJ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DCytochrome%2520c%2520release%2520from%2520oridonin-treated%2520apoptotic%2520A375-S2%2520cells%2520is%2520dependent%2520on%2520p53%2520and%2520extracellular%2520signal-regulated%2520kinase%2520activation%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D96%26spage%3D155%26epage%3D163%26doi%3D10.1254%2Fjphs.FPJ04008X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2009.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1016%2Fj.abb.2009.08.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2009&pages=70-75&author=Y.+Chengauthor=F.+Qiuauthor=Y.+C.+Yeauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Oridonin+induces+G2%2FM+arrest+and+apoptosis+via+activating+ERK-p53+apoptotic+pathway+and+inhibiting+PTK-Ras-Raf-JNK+survival+pathway+in+murine+fibrosarcoma+L929+cells&doi=10.1016%2Fj.abb.2009.08.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DY.%2BC.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DOridonin%2520induces%2520G2%252FM%2520arrest%2520and%2520apoptosis%2520via%2520activating%2520ERK-p53%2520apoptotic%2520pathway%2520and%2520inhibiting%2520PTK-Ras-Raf-JNK%2520survival%2520pathway%2520in%2520murine%2520fibrosarcoma%2520L929%2520cells%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D490%26spage%3D70%26epage%3D75%26doi%3D10.1016%2Fj.abb.2009.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Augmentation of oridonin-induced apoptosis observed with reduced autophagy</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1254/jphs.FPJ06003X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1254%2Fjphs.FPJ06003X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=16861822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFalsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=230-239&author=Q.+Cuiauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Augmentation+of+oridonin-induced+apoptosis+observed+with+reduced+autophagy&doi=10.1254%2Fjphs.FPJ06003X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Augmentation of Oridonin-induced apoptosis observed with reduced autophagy</span></div><div class="casAuthors">Cui, Qiao; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-239</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Our previous studies showed that oridonin could induce apoptosis in HeLa cells; and in this study, we further investigated autophagy induced by oridonin in HeLa cells and the relationship between apoptosis and autophagy.  HeLa cells were exposed with oridonin after 3-methyladenine (3-MA) pre-culture, and we evaluated the growth inhibitory ratio, morphol. changes, DNA fragmentation, proteins expression as well as autophagic and apoptotic levels.  Oridonin inhibited the proliferation of HeLa cells in vitro and induced autophagy.  Oligonucleosomal fragementation of DNA as well as increased activities of Bax proteins were induced by oridonin, but the expression of p-Bcl-2 protein was reduced.  In the condition of oridonintreatment, when the inhibitor of phosphoinositide 3-kinase (PI3K), wortmannin, was applied, the autophagic level was significantly decreased, while the apoptotic level was increased, indicating that PI3K is a key regulator of both autophagy and apoptosis.  Akt, down-stream factor of PI3K, was activated in autophagic process but suppressed in apoptosis in this study.  In addn., when autophagy was blocked by 3-MA, the expression of SIRT-1 was decreased, indicating SIRT-1 contributed to autophagy.  Taken together, oridonin simultaneously induced HeLa cell both apoptosis and autophagy in HeLa cells, and inhibition of autophagy contributes to upregulation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnmqdDBZ9UYLVg90H21EOLACvtfcHk0ligJtne4FYYaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFalsLw%253D&md5=1e9dd4a14ba3021b72d9653b3335f00e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FPJ06003X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FPJ06003X%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DAugmentation%2520of%2520oridonin-induced%2520apoptosis%2520observed%2520with%2520reduced%2520autophagy%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D101%26spage%3D230%26epage%3D239%26doi%3D10.1254%2Fjphs.FPJ06003X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1248/bpb.30.859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1248%2Fbpb.30.859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=17473426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlKlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=859-864&author=Q.+Cuiauthor=S.+Tashiroauthor=S.+Onoderaauthor=M.+Minamiauthor=T.+Ikejima&title=Autophagy+preceded+apoptosis+in+oridonin-treated+human+breast+cancer+MCF-7+cells&doi=10.1248%2Fbpb.30.859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells</span></div><div class="casAuthors">Cui, Qiao; Tashiro, Shin-ichi; Onodera, Satoshi; Minami, Mutsuhiko; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">859-864</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Recent studies have shown that MCF-7 cells undergo autophagy under some conditions, such as tamoxifen treatment and starvation.  In this study, we investigated autophagy in MCF-7 cells under oridonin treatment and further examd. the relationship between autophagy and apoptosis.  After 3-MA (the specific inhibitor of autophagy) pre-culture, MCF-7 cells were exposed to oridonin, and the growth inhibitory ratio, morphol. changes, DNA fragmentation, proteins expression, autophagic ratio and apoptotic ratio were evaluated.  Oridonin inhibited the proliferation of MCF-7 cells and induced autophagy in vitro.  MDC (a specific dye for autophagosome) recruitment and typical apoptotic features, including apoptotic bodies, membrane blebbing as well as nuclear condensation, were induced by oridonin.  Oridonin downregulated the phosphorylation of ERK, whereas those of JNK and P38 kinase were upregulated.  In the condition of oridonin treatment, 3-MA significantly reduced the autophagic level, and the apoptotic cell ratio was also declined.  Furthermore, combined treatment with oridonin and 3-MA upregulated ERK phosphorylation and downregulated JNK and P38 kinases phosphorylation compared with oridonin alone treatment groups, indicating that autophagy facilitated apoptosis in oridonin-induced MCF-7 cells.  In addn., 3-MA application downregulated DNA ladder and Bax expression but upregulated Bcl-2 expression, compared with oridonin alone treatment.  Taken together, oridonin simultaneously induced MCF-7 cells both apoptosis and autophagy, and in this settings, inhibition of autophagy induced lowered apoptotic level, therefore, autophagy participated in upregulation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxPzyRRDgaMLVg90H21EOLACvtfcHk0ligJtne4FYYaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlKlurY%253D&md5=2829fc94ebb5ea520184720390f93afc</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.859%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DAutophagy%2520preceded%2520apoptosis%2520in%2520oridonin-treated%2520human%2520breast%2520cancer%2520MCF-7%2520cells%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D859%26epage%3D864%26doi%3D10.1248%2Fbpb.30.859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejima, T.</span></span> <span> </span><span class="NLM_article-title">Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.1248/bpb.27.1527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=10.1248%2Fbpb.27.1527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=15467189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSit7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1527-1531&author=C.+L.+Zhangauthor=L.+J.+Wuauthor=S.+Tashiroauthor=S.+Onoderaauthor=T.+Ikejima&title=Oridonin+induces+a+caspase-independent+but+mitochondria-+and+MAPK-dependent+cell+death+in+the+murine+fibrosarcoma+cell+line+L929&doi=10.1248%2Fbpb.27.1527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929</span></div><div class="casAuthors">Zhang, Chun-Ling; Wu, Li-Jun; Tashiro, Shin-ichi; Onodera, Satoshi; Ikejima, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1527-1531</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Oridonin, an active component isolated from Rabdosia rubescences, has been reported to exhibit antitumor effects, but little is known about its mol. mechanisms of action.  In this study, the growth-inhibitory activity of oridonin for L929 cells is in time- and dose-dependent manner.  After treatment with various concns. of oridonin for 12 h, the majority of L929 cells underwent apoptosis as measured by an LDH activity-based assay.  Although apoptotic bodies were obsd. in oridonin-treated L929 cells, DNA fragmentation as a hallmark of apoptosis was not found.  The pan-caspase inhibitor, z-VAD, and caspase-3 inhibitor, z-DEVD, sensitized L929 cells to oridonin, however, a PARP inhibitor (DPQ) effectively blocked oridonin-induced cell death.  After 12 h treatment, PARP proenzyme was significantly cleaved.  This result indicated that oridonin-induced L929 cell death required PARP degrdn. in a caspase-independent manner.  In addn., an MEK/ERK inhibitor (PD98059) markedly blocked oridonin-induced cell death, whereas a p38 inhibitor (SB203580) and JNK inhibitor (SP600125) weakly protected the cells against death.  Treatment with 41.2 μM oridonin for 12 h induced significant and persistent ERK activation and p38 inactivation in L929 cells without evident changes in the protein levels.  The responsiveness of ERK and p38 to oridonin suggests the involvement of these kinases in this apoptotic process.  Moreover, oridonin increased the ratio of Bax/Bcl-2 protein expression, whereas it had no effect on the expression of Bcl-xL.  These results indicate that regulation of the Bcl-2 and MAPK families maybe the effector mechanisms of oridonin-induced L929 cell death, independent of the caspase pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolRKNoop7647Vg90H21EOLACvtfcHk0ljy8R3LrhhE-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSit7fN&md5=3d6c91c940184002d3edf4b980f202cd</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1248%2Fbpb.27.1527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.27.1527%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DL.%2BJ.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DOnodera%26aufirst%3DS.%26aulast%3DIkejima%26aufirst%3DT.%26atitle%3DOridonin%2520induces%2520a%2520caspase-independent%2520but%2520mitochondria-%2520and%2520MAPK-dependent%2520cell%2520death%2520in%2520the%2520murine%2520fibrosarcoma%2520cell%2520line%2520L929%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2004%26volume%3D27%26spage%3D1527%26epage%3D1531%26doi%3D10.1248%2Fbpb.27.1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01514">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45408"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01514">10.1021/acs.jmedchem.7b01514</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures showing the reactivity of oridonin and its derivatives with GSH determined by the <sup>1</sup>H NMR and HRMS, the reaction of representative aziridine compound and oridonin analogue, growth-inhibitory effects of the oridonin derivatives on MCF-7 and MDA-MB-231 cell lines, cell viability, microsomal and plasma stability, cell density, and <sup>1</sup>H and <sup>13</sup>C NMR spectra for the new compounds described in this paper. A table showing X-ray CIF file for compound <b>22</b>. Molecular formula strings. (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Crystallographic data for a selection of experimental compounds. (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_001.pdf">jm7b01514_si_001.pdf (10.52 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01514/suppl_file/jm7b01514_si_002.csv">jm7b01514_si_002.csv (1.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01514&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01514" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01514" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b395d7be13cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
